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There is consistent evidence that incidence rates of psychotic disorders 
vary in different geographical areas. The variation of the distribution of a 
disease can give clues to the role played by different risk factors. 
In Italy there are only a few epidemiological studies on psychosis. In this 
thesis I aimed to contribute by a) widening Italian epidemiological research 
on the incidence of psychoses and b) investigating the role of some of the 
putative risk factors associated with this group of disorders.  
Results in this thesis are presented in two parts. The first part reports 
incidence rates of psychoses in Palermo. I collected data on 204 first 
episode psychosis patients, presenting to the mental health services, over 
a period of 3 years in a well-defined catchment area of Palermo, Italy. I 
carried out an incidence study and I calculated crude and adjusted 
incidence rates of affective and non-affective psychoses. I compared the 
Palermo incidence data I acquired with the existing UK data from the 
AESOP study.  
My findings were consistent with the literature indicating that there is an 
increased risk for all psychotic disorders in males and in migrants. 
Incidence rates of all psychoses in Palermo were lower than in UK except 
for schizophrenia and the most striking difference was in the likelihood to 
develop affective psychoses which was significantly greater in UK.  
The second chapter of results describes the prevalence of some putative 
risk factors associated with the development of psychotic disorders, such 
as cannabis and other illicit drug consumption, family history of psychiatric 
disorders and psychosis, childhood traumatic experiences, adult adverse 
life events. I carried out a case control study on a subsample of 68 first 
episode psychotic patients and a sample of 74 healthy controls 
representative of the local population.  
Family history for psychiatric disorders was more common among patients 
than controls; cannabis consumption was higher among cases at the time 
of assessment. Patients were more likely than healthy controls to have 
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started to smoke cannabis before 15 years of age, and to report a higher 
frequency of use.  
Some experiences (having been injured or assaulted, having experienced 
having been expelled from school, running away from home, having been 
forced into authority care) and physical and sexual abuse in childhood 
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Organization of the thesis  
This Thesis comprises a total of 6 chapters.  
Chapter 1 is the Introduction that covers, through an examination of the 
literature, two main topics: the epidemiology of psychotic disorders and 
the risk factors associated with the development of psychoses.  
Chapter 2 describes the aims and the hypotheses.  
In Chapter 3 methods and statistical analyses are presented both for the 
incidence and for the case control parts of the study. 
Chapter 4 describes the results about incidence and chapter 5 the results 
about the case control analyses on the prevalence of risk factors for 
psychosis.  
Chapter 6 summarizes the findings of the research project discussing the 
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Chapter 1   
Definition, epidemiology and risk factors of psychotic 
disorders 
 
In this chapter I will describe the concepts of schizophrenia and psychosis 
and their current classification (paragraph 1.1), the epidemiology of 
psychotic disorders (paragraph 1.2) and the risk factors (paragraph 1.3). I 
then focus on the literature about risk factors associated with psychosis 
that will be explored in this work (paragraph 1.4) and the literature about 
epidemiology and risk factors in Italy (paragraph 1.5).  
To identify relevant papers on epidemiology of psychosis I searched 
PubMed and PsychINFO from 1980 to January 2015 using the 
combination of the following search terms: psychosis, incidence, 
schizophrenia, epidemiology, Italy. The same databases were used to 
search for papers on the risk factors associated with psychosis combining 
schizophrenia, psychosis, risk factors, aetiology, and then separately for 
each risk factor combining the specific key word (e.g. cannabis) and 
psychosis or schizophrenia. The literature search was then repeated 
introducing the term Italy or Italian for each risk factor under investigation.  
 
1.1 Introduction 
The term psychosis was introduced in the nineteenth century meaning 
“mental illness”, and indicated a heterogeneous group of diseases 
characterized by a loss of contact with reality, thought disorders, 
perceptual abnormalities such as hallucinations, emotional disorders, 
cognitive deterioration, lack of insight, motor and behavioural 
abnormalities.  
Kraepelin (1896) grouped under the term dementia praecox some 
conditions previously observed by other authors: hebephrenia, catatonia 
and paranoia. He described dementia praecox as a disorder 
characterized by an early onset, a deteriorating course with cognitive 
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impairment, delusions, hallucinations, emotional flattening. He 
distinguished this condition from manic-depressive psychosis. 
Subsequently Bleuler (1911) coined the term schizophrenia coming from 
the Greek word “schizein” “separating” and “frenos” “mind, to indicate a 
group of disorders not invariably characterized by a cognitive 
deterioration, but with a common central feature which was the “splitting 
of psychic functions”. He distinguished primary symptoms (indicated by 
the “4 As”: autism, associative disturbance, affective blunting, 
ambivalence) and secondary symptoms (delusions and hallucinations). 
Schneider (1950) described first rank symptoms in order to better 
characterize the diagnosis of schizophrenia from other psychotic 
disorders. The first rank symptoms were auditory hallucinations 
(commenting voices or arguing voices), thought interference (thought 
withdrawal, insertion, broadcasting), feelings impulses or acts 
experienced as being under external control, delusional perception. 
People with schizophrenia typically hear voices, often criticising or 
abusing them. The voices may speak directly to the patient, comment on 
the patient’s actions, or comment about the patient among themselves; 
people who hear voices often try to make some sense of these 
hallucinations, and this can lead to the development of strange beliefs or 
delusions. Many patients also have thought disorder and negative 
symptoms (affective flattening, alogia, avolition, anhedonia, attentional 
impairment) (Picchioni and Murray, 2007). 
During the last century operational criteria to define schizophrenia were 
developed. The first was the Present State Examination (PSE/CATEGO) 
(Wing, Cooper et al. 1974) based on Schneider’s first rank symptoms; 
then the Research Diagnostic Criteria (RDC, Spitzer, Endicott et al., 
1978), the International Classification of Diseases (ICD-10; WHO, 1992), 
and the Diagnostic and Statistical Manual of Mental Disorders DSM III, IV 
and 5 (American Psychiatric Association, 1980, 1994, 2013). 
Although many definitions of psychosis have been proposed, the 
diagnostic boundaries of schizophrenia and other psychosis remain still 
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uncertain and the categorical distinction between schizophrenia and 
bipolar disorder is unsatisfactory because of the incomplete knowledge 
about the aetiology and the pathogenesis of these disorders.  
Schizophrenia merges on one side with bipolar disorder and on the other 
with schizotypal and paranoid personality disorder (Murray and Dean, 
2008). Sometimes people affected by psychosis show a marked affective 
component and such conditions are often defined as schizoaffective 
disorders, but is not infrequent that people firstly diagnosed as affective 
psychosis are then re-categorised as affected by schizophrenia. 
A new conceptualization of psychosis is based on a “continuum model” 
according to which psychotic symptoms are on a continuum with normal 
mental states; recent research has pointed out that psychotic-like 
symptoms can be experienced by the general health population (van Os, 
Linscott et al., 2009). It has been observed that first degree relatives of 
patients affected by a psychotic disorders have a higher probability to 
show paranoid, schizoid or schizotypal characteristics together with some 
impairments in cognitive performances at an intermediate level between 
patients and normal controls (Murray and Dean, 2008).  
Schizophrenia onset is frequently placed in late adolescence or early 
adult life. Males have an earlier onset of schizophrenia than women and 
show a peak of incidence between 20 and 24 years while females show a 
peak between 29 to 32 years with a larger number of cases presenting 
later in life  (Lewine 1981; Castle, Sham et al. 1998; Hafner 2003). The 
AESOP study confirmed an earlier age at first presentation for all 
psychotic disorders in men (29.6 years) than women (32.6 years) 
(Kirkbride, Fearon et al. 2006). Females tend to have fewer negative 
symptoms and a better outcome than males.  
Some studies report an earlier age of onset of schizophrenia in those with 
a family history of psychosis (Albus, Schere et al., 1994; Byrne, Agerbo et 
al., 2002).  
The classification of psychotic disorders depends upon duration, type of 
symptoms and presence or absence of affective symptoms.  
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There are two main systems to classify psychotic disorders; the ICD-10 
(World Health Organization, 1992) and the DSM 5 (APA, 2013).  
These two systems differentiate psychotic disorders according to type 
and duration of symptoms and to the presence of affective symptoms.  
For example in the ICD-10 classification system (World Health 
Organization, 1992), one month of psychotic symptoms is sufficient to 
make a diagnosis of schizophrenia while in the DSM 5 symptoms have to 
last at least six months. 
Appendix I shows the current classification of psychotic disorders in ICD-
10 which will be used in this thesis as a classification system.   
Acute and transient Psychosis (ICD 10) or Brief Psychotic Disorder in 
DSM 5 lasts no longer than one month.  
Schizophreniform disorder in DSM 5 is diagnosed when psychotic 
symptoms persist between one and six months. 
Delusional disorder is characterized by a single delusion or of a set of 
related delusions which should persist for at least three months (ICD 10) 
or one month (DSM 5). The delusions may persist and vary in their 
content (paranoid, hypochondriacal, megalomaniac). Other 
psychopathology is typically absent except for transient and occasional 
auditory hallucinations and the subject usually performs well in all the 
areas not related to the delusion.  
Schizoaffective disorders are episodic disorders in which both affective 
and schizophrenic symptoms are prominent within the same episode of 
illness, simultaneously, or at least within a few days of each other. 
Schizoaffective disorder may be of depressive or manic type.  
When psychotic symptoms occur only in the context of a mood disorder 
which does not meet criteria for Schizoaffective Disorder, they are 
classified as Affective Psychosis.   
In the ICD 10, Affective Psychoses include: Bipolar disorder with 
psychotic features, Major Depressive Disorder with psychotic features, 
Mania with psychotic symptoms. The presence of psychotic symptoms 
which do not fit to any of the above categories will be diagnosed as Other 
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non Organic Psychotic Disorders or Unspecified Non Organic Psychosis 
in ICD 10. 
 
Table 1 shows the main diagnostic categories of psychotic disorders.  
Table 1: ICD-10 diagnostic category of psychotic disorders 
ICD-10 diagnostic category of psychotic disorders  
Non affective psychotic disorders:  
Schizophrenia (F20) 
Schizotypal disorder (F21) 
Delusional disorder (F22) 
Brief psychotic disorder (F23) 
Schizoaffective disorder (F25) 
Psychotic disorder not otherwise specified (F28–F29) 
Affective psychotic disorders:  
Bipolar disorder with psychotic features (F31.2, F31.5)  
Major depressive disorder with psychotic features (F32.3, F33.3) 
Mania with psychotic symptoms (F30.2) 
 
The definition of schizophrenia has changed through the six editions of 
the Diagnostic and Statistical Manual of Mental Disorders. The DSM IV 
construct of schizophrenia has a fair reliability and a high diagnostic 
stability; 80-90% of diagnosis of schizophrenia is confirmed after 1-10 
years (Tandon, Gaebel et al 2013).   
In the newest version of DSM 5 criteria for the diagnosis of schizophrenia 
have slightly changed.  
The note to criterion A considering bizarre delusions and Schneiderian 
“first rank” symptoms (conversing and commenting voices) as 
pathognomonic signs of schizophrenia has been deleted because they 
are not specific and they do not require special treatments. To confirm the 
diagnosis of schizophrenia, two of the five symptoms of the criterion A 
(delusions, hallucinations, disorganized speech, disorganized or catatonic 
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behaviour, and 5) negative symptoms) must be present, and at least one 
should be delusions, hallucinations or disorganized speech.  
The distinction in subtypes for schizophrenia (paranoid, disorganized, 
catatonic, undifferentiated, and residual) disappeared because it has 
been found unhelpful in establishing prognosis and treatment strategies 
Catatonia has been conceptualized as a separate diagnosis; it may occur 
in several conditions so it can be described as a specifier of other 
disorders “Catatonia associated to another mental disorder” (depression, 
bipolar disorder or psychotic disorders) or as a symptom in the context of 
another medical condition: “Catatonic disorder due to another medical 
condition”. The category “other specified Catatonic Disorder may be used 
when the underlying condition associated with catatonia is unknown 
(DSM 5, APA, 2013).  
The diagnosis of schizoaffective disorder requires a major mood episode 
to be present for a majority of the disorder’s total duration after Criterion A 
has been met. The diagnosis became longitudinal rather than episodic, 
taking into account the entire course of the disease (Malaspina, Owen et 
al. 2013).  
Delusional disorder has been distinguished from the psychotic variants of 
obsessive-compulsive disorder and body dysmorphic disorder.  
Further, the presence of bizarre delusions no longer represents an 
exclusion criterion for the diagnosis of delusional disorder; shared 
delusional disorder is no longer a distinct, separate disorder.  
Beside the traditional categorical classification, a dimensional approach 
has been introduced to help the individual assessment through the 
course of treatment and to improve the prediction of course and outcome. 
Section III of DSM 5 includes a dimensional approach to rate the severity 
of the core symptoms of schizophrenia to capture the important 
heterogeneity in symptom type and severity expressed across individuals 
with psychotic disorders (DSM 5, APA, 2013). 




Figure 1: comparison between DSM IV and DSM 5 diagnostic criteria for 
schizophrenia (Tandon, Gaebel et al. 2013).
 
 
1.2 Epidemiology of schizophrenia and other psychoses 
Despite its relatively low incidence (e.g. 15.2/100,000), the prevalence of 
schizophrenia (7.2/1000) (Saha, Chant et al. 2005) is relatively high, 
because it often starts in early adult life and becomes chronic (Picchioni 
and Murray, 2007).  
For many years it had been thought that the incidence of schizophrenia 
does not vary much across space and time, but according to more recent 
data we should replace this dogma with the evidence of a true 
geographical variation (McGrath, Saha et al. 2004).  
The absence of an epidemiological variation would represent an 
exception rather than a rule for any medical disease; it is well known that 
different biological and environmental risk factors underlying complex 
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diseases with a multi factorial aetiology such as schizophrenia play a role 
in modulating the distribution of the illnesses.   
The World Health Organization “Ten country study” (Jablensky, Sartorius 
et al. 1992) carried out a multicentre study in 8 sites. It found that the 
incidence of “broad” schizophrenia diagnosed by ICD-9 criteria was 
significantly different across sites ranging from 16 to 42 per 100,000. 
However, when “narrow” criteria were applied, the range decreased from 
7 to 14 per 100,000 person/years and, despite the twofold difference, 
they concluded that there was a uniform incidence of schizophrenia 
around the world (Sartorius, Jablensky et al., 1986; Jablensky, Sartorius 
et al., 1987, 1992). This contributed to the spread of a false idea that 
schizophrenia was considered as an “egalitarian” disorder without 
differences in terms of sex, time and place.  
This myth has been disconfirmed by a systematic review on the incidence 
of schizophrenia by McGrath and colleagues (2004) examining 158 
studies from 32 different countries in the world, showing that 
schizophrenia is characterized by prominent variation across time and 
place. Rates of the incidence of schizophrenia fall within a range of 7.7 to 
43.0 per 100,000, which is over a fivefold difference. The median value 
was 15.2 per 100,000 and it is about 40% greater in men than in women, 
and the rate ratio for males versus females was 1.4 (McGrath, Saha et al 
2004). In a review by the same research group, increased incidence rates 
in migrants compared to native-born population were reported. Higher 
median estimates were reported for those living in higher latitudes only 
for males (McGrath, Saha et al. 2008) 
Perhaps the most comprehensive epidemiological study so far is the 
Aetiology and Ethnicity in Schizophrenia and Other Psychosis (AESOP) 
study (Kirkbride, Fearon et al., 2006); this is a three-centre population-
based incidence and case control study of first episode psychosis (FEP), 
aimed at investigating the variation of the incidence of schizophrenia and 
other psychotic disorders in terms of place, ethnicity, age and sex. It 
showed a variation in incidence rates of schizophrenia and other 
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psychoses in the three study centres in England (London, Nottingham 
and Bristol); the overall incidence rate for all psychotic disorders was 32.1 
per 100,000 persons years across the three centers but it was 
significantly higher in South London (49.4 per 100,000 persons years) 
than in Nottingham (23.9 per 100,000 persons years) and Bristol (20.4 
per 100,000 persons years), confirming the observation that a higher 
gradient of urbanicity is associated with an increased risk of developing a 
psychotic disorder (Kirkbride, Fearon et al 2006).  
On the other hand, the Cavan-Monaghan study was carried on in a rural 
area of Ireland with a homogenous ethnic and socio-economic population 
characterized by a low social mobility. The incidence of psychotic 
disorders was 18.7/100,000 persons year (Scully, Quinn et al. 2002). 
Further, the incidence of schizophrenia can change over time (Allardyce, 
Morrison et al. 2000, Al Mousawi, Dunstan et al. 1998, Suvisaari, Haukka 
et al. 1999, Boydell, van Os et al. 2003). Boydell and colleagues 
demonstrated that the incidence of schizophrenia in South London 
doubled between 1965 and 1997. However, Kirkbride and colleagues 
examined the incidence of psychotic disorder in three different periods of 
time and they found out a substantial stability in the incidence of affective 
and non-affective psychoses but an increase of substance induced 
psychosis (Kirkbride, Croudace et al. 2009). 
A recent meta-analyses carried on published data between 1950 and 
2009 on the incidence of psychotic disorders in England confirmed the 
heterogeneity of incidence by sex, age, place and migration 
status/ethnicity. The authors found that the pooled incidence for all 
psychotic disorders was 31.7 per 100,000 person years, 23.2 for non-
affective psychosis, 15.2 for schizophrenia, and 12.4 for affective 
psychosis. The authors pointed out that the incidence of psychotic 
disorders tended to remain stable over the period considered (Kirkbride, 
Errazuriz et al., 2012).   
There are few data on the incidence of Bipolar Disorder. Lloyd and Jones 
reported a range of 2.6 to 20.0 per 100 000 per year (Lloyd and Jones, 
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2002). In the AESOP study the overall incidence of Bipolar Disorders  
across the three centers was 4 per 100,000 per year but in South East 
London it was more than double than in Nottingham and Bristol and the 
risk was fivefold higher in African-Caribbean and Black African compared 
to White people; no differences in incidence rates have been found in 
men and women (Lloyd, Kennedy et al. 2005). 
In San Paulo Brazil, Menezes and colleagues reported an incidence rate 
of psychoses of 15.8 per 100,000 per year for any psychotic disorder; this  
was lower than expected for a large metropolis (Menezes, Scazufca et 
al., 2007).  
The geographical incidence variation could be due to the different 
distribution of environmental and biological risk factors. There is now 
evidence concerning the role played by social factors such as urbanicity, 
migration, childhood adversities and social isolation, and by biological 
factors such as family history of psychosis, obstetric complications, 
substance abuse, advanced paternal age (Stilo and Murray, 2010).  A 
more detailed description of the risk factors for schizophrenia will follow in 
this chapter.  
 
1.3 Risk factors for psychotic disorders  
Psychotic disorders are currently interpreted as illnesses with a complex 
aetiology involving both genetic and environmental risk factors.  
Risk factors for psychotic disorders can be divided into biological and 
social (Stilo and Murray 2010). 
Among biological factors there are: 
• Genetic susceptibility 
• Advanced parental age 
• Pre and perinatal events often collectively termed obstetric 
complications  
• Viral infections  
• Exposure to illicit drugs  
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Social factors implicated in the development of psychotic disorders are: 
• Urbanicity 
• Migration 
• Childhood adversities 
• Adult adversities  
Discovering the complex aetiology of schizophrenia is still a challenge.  
The two major theories schizophrenia are the neurodevelopmental 
hypothesis and the dopamine hypothesis. Now the two hypotheses are 
beginning to integrate: early developmental factors interact with 
environmental and social pressures during childhood and adolescence 
and result in dopaminergic dysregulation that ultimately turns normal 
beliefs into delusions (Murray, Lappin et al. 2008).  
The dopamine hypothesis of schizophrenia was proposed over 40 years 
ago and it states that schizophrenia is associated with an excess of 
dopaminergic function in the brain. It derives from the evidence that all 
antipsychotics block dopamine D2 receptors whereas direct or indirect 
dopamine agonists elicit positive symptoms of schizophrenia (Murray, 
McDonald et al 2002). 
It has been observed that there is an excess of dopamine release in the 
striatum of people at ultra high risk of psychosis and in people affected by 
their first episode of psychosis (Howes, Montgomery et al.2007). 
Dopamine dysregulation is now postulated to be one of the final steps in 
a complex development cascade towards schizophrenia that starts early 
in life and which may be underlined by different mechanisms such as 
neurodevelopmental impairment, drug abuse, severe chronic social 
stress as shown in Fig 2.  
Different kinds of cerebral damage such as hypoxia, drug exposure, 
obstetric complications may cause a D2 dopamine receptor high affinity 
state, determining “dopamine super-sensitivity”. Dopamine super-




Mesolimbic dopamine system mediates the “attribution of salience” of 
external stimuli, that is the attribution of meaning to ideas and objects 
(Berridge and Robinson 1998) which will be represented as negative or 
positive, thus leading goal-oriented behaviour.  
A dysregulated hyperdopaminergic state is suggested to lead to an 
aberrant assignment of salience to normal stimuli and delusions 
represent a cognitive effort by the patient to make sense of these 
aberrantly salient experiences (Kapur 2003).  
In animal models, being reared in isolation alters dopamine function in the 
nucleus accumbens (Hall, Wilkinson 1998). In humans, subjects with a 
history of low maternal care show a higher release of striatal dopamine 
when exposed to psychosocial stressors as showed by a PET study by 
Pruessner and colleagues (Pruessner, Champagne, et al.2004).  
Chronic experiences of social adversities may lead to changes in the 
dopamine system via the hyperactivation of the hypothalamic-pituitary-
adrenal axis (HPA) (Lodge and Grace 2011). 
Thus, the two major theories of schizophrenia, the neurodevelopmental 
and the dopamine hypotheses may be integrated conceptualizing a 
common final mechanism implying a dopamine dysregulation which may 
be caused by the interplay of different environmental and genetic factors 
acting indifferent stage of life and finally flowing into a final common 
pathway (Di Forti, Lappin et al 2007; Howes and Murray 2013) (Fig. 2). 
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The next two paragraphs present an overview of the biological and the 
social factors associated to psychosis risk.  
 
1.3.1 Biological factors  
Schizophrenia has a genetic component. The role of genetic load in the 
development of psychosis is confirmed by twin studies. Many such 
studies have been carried out. For example, Cardno and colleagues 
reported that the concordance rates for schizophrenia in monozygotic 
twins was 42.6% and that monozygotic co-twins of schizophrenic patients 
were more likely to develop schizophrenia than the dizygotic co-twins 
(Cardno, Marshall et al. 1999). Adoption studies showed higher rates of 
schizophrenia among the adopted offspring of parents affected by 
schizophrenia than adopted offspring of healthy people (Tienari, 2004). 
However it is unlikely that genes directly determine the disease; they are 
more likely to play a role in creating a susceptibility possibly based on  
biological deficits; for example the first degree relatives of patients 
affected by schizophrenia may show subtle biological abnormalities such 
as delayed P300 potentials, abnormal eye movements, MRI 
abnormalities and poorer cognitive performances than healthy controls.  
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Since 2002 a number of susceptibility genes for schizophrenia have been 
reported. Recent research indicates genetic overlap between 
schizophrenia and neurodevelopmental disorders. Psychoses may be 
part of a continuum of a group of neurodevelopmental syndromes such 
as autism and learning disabilities that result in part from a combination of 
genetic and environmental effects on brain development and are 
associated with impairment of cognitive function (Owen, O’Donovan et al., 
2011).  
Recently a systematic analysis of genome-wide association data by the 
Schizophrenia Working group of the Psychiatric Genomics consortium 
found out that genetic risk is conferred by a large number of alleles of 
small effect. They identified 108 independent genomic loci significantly 
associated to schizophrenia; genes identified are related to dopamine 
receptor DRD2 and glutamatergic neurotrasmission providing initial clues 
on the pathophysiology of schizophrenia (Ripke, Neale et al. 2014). Other 
studies have shown that a small proportion of schizophrenia (possibly 
about 3%) is due to copy number variants (Kirov, Holmans et al., 2011).  
Advanced paternal age is a risk factor for schizophrenia in the offspring 
(Malaspina, Harlap et al. 2001; Torrey, Miller et al.1997). Some studies 
suggest that increased mutations in older paternal germ cells may 
increase the risk of schizophrenia (Malaspina, Harlap et al. 2001).  
Zammitt and colleagues (Zammitt, Allebeck et al. 2013) tested the 
hypothesis that premorbid schizoid or schizotypal personality traits of 
older fathers could represent a confounder of the association of advanced 
paternal age and schizophrenia but they concluded that older aged 
fathers did not show more schizophrenic traits than controls, so that the 
association is more likely explained by a mechanism of DNA aging. On 
the other hand, there are several recent studies saying that de novo 
mutations of DNA can’t explain the relationship between paternal age and 
the risk of schizophrenia; some authors concluded that the association 
between increased paternal age and the risk of schizophrenia depends 
on the father’s age at the time of his first child rather than the age at child 
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birth disconfirming the putative role of DNA aging (Pedersen, Mortensen 
et al. 2013).  
Population based studies meta-analysis has shown an association 
between obstetric complications and schizophrenia (Cannon, Jones et 
al. 2002). The obstetric complications can be divided into three 
categories: complications of pregnancy, abnormal foetal growth and 
development and complication of delivery. 
Exposure to obstetric events especially hypoxia increases the risk of 
schizophrenia. Such events may impact on the brain structure (Stefanis, 
Frangou et al. 1999; Cannon, van Erp et al. 2002) and on the dopamine 
system (El-Khodor and Boksa 2001). Two meta-analyses confirmed the 
association between obstetric complications and schizophrenia with an 
OR of approximately 2 (Geddes, Lawrie et al 1995; Verdoux, Geddes et 
al. 1997). 
It has been reported that there is an excess (7-10%) of winter-springs 
births among schizophrenic patients in the Northern hemisphere (Torrey, 
Miller et al., 1997). This could be due to prenatal exposure of mothers to 
pre and postnatal viral infections that may impact on foetus 
development. Prenatal exposure to influenza in the second trimester has 
been reported to be associated with an increased risk of schizophrenia in 
the offspring (Mednick, Machon et al.,1988; Byrne, Agerbo et al., 2007) 
but the results remain inconsistent because they have not been fully 
replicated in all the research studies. 
Other infectious agents may be implied in increasing the risk of 
developing a psychotic disorder such as rubella, herpes simplex and 
toxoplasma (Murray and Dean 2008) but these data are controversial; 
according to Khandaker and colleagues prenatal exposure to herpes 
simplex or cytomegalovirus is not associated to an increased risk of 
psychosis (Khandaker, Zimbron, et al. 2013). 
Also non infectious environmental conditions as poor maternal 
malnutrition (Susser, Hoek et al., 1998), diabetes (Cannon, Jones et al., 
2002), smoking (Sacker, Done et al., 1995) and rhesus incompatibility 
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(Hollister, Laing et al., 1996) may increase the risk of developing a 
psychotic disorder but none of them can be considered as a proven risk 
factor. A later exposure to infection has been associated to a higher risk 
of schizophrenia. A recent meta-analysis reported an increased risk of 
schizophrenia in people exposed to viral infection of the central nervous 
system (CNS) during childhood; it could be a direct effect of the virus on 
the CNS or the inflammatory response in the brain (Khandaker, Zimbron, 
et al. 2012). For example early exposure to Epstein Barr virus (EBV) is 
associated to psychotic experiences in adolescence (Khandaker, Stochl, 
et al. 2014).  
Imaging studies show structural brain changes such as increased 
ventricular size and decreased cortical grey matter volume especially in 
the hippocampus, amygdala and thalamus in subjects with schizophrenia 
in some schizophrenic patients (Wright, Rabe-Hesketh et al., 2000).  
These are often present since the time of onset suggesting that they can 
be the result of abnormal neurodevelopment (Gilmore, 2006; Nosarti, Al-
Asady et al., 2002) but some structural changes in the amygdale–
hippocampal complex may appear after the onset of psychosis 
(Velakoulis, Wood et al. 2006) and some structural abnormalities may 
worsen during the course of the illness.  
Pantelis and colleagues demonstrated that subjects at risk for 
development of psychosis had grey matter abnormalities prior to 
development of psychosis, but they found additional reductions in grey 
matter when some of the subjects were rescanned following development 
of a psychotic illness (Pantelis, Velakoulis et al., 2003).  
Job and colleagues found that high risk individuals who later developed 
schizophrenia showed particular reductions in grey matter in the period 
immediately prior to development of psychosis (Job, Whalley et al., 
2005). 
It is still unclear whether structural abnormalities represent ongoing 
neurodevelopmental and degenerative changes or they are influenced by 
the antipsychotic treatment (Zipursky, Reilly and Murray 2012). Typical 
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antipsychotics seem to affect brain morphology to a larger extent 
compared to the atypicals (Lieberman, Tollefson et al 2005, Dazzan, 
Morgan et al. 2005). Brain abnormalities may be determined by genetic 
factors which might impact on the neurodevelopment with a further effect 
played by environmental factors damaging the brain (Murray and Dean 
2008).  
Substance abuse (especially stimulants and cannabis consumption) has 
been associated to an increased risk of developing psychosis.  
Drug induced psychosis has deepened the understanding of the complex 
aetiology of schizophrenia. Research into the effects of LSD provided the 
basis for the serotoninergic model, amphetamines for the dopamine 
hypothesis, PCP and ketamine for the glutamatergic hypothesis 
(Paparelli, Di Forti, et al., 2011).  
In animal models, repeated exposure to drugs such as amphetamines 
and cocaine induces dopamine sensitization. Repeated exposure to 
cannabis induces sensitization to amphetamine in rats (Gorriti, Rodriguez 
de Fonseca 1999) and some studies suggest dopamine release in 
humans (Voruganti, Slomka et al 2001). 
The availability, type and patterns of illicit drugs abuse vary across 
different geographical areas; so there might be a difference in the impact 
of substance of abuse in the development of a psychotic disorder. 
Amphetamine-induced psychosis was described in the 1950s (Tatetsu, 
Goto et al., 1956). It was reported that amphetamine administration 
produced paranoid states in healthy subjects (Angrist, Sathananthan et al 
1974) and could exacerbate psychotic symptoms in schizophrenics 
(Lieberman, Kane et al., 1987).  
The observation that experimental amphetamine administration 
stimulates the release of dopamine in the striatum and that antipsychotics 
block psychotic symptoms induced by amphetamines provided the basis 
for the dopamine hypothesis of schizophrenia (Snyder, 1972). 
Also metamphetamine users developed positive symptoms resembling 
those found in schizophrenia (paranoia, suspiciousness, disorganization 
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of thoughts, auditory hallucinations, lack of insight, anxiety increased 
motor activity) (Chen, Lin et al. 2003). Schizophrenia spectrum disorder 
and amphetamine-induced psychosis seem to share a degree of common 
vulnerability that may be determined by genetic factors. Chen and 
colleagues found that the probability to develop a methamphetamine 
induced psychosis, its duration and severity, were influenced by individual 
psychosis proneness and family history for psychotic disorders; earlier 
and greater use was associated to an increased risk (Chen, Lin et al.  
2003).  
Most cases of metamphetamine psychosis recover after ceasing drug 
consumption; however in a proportion they do not  remit so readily if ever; 
relapses may occur after a further abuse or even triggered by social 
stress (Murray, Paparelli et al. 2013). Although amphetamine psychosis 
has been considered as a distinct entity from schizophrenia, a recent 
large cohort study found a nine-fold increased risk of developing 
schizophrenia in metamphetamine users (Callaghan, Cunningham et al 
2012). 
Amphetamines and metamphetamines probably act via dopamine 
sensitization; repeated amphetamine administration in healthy humans 
produces greater dopamine release in the striatum and behavioural 
response even one year after the first experimental administration 
(Boileau, Dagher et al. 2006). 
According to a recent meta-analysis patients with a first episode of 
psychosis have a higher prevalence of tobacco use, they start to smoke 
before the onset and are more likely to smoke than controls (Gurillo, 
Jauhar et al. 2015).  
The association of cannabis exposure and psychosis will be described in 
details in paragraph 1.4.  
 
1.3.2 Social factors  
From the mid-1980s schizophrenia was largely conceptualized as a 
neurodevelopmental disorder, however during the past decades there 
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has been a renewed interest in the role played by social factors in the 
aetiology of psychosis. Urbanicity, migration, childhood abuse and 
adversities and discrimination represent risk factors for the development 
of psychotic disorders (Sharpley, Hutchinson et al. 2001; Pedersen and 
Mortensen 2001; Stilo, Di Forti et al. 2013) even though the exact 
mechanism by which they increase the risk is still unclear. It is possible 
that psychosocial factors exerting their role in different stage of life may 
increase the risk of developing psychosis in vulnerable individuals (e.g. 
with a genetic susceptibility or with early neurodevelopmental 
abnormalities). Some suggest that social adversities appear to act in 
cumulative way e.g. being unemployed, single, living alone having poor 
education and having no close friends are associated with an increased 
risk of psychosis (Murray, Lappin et al. 2008). 
Urbanicity has been associated with the risk of developing 
schizophrenia.  
In 1939 Faris and Dunham reported higher admission rates of 
schizophrenia in the most urbanized areas of Chicago. Further, they 
noted that the incidence was higher in more disorganised areas where 
people were more isolated (Faris and Dunham, 1939).  
Incidence rates of schizophrenia vary within the same country between 
rural and urban population (Fuller Torrey, Bowler et al. 1997; Allardyce, 
Kelly et al. 2001; McGrath, Saha et al. 2008) and being born or being 
brought up in a city increases the risk of developing schizophrenia. There 
is a dose-response relationship because the larger the town and the 
longer the individual has lived there, the greater the risk (Mortensen, 
Pedersen et al. 1999; Krabbendam and van Os 2005; Pedersen and 
Mortensen 2001). Those differences have not been found for manic 
depression. 
Two main hypotheses have been formulated to explain this phenomenon. 
One is that of the “drift” hypothesis: it might be that people already prone 
to develop a psychotic disorder could move in more urbanized and 
anonymous areas; another explanation is that living in more urbanized 
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cities exposes the individuals to other risk factors for psychosis such 
social isolation and lack of social cohesion.  
The urbanicity excess has been confirmed by studies carried on in 
Northern Europe countries such as in Sweden (Lewis, David et al. 1992), 
Denmark (Mortensen, Pedersen et al. 1999) and in UK. In the AESOP 
study the incidence of all psychotic disorders in South London was 
double than in Nottingham and Bristol (Kirkbride, Fearon et al., 2006; 
Morgan, Dazzan et al. 2006) and within South East London it was higher 
in areas with lower social cohesion (Kirkbride, Fearon et al. 2007).  
However a recent study run in a rural area in UK (SEPEA study), reported 
a higher psychosis morbidity than expected: 45.1/100 000 person-years 
(Kirkbride, Stubbins et al. 2012).  
The way urbanicity impacts on the risk of schizophrenia is still unclear but 
it seems that some factors at an individual (social isolation) (Thornicroft, 
Bisoffi et al. 1993; Boydell, van Os et al 2004, Morgan, Burns et al. 2007) 
and at the neighbourhood level (Kirkbride, Fearon et al. 2007) may play a 
role in increasing the risk.  
The other social factors thought to be associated to psychosis risk 
(migration, exposure to childhood and adult adversities) explored in this 
work will be described in detail in the next paragraph.  
 
1.4 Risk factors for psychoses on which this Thesis will focus  
In this paragraph I will describe in details risk factors associated to 
psychosis risk which will be explored in this work.   
Many studies reported gender differences in psychotic disorders. The 
incidence of schizophrenia is higher among males than females and two 
meta-analyses showed that the male-female risk ratio was around 1.4 
(Aleman, Kahn et al. 2003; McGrath, Saha et al. 2004; Ochoa, Usall et al. 
2012 ).  
Data from the AESOP study also report a higher incidence of 
schizophrenia among men with an incident risk ratio of 2.3, while affective 
psychoses occurred equally in both sexes (Kirkbride, Fearon et al. 2006).  
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Gender differences in schizophrenia might reflect the differential 
proneness of men and women to two different subtypes of schizophrenia 
presenting in different stages of life; men might be more vulnerable 
towards neurodevelopmental disorders while women are more likely to 
develop a psychotic disorder with an affective component than males 
(Castle, Sham et al. 1994).  
Another explanation takes into account the role of protective or 
precipitating factors; women tend to show a later onset of psychotic 
disorders and this might be due to the declining of the protective effect 
exerted by oestrogens (Häfner, Riecher-Rössler et al. 1993; Häfner 
2015).  
Family history of psychosis in a first degree relative is a well-
established risk factor for schizophrenia and other psychosis (Helenius, 
Munk-Jørgensen et al. 2012). It is a proxy of the genetic load of the 
disease. The lifetime risk of schizophrenia is higher among first-degree 
relatives of people affected by the disease (Kendler, McGuire et al., 
1993). Patients with a higher familial load of psychosis have an earlier 
age of onset of the disorder compared to those without (Suvisaari, 
Haukka et al. 1998). 
Patients affected by schizophrenia are also more likely to have one or 
more first-degree relatives affected by any psychiatric disorder than 
healthy individuals (Byrne, Agerbo et al. 2002).  
There is evidence that the incidence of all psychoses is higher in migrant 
and minority ethnic populations in a number of countries (Cantor-Graae 
and Selten, 2005; Morgan, Charalambides et al. 2010; Veling and 
Susser, 2011; Veling, 2013). 
In 1932, Ødegaard reported high admission rates for schizophrenia 
among Norwegian migrants in the US (Ødegaard, 1932). A meta-analysis 
of population-based studies confirmed a higher incidence of 
schizophrenia among first generation migrants and ethnic minority groups 
with a mean relative risk of 2.7 (95% CI 2.3-3.2), especially for black 
migrants moving to European countries. The risk was higher in people 
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coming from developing countries and for those who were black skinned 
among a white population. The relative risk was even higher for second-
generation migrants, OR 4.5 (Cantor-Graae and Selten, 2005). 
African-Caribbean and Black African people resident in UK show a higher 
incidence of psychosis when compared to the host population (Harrison, 
Owens et al., 1988; van Os, Castle et al., 1996; Harrison, Glazebrook et 
al., 1997; Bhugra, Leff et al., 1997; Sharpley, Hutchinson et al., 2001). In 
the AESOP study the incidence of schizophrenia across the three centres 
involved was 9 fold higher in African-Caribbeans and 6 fold higher in 
Black Africans than in the White British population (Fearon and Morgan 
2006); they also found a higher incidence rate for mania in both ethnic 
groups. However, when incidence studies were carried out in the 
Caribbean countries, the excess of psychosis for this population found in 
the UK was no longer observed (Bhugra, Hilwig et al., 1996, Mahy, 
Mallett et al. 1999). 
Higher incidence rates of psychosis have been observed among other 
ethnic minority groups in the Netherlands (Selten, Veen et al., 2001) in 
Denmark (Cantor-Grae, Pedersen et al., 2003), in Sweden (Zolkowska, 
Cantor-Grae et al., 2001) and in Italy (Tarricone, Mimmi et al 2012; 
Lasalvia, Bonetto et al. 2014). 
Other studies have also shown a higher incidence of affective psychosis 
in migrant groups (Bebbington, Hurry et al., 1981; Lloyd, Kennedy et al., 
2005). 
However, the increase in the incidence rates for migrant groups 
disappears when studies are carried out in the country of origin (Bhugra, 
Hilwig et al., 1996; Hickling, Rodgers-Johnson et al. 1995, Mahy, Mallett 
et al., 1999); all these data show that migration, and not belonging to a 
certain ethnic group per se, could represent a risk factor associated to 
psychotic disorders possibly as a consequence of social discrimination. It 
has been reported that migrants are especially vulnerable if relatively 
isolated in localities where their own ethnic group represent a small 
minority (Boydell, van Os et al., 2001) and this might be explained by an 
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increased exposure to racial discrimination in areas with low density of an 
ethnic minority group. Social disadvantage has been associated to the 
risk of psychosis. In the AESOP study some ethnic minorities such as 
Black Caribbeans in South East London were more exposed to social 
disadvantage than White British  (Morgan, Kirkbride et al., 2008).  
Belonging to an ethnic minority group in a foreign country is postulated to 
increase the risk of developing schizophrenia probably through the effect 
of social discrimination and social defeat. Some suggest that exposure to 
social discrimination for any reason e.g. sexual orientation, appearance 
or handicap is associated with an increase of psychotic symptoms in 
general population (Janssen, Hanssen et al. 2003). 
Experiences of discrimination may contribute to the creation of a paranoid 
attributional style that facilitates the development of psychotic symptoms 
(Garety, Kuipers et al. 2001); even in healthy people, perceived 
discrimination predicts the development of psychotic symptoms (Janssen 
Hanssen et al. 2003).  
Recent studies suggest childhood adversities such as physical, sexual, 
psychological abuse and neglect represent risk factors for the 
development of psychotic symptoms.  Parental loss or permanent 
separation from parents before age 16 is associated with a more than 
threefold increase in the risk of developing psychosis in adulthood 
(Morgan, Kirkbride et al 2006); living in a single-parent household (Wicks, 
Hjern et al., 2005) or being institutionalised (Bebbington, Bhugra et al., 
2004) increase the risk.  
According to the World Health Organization (WHO), child maltreatment 
includes all forms of physical and emotional maltreatment, sexual abuse, 
neglect, and exploitation that result in actual or potential harm to the 
child’s health, development or dignity. Within this broad definition, five 
subtypes can be distinguished – physical abuse; sexual abuse; neglect 
and negligent treatment; emotional abuse; and exploitation (WHO, 1999). 
Unfortunately these kinds of abuse often coexist.  
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There is still some controversy about child abuse being a risk factor for 
psychotic disorders. Several large population-based studies have found 
associations between various types of early trauma and psychosis-like 
experiences in adulthood and others have reported a relatively high 
prevalence of childhood abuse in samples of patients with psychotic 
symptoms (Fisher, Morgan et al. 2009). Three reviews analysed the 
association between childhood abuse and psychosis. Read and 
colleagues found a prevalence of either sexual and physical abuse of 
59% in males and 69% in females affected by a psychiatric disorder 
(Read, van Os et al. 2004), however Morgan and Fisher (2007) 
recalculated the weighted prevalence focusing only on those studies 
considering psychotic patients and excluding adolescents. They found a 
lower prevalence of either one or another type of abuse of 50% in both 
males and females. Girls were more exposed to sexual abuse, while the 
prevalence of physical abuse was almost the same in males and females. 
They concluded that the evidence for a role of childhood trauma on 
psychosis was controversial also because of methodological limitations of 
previous studies. The impact of the abuse experience in childhood may 
be influenced by gender. Fisher and colleagues report an association 
between severe physical and sexual abuse and the risk of psychosis in 
women but not in men (Fisher, Morgan et al. 2009). They also indicated a 
specificity of the type of abuse, finding that patients affected by psychosis 
were 3 times more likely to report severe physical abuse from their 
mothers compared to healthy controls (Fisher, Jones et al., 2010). 
Two recent meta-analyses support the association between childhood 
adversities and psychosis (Matheson, Shepherd et al. 2012; Varese, 
Smeets et al. 2012). Varese and colleagues reported an increased risk of 
developing psychosis when children were exposed to traumatic 
experiences (abuse, neglect, parental death, bullying) with an OR of 2.8 
excluding parental loss; Matheson and colleagues confirmed this 
association finding an OR of 3.6. These meta-analyses failed to find 
specificity for different types of adversities. 
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Several studies report that when an individual is exposed to an increasing 
number and frequency of abuse, there is a dose-response mechanism in 
increasing the risk of developing psychosis (Janssen, Krabbendam et al. 
2004; Shevlin, Houston et al., 2008).   
Recent research focused on the role of the exposure to bullying during 
childhood and the risk of psychosis. Bullying is a common form of early 
victimisation and it is associated with a wide range of mental health 
problems in adolescence (Arseneault, Bowes et al., 2010) as well as sub-
clinical psychotic symptoms (Arseneault, Cannon et al., 2011; Campbell 
and Morrison, 2007; Fisher, Schreier et al., 2012; Lataster, van Os et al., 
2006). However the association of being bullied in childhood and 
psychosis risk is still controversial. Trotta and colleagues observed that 
people affected by a first episode of psychosis were more likely to report 
bullying victimisation when compared to healthy controls (Trotta, Di Forti 
et al., 2013).  
The mechanism by which childhood trauma increases the risk of 
psychosis is not completely understood yet. One hypothesis is that child 
abuse produces enduring changes in the Hypothalamus-Pituitary Adrenal 
(HPA) axis which interacts with the dopamine system. 
Research has been complicated by the fact that it is not easy to have a 
precise estimate of the abuse occurring in the general population 
because only a small proportion of maltreatment is regularly reported to 
the authorities (Theodore, Dunyan, 1999). The World Report on Violence 
and Health (WHO, 2002) state that childhood sexual abuse occurs in 
20% of women and in 5-10% of men (Finkelhor, 1994). There are some 
variations in the diffusion of the phenomenon that are context and 
culturally based.  
According to the vulnerability-stress model (Nuechterlein and Dawson, 




Data from the Camberwell Collaborative Psychosis Study confirmed an 
excess of life events preceding the onset of psychoses of all types 
(Bebbington, Wilkins et al., 1993). 
Life events, defined as situations that bring about a positive or negative 
change in personal circumstances or involve an element of threat, are 
associated to increased relapse rates and exacerbation of symptoms in 
psychotic patients (Bebbington, Wilkins et al. 1993; Ventura, Nuechterlein 
et al., 2000) and may trigger psychotic symptoms in general population 
(Johns, Cannon et al 2004; Wiles, Zammitt et al., 2006). In the second 
British National Survey of Psychiatric Morbidity, Bebbington and 
colleagues found a higher prevalence of victimization experiences (sexual 
abuse, bullying, to be taken into local authority care, violence at home or 
at work, running away from home, time spent in a children’s institution, 
being expelled from school, being homeless, having experienced serious 
illness, injury o assault) among people affected by psychotic disorders. 
They found that some of these experiences were associated to psychotic 
disorders. The highest risk was reported for sexual abuse (Bebbington, 
Bhugra et al., 2004). 
A recent meta-analysis of 16 studies confirmed a positive association 
between adverse adult life events and onset of psychotic disorder with an 
overall weighted OR of 3.19. Further, adverse life events were associated 
to the occurrence of psychotic symptoms in the general population. In the 
clinical studies, cases affected by psychosis were 2 to 8 times more likely 
to report life events in the period preceding the onset, ranging from 3 
months to 3 years prior to the onset (Beards, Gayer-Anderson et al., 
2013).  
The mechanism by which the exposure to life events may increase the 
risk of psychosis is not fully understood. There can be an influence of 
stressful events on the hypothalamic-pituitary adrenal axis HPA and 
subsequently on the dopamine system or there might be a genetic-
environmental interaction between stress and genetic susceptibility 
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(Howes and Murray, Lancet 2014). Further studies are needed in order to 
clarify the nature of this association. 
Cannabis exposure has been associated to an increased risk of 
developing psychosis. Cannabis is the most popular illicit drug worldwide 
and it has been considered a “light” drug for many years. Although most 
people who smoke cannabis do not  become psychotic, evidence from 
the literature supports an association between cannabis use and an 
increased risk of developing a psychotic disorder (Henquet, Murray et al. 
2005; Moore, Zammit et al 2007).  
The main psychoactive component of cannabis is delta-9-
Tetrahydrocannabinol (THC); it is responsible of the psychotogenic effect 
of cannabis. The other main constituent of cannabis is cannabidiol (CBD) 
which has anti anxiety and antipsychotic properties, and seems to 
“balance” the psychotogenic effect of THC (Di Forti. Morgan et al., 2009; 
Bhattacharyya, Morrison et al., 2010). 
Recently, high potency varieties of cannabis such as “skunk” have 
become available in the market over much of Europe. Such varieties of 
cannabis contain a high concentration of THC and a lower proportion of 
CBD which seems to “balance” the psychotogenic effect of the former (Di 
Forti, Morgan et al., 2009; Bhattacharyya, Morrison et al. 2010). 
Cannabis intoxication can cause brief psychotic episodes or may 
exacerbate pre-existing psychotic symptoms (Thornicroft 1990; Mathers 
and Ghodse 1992). It has been shown that healthy people who are 
administered THC intravenously were more likely to develop transient 
psychotic like experiences and that THC worsens psychotic symptoms in 
people suffering from psychosis (D’Souza, Perry et al. 2004). THC exerts 
its psychotogenic role by modulating the dopamine neurotransmission, 
involved in development the psychotic symptoms. 
The first report suggesting that cannabis might be a risk factor for 
psychosis was the Swedish Conscript study. This was a 15 year follow up 
of a cohort of 45.570 conscripts into the armed forces. The risk of 
schizophrenia was 2.3 fold higher among subjects who had used 
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cannabis by 18 years and there was a dose response relationship as the 
risk of developing schizophrenia was even higher in those who had 
smoked cannabis more than 50 times (Andreasson, Allebeck et al., 
1987). 
A series of cohort studies have shown that cannabis use generally 
predates the psychosis (Arseneault, Cannon et al., 2002, 2004; Zammitt, 
Allebeck et al., 2002; van Os, Bak et al., 2002; Fergusson, Horwood et 
al., 2003). The Dunedin cohort study showed that children and 
adolescents who had used cannabis by the age of 15 years were 4.5 
times more likely to develop schizophreniform psychosis at the age of 26 
years (Arseneault, Cannon et al., 2002). 
van Os and colleagues reported a three times higher risk of developing 
psychotic symptoms in the general population associated to cannabis 
consumption in the NEMESIS study (van Os, Bak et al. 2005) 
Two meta-analyses (Henquet, Murray et al. 2005; Moore, Zammit et al. 
2007) concluded that cannabis consumption was associated with 
approximately two-fold increased risk of developing a psychotic disorder. 
Individuals who had shown any evidence of psychosis proneness appear 
especially vulnerable, as those who start use of cannabis in early 
adolescence. A meta-analysis by Large and colleagues supported the 
association between cannabis consumption and an earlier age at first 
presentation of psychosis (Large, Sharma et al., 2011). Other studies 
confirmed that cannabis use is associated to an earlier age at first 
presentation of schizophrenia and that there is an interaction between 
cannabis use and gender difference in age at first presentation; the 
difference by gender in age at first presentation is reduced in cannabis 
users (Donoghue, Doody et al., 2014).  
Recent evidence shows that high potency cannabis and higher frequency 
of use are associated with a higher risk of developing psychosis (Di Forti, 
Morgan et al., 2009).  
Only a small proportion of cannabis users develop psychotic symptoms or 
schizophrenia. It is thought that some individuals may have a genetic 
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susceptibility to develop psychosis if the are cannabis users; for example 
they might be carrier of particular polymorphism in candidate genes which 
are implied in the dopamine neurotransmission or catabolism. An initial 
finding reported an association between exposure to cannabis and a 
functional polymorphism in the COMT gene, which has a role in the 
catabolism of dopamine in the prefrontal cortex (Caspi, Moffitt et al., 
2005; Henquet, Rosa et al., 2006).  
Other studies report the role of a polymorphism of the gene AKT1, 
involved in the dopamine neurotransmission in influencing the risk of 
cannabis use in causing psychosis (Thiselton, Vladimirov et al., 2008; 
Bolog, Kiss et al. 2012; van Winkel, van Beveren 2011; Di Forti, Iyegbe et 
al 2012). However these results need to be further replicated.  
 
1.5 Incidence and risk factors of psychosis in Italy  
In Italy there are few available data on the incidence of psychotic 
disorders.  
A case register study carried out in Verona, Italy, reported an incidence of 
schizophrenia and related psychoses of 11 per 100,000 person/years.  
Data were collected by the South-Verona Psychiatric Case Register 
(PCR) over a ten-year period (1979-1988). The rate of schizophrenia and 
other functional psychoses was 9.9 per 100,000 per year. Rate of 
affective psychoses was 4 per 100,000 per year which was lower than 
those reported by other case-registers in Europe suggesting that this 
could possibly be due to a major role in the treatment of affective 
disorders carried out by Italian general practitioners (Tansella, Balestrieri 
et al. 1991). 
Another case register study conducted over a 8 year period (between 
1982 and 1989) in Portogruaro, in north-eastern Italy, collected 
information on the access to mental health services (inpatient services, 
community services, private mental hospitals and forensic hospitals) by 
the residents aged 15-64 years affected by schizophrenia and other non 
affective psychosis. The authors reported incidence rates for 
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schizophrenia of 17 per 100,000 per year for both males and females 
considering first ever contact with psychiatric services. Males had an 
earlier contact with psychiatric services compared to females but there 
were no differences in incidence rates by gender (de Salvia, Barbato et 
al. 1993). This study did not report the incidence for affective psychotic 
disorders.  
Case register studies have been useful tools in psychiatric epidemiology. 
They are suitable for relatively rare disorders but they have some 
limitations: information quality may be influenced by the lack of 
standardized assessment and the diagnosis might be unreliable (Perera, 
Soremekun et al. 2009).  
Preti and Miotto (2000) reported first admission rates to Italian psychiatric 
wards of patients affected by schizophrenia, affective psychoses and 
other non-affective psychoses. They used first admission rates as an 
estimate of incidence rates over a ten-year period (from 1984 to 1994). 
They reported a rate of schizophrenia ranging from 6 to 8.8 per 100,000 
person/year, from 5.7 to 7.8 per 100,000 for other non-affective 
psychoses, from 3.3 to 8 per 100,000 for affective psychoses. However 
this study is based on data published on the Italian National Institute for 
Statistics (ISTAT) in the health-care statistics yearbooks; as the authors 
outlined, they reported just a crude measure of incidence based on 
admission to psychiatric services and they were aware about the possible 
underestimation or overestimation of true rates and about the 
unavailability of age and gender standardised rates. They also pointed 
out an excess of admission rates for schizophrenia compared to those of 
depressive disorders, as an opposite trend respect to other countries 
admission rates. They hypothesized that patients affected by depression 
could be more likely admitted to private mental health facilities or to non-
psychiatric structures (Preti and Miotto, 2000).   
More recently, two studies reporting incidence rates have been published. 
These studies collected data on patients affected by a first episode of any 
psychosis disorder presenting to a well-defined catchment area.  
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The Psychosis Incident Cohort Outcome Study (PICOS) is a multi-site 
population based first episode psychosis study carried out in Veneto 
region in northern Italy. The authors found an incidence of psychotic 
disorders of 18.1 per 100,000 per year. Incidence rates were 5.6 per 
100,000 per year for schizophrenia, 3.8 per 100,000 per year for affective 
psychoses, 14.3 per 100,000 per year for other non affective psychoses. 
They also found that the incidence rate for all psychoses was higher in 
young people and migrants; they did not find any gender differences for 
all psychosis except that schizophrenia was more common in males 
(Lasalvia, Bonetto et al. 2014).  
Another study in Italy is the Bologna FEP study (BoFeP), an 8-year 
prospective study reporting an incidence of 16.4 per 100,000 for 
psychotic disorders (Tarricone, Mimmi et al. 2012) and 7.3 per 100,000 
for schizophrenia. Like other international first episode psychosis studies 
the authors found a higher incidence in young people, in migrants and in 
males.  
The BoFeP and the PICOS studies both reported an increased risk of 
psychosis in migrants. In Bologna migrants had an increased risk of 
developing a psychotic disorder when compared to local population (IRR: 
2.5, 95% CI 2.2-2.9) (Tarricone, Mimmi et al. 2012); in Veneto the risk 
ratio for migrants was 2.3 (95% CI 1.8-2-7) (Lasalvia, Bonetto et al 2014).  
The limitation of these studies is that they did not apply a standardization 
procedure in order to allow a comparison between incidence rates with 
other Italian or European sites.   
In Italy there are only a few studies on risk factors associated with first 
episode psychotic disorders. Tosato and colleagues (2013) reported an 
association between cannabis consumption in first episode psychotic 
patients and an earlier age of onset (Tosato, Lasalvia et al. 2013). 
Another Italian study, the BoFePs study reported an association between 
cannabis and an earlier onset of psychosis after controlling for the effect 
of other drug; they also reported an earlier age of onset of psychosis in 
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males who used other psychoactive substances (Allegri, Belvederi et al 
2013).  
However both studies do not report a comparison of patterns of cannabis 
use between patients and a healthy control sample.  
In sample of 285 first episode schizophrenic patients at their first 
admission to a psychiatric ward in Milan, 34.7% had a lifetime history of 
substance abuse and most of those who have used illicit drug had a 
history of cannabis consumption (80%). Substance abusers had an 
earlier age of onset and a different symptom presentation (higher scores 
in thought disturbance and hostility) than non-abusers (Mauri, Volonteri et 
al. 2006).  
As far as I know only one study explored the association between 
exposure to early trauma and psychosis in Italy.  
In a case control study, Rubino and colleagues (2009) found that early 
childhood traumatic experiences (any kind of emotional, psychological, 
physical, or sexual abuse before the age of 17 years) increased the risk 
of schizophrenia by six-fold in a sample of 174 patients affected by 
schizophrenia, with a dose response pattern (considering the frequency 
of abuse and the sum of different types of abuse). They reported an effect 
of physical abuse on schizophrenia risk OR: 1.5 (95% CI: 1.17–1.82), 
while they did not find an increased risk for sexual abuse. They also 
found a six-fold increase of the risk for schizophrenia in those who had at 
least one parent affected by any psychiatric disorder. Parental separation 
before 16 years was not associated to an increased risk of schizophrenia 
after controlling for parental discord (Rubino, et al. 2009). 
It is clear from the above that it would be valuable to widen the 
knowledge of the epidemiological distribution of psychosis in different 
Italian sites by including a study from the south of 
Italy; also it would be useful to replicate previous findings from other 
European studies on the role and the distribution of several risk factors 





Aims and Hypothesis 
2.1 Introduction  
I will now clarify the aims of my thesis.  
 
2.2 Aims  
The main aims of this project are:  
1. To calculate the incidence of new cases of psychosis presenting to the 
identified Palermo Mental Health Services over a period of three years 
(2008-2011) using the local population census data as the population at 
risk. 
2. To identify subgroups at higher risk of psychoses (e.g. migrants versus 
native Italians, males versus females).  
3. To compare the newly acquired Palermo incidence data with the existing 
UK ones from the AESOP study (Kirkbride, Fearon et al. 2006). 
4. To identify the impact of genetic (using family history of psychiatric 
disorders as a proxy) and environmental risk factors such as cannabis 
consumption, other illicit drug abuse, migration, childhood traumatic 
experiences, adult stressful life events in the FEP Palermo sample. 
5. To compare the prevalence of the environmental risk factors associated 
with psychosis in Palermo sample to other first episode studies analyzing 
the same risk factors (Genetic and Psychosis study, GAP; and Aetiology 
and Ethnicity in Schizophrenia and Other Psychoses AESOP study). 
 
The results of the thesis will be presented into two separate chapters. The 
fourth will focus on incidence data and it will cover the first three points; 
the fifth will describe the results of a case control analysis performed in a 
subgroup of FEP compared to healthy controls to investigate the 
distribution of risk factor for psychosis (see the next chapter for a detailed 




2.3 Hypothesis  
2.3.1 Hypothesis for the incidence study  
I will test the following hypotheses:  
1. I expect similar incidence rates of psychoses when compared to those 
reported in other Italian sites (Lasalvia, Tosato et al. 2012, Tarricone, 
Mimmi et al., 2012; Lasalvia, Bonetto et al. 2014),.  
2. I expect to find an increased risk of psychosis in some subgroups (males 
and migrants).  
3. I expect lower rates than those reported in UK in the AESOP study.  
 
2.3.2 Hypothesis for the case control study 
1. Family history of psychiatric disorder: I expect a higher prevalence of 
psychiatric and psychotic disorders in first-degree relatives of patients 
when compared to relatives of healthy controls. 
2. Cannabis consumption: I expect a different pattern of cannabis 
consumption between cases and controls. I expect cases to report a 
higher exposure to cannabis (e.g. frequency of cannabis use, total 
number of times of cannabis consumption). 
3. I expect an excess of childhood traumatic experiences (separation or 
death of a parent, physical and sexual abuse) in cases compared to 
controls. 
4. I expect at least some of the victimization experiences to be more 










Chapter 3  
Methods 
3.1 Introduction  
In this chapter I present the design of 1) an incidence and 2) a case 
control study on patients at their first episode of psychosis, run in 
Palermo, the capital of Sicily (Italy), between 1 May 2008 and 30 April 
2011.  
This work was born because of the interest in, and thanks to the 
collaboration with two research studies run at the Institute of Psychiatry, 
King’s College of London: the Genetic and Psychosis (GAP) study and 
the Aetiology and Ethnicity in Schizophrenia and Other Psychoses 
(AESOP) study.  
AESOP is a multi-centre population based incidence and case control 
study conducted in South East London, Nottingham and Bristol over a 
period of 3 years (1997-2000) on patients with their first episode of 
psychoses (ICD-10 F20-F29, F30-F33; World Health Organization, 
1992) (Kirkbride, Fearon et al. 2006).  
GAP is a case-control study, conducted over a period of 5 years (2005-
2010) on patients affected by a first episode of psychosis who presented 
to psychiatric services in South East London (Di Forti, Morgan et al., 
2009).  
GAP and AESOP studies were focused in identifying the role of 
cannabis, social adversities and ethnicity in the risk for psychotic 
disorders.   
In 2008 the Psychiatric Section of Palermo University Department 
“Biomedicina Sperimentale e Neuroscienze Cliniche” (Bionec), started 
the Sicilian Genetic and Psychosis (SGAP) project, an incidence and a 
case control study aimed at collecting epidemiological data on the 
incidence of psychotic disorders in Palermo and at identifying the role of 




In 2010 the Palermo research team and I joined one of the large 
European first episode psychosis study: “the European network of 
national schizophrenia networks studying gene-environment interaction 
study (EUGEI)”. This is an ongoing multi-centre European study 
investigating the interaction between genetic and environmental factors 
potentially involved in increasing the risk of schizophrenia and other 
psychotic disorders (www.eu-gei.eu). 
In this thesis, I discuss separately the incidence and the case-control 
parts of the study. I define the catchment area and I outline screening, 
recruitment and assessment procedures to identify cases, controls and 
the population at risk. 
I describe statistical analysis and power calculations and my personal 
contribution to the collection and the analysis of the data. Results for 
incidence and case control analysis are reported into two separate 
chapters.  
While presenting the results in my sample, I discussed the most striking 
similarities and differences comparing Palermo data to AESOP and GAP 
studies looking at differences or similarities in the incidence of psychotic 
disorder and in the distribution of environmental risk factors across the 
two samples of first-episode psychosis patients.  
 
3.2 Incidence of psychosis in Palermo 
3.2.1.The population at risk 
Palermo is an urban area and it is the fifth Municipality in terms of number 
of residents in Italy.  
The incidence of psychotic disorders will be calculated using as a 
denominator the “population at risk” that is all the people resident in 
Palermo aged 18-65 years over a period of 3 years (between 1 May 2008 
to 30 April 2011).  
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To obtain the most accurate data on the population at risk, I used the last 
census data run in 2011 in Italy by the National Institute of Statistics 
(Istat, 2011).  
According to ISTAT, there were a total of 427,913 residents aged 18-65 
(207,552 males and 220,361 females) in Palermo in 2011. 
The population is largely homogenous in terms of ethnicity that is mostly 
white Caucasian.   
During the last decade, the population of migrants resident in Italy had a 
threefold increase. However, migrants tend to live in the northern regions 
of Italy (1.356.937 in North-West; 1.066.393 North-East) rather than 
southern Italy (338.871) or the Islands (Sicily and Sardinia: 140.655) 
(Istat, 2011). This might be explained by the differences in the chances 
of getting a job between northern and southern Italy. In 2011 the 
unemployment rate in the north of Italy was 5.8% while in the south it 
was 13.6% (Istat, 2011). 
The annual report of statistics of Palermo Municipality, at the end of 
2011 reported that 4.2% of the total population in Palermo was foreign 
(SISTAN, 2012). In this thesis I will term “migrants” all the people who 
originally born outside Italy. 
According to the definition of the 15° census, the term migrant refer to 
people who were born abroad who live in Italy. Migrants can have Italian 
citizenship but they are still defined as migrant because the term refers 
to people who were born outside Italy.  
Most of the foreigners in Palermo are first generation migrants, and 
males are more represented than females.   
Second generation migrants (people under 18 who were born in Italy 
from foreign parents) comprised 3684 people.  
35.1% of the foreigners in Palermo come from Middle-Southern Asia, 
16.8% from other European countries, 12.8% from Northern Africa, 




The most represented ethnic groups come from Sri Lanka (16.3% 
migrants), followed by Bangladesh (15.7%) and Romania (10.2%) 
(SISTAN, 2012).  
In 2011, 80% of migrants in Palermo were 18-64 years old according to 
the last census (15° general population census statistical information, 
n°4/2012).  
In terms of the at risk population, migrants aged 18-65 years resident in 
Palermo at 1° January 2011 were 15,142 (7600 males, 7542 females) 
and they represented the 3.5% of the resident population.  
3.2.2.The catchment area  
The catchment area was the whole city of Palermo. All the inpatient and 
outpatient units of the Palermo Mental Health Department and all the 
private hospitals in Palermo were included in the study.  
Palermo is served by a number of mental health services: all inpatient 
units (five), private psychiatric hospitals (four) and outpatient services 
(five) were examined in order to evaluate the incidence of psychosis in 
Palermo. During this period one inpatient unit closed and another one 
was opened, so that the numbers of beds available in the catchment 
area did not change significantly; a private hospital initially serving part 
of the catchment area closed after one year and it was not replaced by 
any service.  
The five inpatients and the five outpatients units are part of the public 
regional mental health service system (Azienda Sanitaria Provinciale of 
Palermo (ASP), Azienda Ospedaliera Universitaria Policlinico, Azienda 
Ospedale Civico ARNAS, Azienda Ospedali Riuniti Villa Sofia and 
Ospedale Cervello) while 4 private hospitals (Villa Margherita, Villa 
Serena, Casa di Cura d’Anna, Casa di Cura Stagno) are private 
psychiatric clinics which are in the network of the regional public mental 
health system. All people can receive care in both public and private 
units because they do not have to pay to receive psychiatric care. 
The term “private” also refers to those patients who seek help from 
private psychiatrists in outpatient settings. Individual private psychiatric 
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care was not included in the study because there is not any official 
register of private care and it would have been hard to detect patients in 
these settings. However, patients affected by a first episode of psychosis 
under antipsychotic treatment usually need a prescription by public 
mental health services to get medications as otherwise antipsychotics 
would be too expensive; so most of the patients who are in the care of  
private psychiatrists have at least one access to mental health services.  
3.2.3 Case definition  
Cases were defined as all the people resident in the catchment area, 
aged 18-65 years and affected by a first episode of psychosis who made 
contact with mental health services within a period of three years (1 May 
2008- 30 April 2011). 
Age at first onset was defined as the age the subject had at the time of 
the first access to psychiatric services.  
Several definitions of age of onset have been used in epidemiological 
studies:  age at first admission, age at first consultation, or age when first 
symptoms or first positive symptoms are manifest. This may lead to 
discrepancies in the reported age of onset across different studies  
(Eranti, Maccabe et al. 2013).  
As in previous first episode studies (Sartorius, Jablensky et al. 1989; 
Kirkbride, Fearon et al. 2006), in this work age of onset was defined as 
the age the subject was at the time of the first access to psychiatric 
services for psychosis symptoms.  
The inclusion criteria for cases were very similar to those of the AESOP 
and EUGEI except for the age. In AESOP the age of patients was 16 to 
64, in EUGEI 18 to 64. In Palermo the age of cases was 18 to 65 
although no patients aged 65 have been recruited.  
Cases were included if they met the following criteria: 
1. Presence of symptoms of any psychosis such as delusions, 
hallucinations, thought disorder, bizarre or disturbed behaviour, 
negative symptoms, mania. 
2. Residence in the catchment area.  
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3. First ever contact with psychiatric services for psychotic 
symptoms.  
4. Age between 18 and 65 years.  
5. Absence of an organic cause of psychosis and severe learning 
disability. 
6. Diagnosis of ICD-10 criteria for schizophrenia (F20), other non-
affective psychoses (F21-29) or affective psychoses (F30-33).  
Cases were excluded if they met any of the following criteria:  
1. Presence of an organic cause underlying psychotic symptoms.  
2. Residence outside the catchment area 
3. Previous contact with mental health services for an episode of 
psychosis.  
4. Age under 18 or over 65.  
5. Presence of psychotic symptoms resulting from acute intoxication 
as defined by ICD-10 criteria. 
3.2.4 Case ascertainment  
A screening was run on all the subjects aged 18-65 years with a first 
episode of psychosis (defined as the first contact with any psychiatrist) 
presenting from 1 May 2008 to 30 April 2011 at the mental health 
services of the catchment area. Each mental health service was 
contacted on a weekly basis.  
It is useful to clarify how the mental health care works in Italy as there 
are some differences from UK. The pathways to care also differ from 
region to region within the country. 
From a recent multi-centric study, in Italy 33.8% of psychiatric patients 
have a direct access to mental health care, 20.3% are referred by 
general hospitals, 33% by general practitioners and 9.8% by private 
psychiatrists (Volpe, Fiorillo et al. 2013). 
There are two main pathways to access to mental health service for a 
first episode psychotic patient in Palermo. If the patient presents an 
acute psychotic episode, which can be associated to behavioural 
disorders, he will be more likely to access an emergency room of a 
55 
 
general hospital and then referred to a psychiatrist. If the symptoms are 
less acute he might be referred to one of the outpatient units of the 
general mental health care by his GP. The family is almost always 
involved in the care of the patient since the first stages.  
The screening and the assessment procedures were similar to those 
used in the AESOP study, a population based case control study 
conducted over 2 years in London, Nottingham and Bristol, aimed at 
comparing the incidence rates of psychotic disorders in three different 
centres (Kirkbride, Fearon et al. 2006).  
The similarities in the methodology allowed me to make comparisons on 
the incidence rates of the overall psychotic disorders, of the specific 
psychotic disorders (schizophrenia, affective psychoses and other non-
affective psychoses) and the risk in specific groups (e.g. in migrants and 
native-born Italians, in males versus females). 
Clinical notes were checked in order to identify new admissions or new 
contacts for a first episode of any psychotic disorder within the 
catchment area.  
When a patient satisfying the inclusion criteria was identified, he/she was 
invited to be enrolled in the study and after signing a consent form 
he/she went through the whole assessment; when the patient did not 
give the consent to be enrolled or he/she was unavailable to be asked 
for the consent, his/her main clinical and socio-demographic data were 
still recorded anonymously in a specific form according to the Italian law 
about the general authorization to process personal data for scientific 
research purposes  (Gazzetta Ufficiale  n° 72, 26 March 2012).  
A retrospective analysis was run on clinical notes in all the services 
involved in the study in order to detect any missing patients.  
If the patient was not available for the clinical assessment because 
he/she has been detected by the retrospective screening, the main 
socio-demographic and clinical information was collected using all 
available sources of data (clinical notes, computerized information 
systems, psychiatrists in charge of the subjects). 
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At the end of the study period, a leakage study was conducted in all the 
mental health services of the catchment area in order to detect all the 
cases of psychosis fulfilling the inclusion criteria, who could have been 
missed by the initial screening. 
 
3.2.5 Case assessment  
The following instruments were used for the assessment  
1. The Schedules for Clinical Assessment in Neuropsychiatry 
(SCAN) (WHO, 1992) was used to interview patients who gave consent 
to go through the whole assessment.  The SCAN Item Group Checklist 
(IGC) section was completed for those cases who refused to be 
interviewed or because of being detected retrospectively by the leakage 
study.  All the raters completed a SCAN training.  
Medical records were checked in detail to collect clinical and socio-
demographic information for those who did not go through the whole 
assessment. 
2.  The Modified version of the Medical Research Council (MRC) 
socio-demographic scale (Mallett, Leff et al. 2002) was used to collect 
the main socio-demographic data on age, gender, ethnicity, place of 
birth, level of education, occupation.  
The diagnosis of cases was made according to ICD-10 criteria for 
psychotic disorders using all the available information (SCAN, case 
notes, narrative history from any informants).  
The diagnosis was confirmed case by case by consensus meetings 
among two psychiatrists and two trainees in psychiatry according to the 
Diagnostic Criteria for Research of the ICD-10 (DCR-10) which are 
designed specifically for research (World Health Organization, 1993). 
DCR-10 criteria for the psychotic disorders considered in this thesis are 
shown in Appendix I.  
The ICD-10 diagnosis were divided as follows: 
• All psychosis (F20-29, F30-33) 
• Schizophrenia (F20) 
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• Other psychoses (F21-29): persistent delusional disorders, acute and 
transient psychotic disorders, induced delusional disorder, 
schizoaffective disorder, other non-organic psychoses, unspecified 
non-organic psychotic disorders.  
• Affective Psychoses included Mania, Bipolar Disorder, Depression 
with psychotic symptoms (F30-33). 
When a patient did not want to take part in the study or he/she was     
identified retrospectively, the diagnosis was formulated on clinical notes 
and by the help of the psychiatrist in charge for that patient. 
Migration status was defined as people who were born outside Italy.  
Ethnicity status was defined by self-ascription and by place of birth. 
I identified a total of 204 psychosis cases. 183 were white Italians born 
and 21 were migrants. 68 cases accepted to be enrolled in the study and 




3.3 Data management  
3.3.1 The population at risk 
Data on Palermo population were obtained through the 15° National 
Census 2011 available online (elaborated by the national Institute of 
Statistics, Istat). Most of the basic socio-demographic information (total 
population aged 18-65 years, split by age, sex, migration status and 
marital status) were downloaded as Excel datasets from the ISTAT 
website (http://www.Istat.it/it/istituto-nazionale-di-statistica). 
As in the AESOP study, the population at risk was broken down by 5-
year age bands, except the first and the last age bands; the first age 
band was 18-24 and the last was 60-65.  
When I standardized Palermo incidence rates to AESOP specific 




The population at risk was further broken down by gender and migration 
status. This allowed me to calculate age and sex adjusted incidence 
rates and age, sex and migration adjusted incidence rate and incidence 
rate ratios. Population data of 2011 were multiplied by 3 to account for 
the 3 years study period to obtain the number of person-year at risk.  
 
3.3.2 Numerator  
Data of cases were built with the following variables: 
• Age of contact with psychiatric services (age at onset) 
• Gender 
• Migrant status  
• Diagnosis  
 
3.3.3 Data manipulation  
Age was converted into nine 5-year age bands for both cases and the 
population at risk. This artifice has been used in order to allow 
comparison between Palermo and UK incidence rates. Both numerator 
and denominator have been stratified by age, gender and migration 
status.  
1. Both cases and the population at risk have been divided in a 
dichotomous category of migrants versus native-born Italians. I 
compared incidence rates between native-born Italians and migrants.  
2. In the AESOP study, cases were divided according to ethnic group. In 
the Palermo sample, migrants were too few to group them for specific 
ethnicity. So I collapsed them into 4 large categories for descriptive 
purposes only: Italians, other Caucasians, Africans, Asians, even 
though I am aware that these groups, especially the last two 
categories, are heterogeneous in terms of ethnicity. For the incidence 
calculation however I only used the dichotomous variable native-born 




3.4 Statistical analysis for incidence  
1. Descriptive epidemiology: I examined the age and sex structure of 
the population of cases and of the population at risk (denominator). I 
described the main socio-demographic characteristics of the sample of 
cases (age, gender, migration, level of education, relationship status, 
employment, living status). 
2. I calculated crude incidence rates and their 95% confidence 
intervals for overall psychotic disorders and for each diagnostic category: 
schizophrenia (F20), affective psychoses including: mania, bipolar 
disorder and depressive psychosis (F30-33) and other psychosis (F21-
29) by gender and by migration status. I calculated crude incidence rate 
ratios (IRR) and their 95% CI for males versus females and for migrants 
versus native-born Italians.  Rates are presented per 100,000 
persons/year. 
3. I calculated age and sex specific incidence rates. 
4.    I applied Poisson regression models to obtain adjusted incidence 
rates and their 95% CI for age, sex and migration.  
I used age as explanatory variable, because the incidence of psychotic 
disorders is influenced by age being higher among young people and in 
males (McGrath, Saha et al. 2004; Aleman, Kahn et al. 2003). I used 
gender as explanatory variable because males have been reported to 
have a higher risk of developing schizophrenia than females (McGrath, 
Saha et al. 2004; Aleman, Kahn et al. 2003). 
I also used migration as an explanatory variable because it has been 
largely reported that being a migrant increases the risk of developing 
psychotic disorders (Cantor Grae and Selten, 2005). 
  5. I used Poisson regression to calculate adjusted incidence rate ratios 
and 95% confidence intervals to estimate the differences in incidence 
risk in different groups in the Palermo sample:  
a. Males versus females (adjusting for age and migration): I applied the 
Likelihood Ratio Test (LRT) to test the interaction between age and 
migration. Since I did not find any significant interaction between age 
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bands and migration I used Poisson models assuming homogeneous 
IRR between migrants and native-born Italians for each age band.  
b. Migrants versus native-born Italians (adjusting for age and sex): I 
applied the Likelihood Ratio Test (LRT) to test the interaction 
between age and sex. Since I did not find any significant interaction 
between age bands and gender I used Poisson models without 
interaction assuming homogeneous IRR between males and females 
for each age band.  
   6.    I calculated standardised incidence rates for overall psychotic 
disorders and for each diagnostic category, by age and gender and by 
age, gender and migration status, using indirect standardisation.  
   I used standardization to be able to compare the incidence rates found 
in Palermo to other populations, adjusting for possible confounders of 
the general population structure (age, gender, migration status). I used 
the indirect standardization instead of the direct standardization used in 
the AESOP study because of data availability.  
I used AESOP data (Kirkbride, Fearon et al. 2006) as the standard 
population and I applied standard (AESOP) age-sex specific rates to 
Palermo population.  
Palermo and AESOP surveillance periods were different (1997-1999 
AESOP versus 2008-2011 Palermo), and this may have affected the 
comparison between sites; however UK incidence rates of psychoses 
were fairly stable over time (Kirkbride, Errazuriz et al., 2012) as 
discussed in more details in Chapter 6. 
I obtained the standardized mortality ratio (SMR) given by the ratio of 
Palermo observed number of cases/expected number of cases in 
Palermo if the age–sex specific rates were the same as those of the 
standard population (Kirkwood and Sterne 2003). Age and sex adjusted 
rates for Palermo were obtained multiplying the SMR to the crude 
morbidity rate of the standard population.  
I also standardized for migrant status. I applied standard (AESOP) 
migrant status (and age and sex) specific rates to Palermo population.  
61 
 
The definition of migration in Palermo was different to that in the AESOP 
study1. Fearon and colleagues (Fearon, Kirkbride et. al, 2006) reported 
higher rates for all psychotic disorders and above all for schizophrenia 
and mania in ethnic minority groups (especially in Afro-Caribbeans and 
in Black African). In this thesis I considered “migrants”, all people who 
born outside Italy, and I compared them to people in the AESOP study 
who “born outside UK”. To avoid a bias based on the different migration 
history of the two populations I used an artifice: AESOP specific 
incidence rates have been re-calculated excluding second generation 
migrants that is people who born in UK but from migrant parents; 
Migration in Palermo is a recent phenomenon compared to UK, and the 
Palermo population is still quite homogenous; almost all the cases were 
born in Palermo from Italian parents. In UK population is made up by 
different ethnicities, and migrants do not  represent a unique category 
(second generation migrants are included among “UK born”), so I 
decided to compare native-born Italians in Palermo with white British in 
AESOP excluding those belonging to ethnic minorities who are UK born 
to see whether there is a difference in terms of incidence. I also 
compared migrants in Palermo to non-UK born people in AESOP. I 
applied the AESOP age-sex rates excluding non-White British people 
from the sample in order to compare Palermo sample to native British 
population and non-British population of cases.   
I did not compare incidence rates for different ethnic groups due to the 
small number of migrants in my sample. 
In their paper Kirkbride and colleagues compared rates of psychosis in 
three centres (London, Nottingham and Bristol); however for this thesis I 
used AESOP data based on the London and Nottingham samples only. I 
excluded Bristol because data were not available for place of birth so I 
could not have identified migrants. 
                                                
1 In AESOP study the term migrants was used to indicate ethnic minorities who 
migrated to UK more recently. The term included also second- generation 
migrants who were born in UK. In this work instead, migrants refer to people 
who were born outside Italy.  
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The AESOP data set was manipulated to allow comparisons between 
the two samples. 19 AESOP cases from Nottingham and London have 
been dropped from the data set because place of birth was missing. 
The age band 16-17 was also deleted to allow comparisons between 
AESOP and Palermo sample.  
I excluded 23 AESOP cases with the diagnosis of substance-use 
psychosis because in Palermo I did not collect data on that.  
I then excluded the non-White British population from the UK born 
people to allow a more sensible comparison to the Palermo sample. The 
total number of cases in AESOP used for the standardization was then 
360.  
For all of the reasons reported above, AESOP specific rates used for the 
standardization differ from those reported by Kirkbride and colleagues in 
their paper (Kirkbride, Fearon et al., 2006).  
   7.   I compared Palermo incidence rates with those found in the AESOP 
study calculating SMR and its reciprocal and 95% CI.  
The analyses were performed using Stata software (version 12). 
 
3.5 Risk factors associated to psychosis: a case control 
comparison  
After analyzing the incidence of psychotic disorders in my area, and after 
the incidence comparison to UK data, I was interested in investigating 
the distribution of environmental risk factors associated to the risk of 
developing psychosis in Palermo. 
A different prevalence of risk factors potentially associated to the 
development of psychoses in my sample might explain, at least in part, 
the differences that have been found in the rates of psychoses between 
Palermo and UK.   
I carried out a case control analysis in a subsample of 68 FEP patients 
identified for the incidence study and 74 healthy controls from the local 
population, aimed at: 
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• Comparing the prevalence of certain supposed environmental risk 
factors for psychosis in patients affected by a first episode of 
psychosis, and in healthy controls.  
• Comparing the prevalence of environmental risk factors between the 
Palermo sample of cases and controls and similar samples of first 
episode psychotic patients recruited in London (GAP and AESOP 
study).  
The case control design is an observational epidemiological study 
allowing to make comparisons of the prevalence of several exposures 
(putative risk factors) between a group of individuals who have the 
outcome of interest (in this case people affected by their first episode of 
psychosis) and a group of healthy people, with similar features to cases 
but without the disease of interest (controls). Case control studies are 
easier and less expensive and time consuming than prospective cohort 
studies, because the disease has already occurred. 
They do not require large sample size unless the variable of exposure is 
very rare (Greenland, 2009) and have the advantage of allowing the 
study of several risk factors at the same time.  
The case control study is prone to several biases, including the improper 
selection of either cases or controls (Parodi and Bottarelli, 2005).  
The true measure of the association between an exposure and an 
outcome can be obtained ideally by measuring the association in the 
entire population; however, because it is not possible to study the entire 
population, the sampling of cases and controls must be representative of 
the exposure-outcome distributions in the overall population. The 
exposure distribution in the controls is used as an estimate of the 
exposure distribution in the overall population in order to compute the 
odds ratio as a measure of association (Boston University School of 
Public Health, 2012).  
Selection bias may occur if the control group selected is not 
representative of the population the cases come from.  
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It may happen that the exposure under study may influence the selection 
of controls and this will lead to a bias in the estimate of the association 
between a certain risk factor and the outcome.  
In case control studies, controls should represent the population at risk 
of the disease. More specifically, they should be individuals who, if they 
had experienced the disease outcome, would have been included as 
cases in the study (Kirkwood and Sterne, 2008).  
Selection bias of cases may occur because of refusal, non-response, or 
agreement to participate that is related to the exposure and disease.  
Another source of bias in case control studies is the recall bias, because 
the information about exposure to risk factors is collected retrospectively 
and people with the disease might be more likely to recall risk factors 
(Greenland, 2009).  
Retrospective studies have more problems with data quality because 
they rely on memory and people with a condition will be more motivated 
to recall risk factors (also called recall bias). 
 
3.5.1 The recruitment of cases and controls  
3.5.1.1. The selection of cases  
During the study period a total of 204 patients affected by a first episode 
of psychosis were identified for incidence calculation.  
Only approximately 1/3 (68) of the sample of incident cases underwent 
the whole assessment. 136 patients were not involved in the study either 
because they refused to give the consent to be interviewed: 72 (53%) or 
because they had been screened and identified retrospectively: 64 
(47%) were not available to be interviewed or they were not any longer 
in charge with psychiatric services.  
68 patients who were actually in the care of psychiatric services 
accepted to be interviewed. They were asked to sign a consent form and 
they were enrolled in the study.  
One issue is the selection bias of cases because it might be that those  
who accepted to be interviewed were more cooperative because of  less 
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severe symptoms. I compared the 68 cases who have been recruited 
with 136 cases who were not enrolled because of refusal or because 
they were no longer in charge with the mental health services.  
There were no significant differences in terms of gender, migration, 
ethnicity, level of education between the two groups. There was a 
difference in mean age at first contact: non-recruited cases were 
younger at their first contact.  
Differences in diagnosis in the two groups were borderline. There was a 
higher proportion of people affected by schizophrenia in those who were 
recruited compared to the non recruited group.  
 
3.5.1.2. The selection of controls   
During the study period a healthy control group (n= 74) was recruited 
from the local population living in the same catchment area of cases. 
The research team and I tried to make any effort to collect a sample of 
controls that was representative of the general population at risk for the 
disease. 
A quota sampling method was applied to select healthy controls. 
Palermo general population aged 18-65 was divided by age bands (18-
34 and 35-65), gender, and migration status (native born people versus 
migrant). The control sample was selected according to the distribution 
of gender, age, and migration status observed in the population. 
Therefore, the control sample was similar on a number of socio-
demographic factors (age, gender, migrant status) to the population the 
cases come from. 
We advertised the recruitment of controls through Internet, newspaper 
advertisements, leaflets placed in churches, gyms, private residences. 
A selection bias could have occurred because people responding to 
advertisement might be more interested to go through a psychiatric or a 
psychological assessment because they suffer from any psychological 
disorder. A psychotic disorder in controls was excluded by administering 
the Psychosis Screening Questionnaire (Bebbington and Nayani 1995). 
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Four people were excluded because of screening positive to the 
questionnaire. 
The leaflet for the advertisement did not mention cannabis, other drug 
consumption, or any other risk factor to minimize the effect of selection 
bias driven by the exposure.  
As mentioned previously, another bias in case control studies may be 
recall bias. However this is a first episode study so that the detrimental 
effect of medication and the impact of cognitive impairment on the ability 
to recall may be reduced.   
 
3.5.2 The assessment of cases and controls 
Beside data on age, gender, the basic socio-demographic data (level of 
education, occupational and social status, living status migration status) 
acquired from the incidence part of the study, the main risk factors 
investigated in this thesis in the case control analyses are:  
• Family history of psychiatric disorders in the first degree relatives  
• Cannabis and other illicit drug consumption 
• Traumatic experiences in childhood and early adolescence (such 
as physical or sexual abuse, separation from parents for more 
than six months, death of one parent) 
• Adult adversities.  
All of these variables have been associated to an increased risk of 
developing a psychotic disorder even though the results of different 
studies are not univocal (see the introduction chapter for further details).  
Data on family history of any psychiatric disorders and psychosis in first 
degree relatives of patients and healthy controls were collected by the 
Family Interview for Genetic study (FIGS), an interview designed to gain 
information about the presence of a psychiatric disorder in first degree 
relatives of the patients (depression, mania, alcohol and other drug 
abuse, psychosis, paranoid/schizoid/schizotypal personality disorder) 
(NIHM Genetic Initiative, 1992). 
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Detailed data on cannabis and other illicit drugs consumption were 
collected by the Cannabis Experience Questionnaire modified version, 
CEQmv, (Di Forti, Morgan et al. 2009) (see Appendix III) to investigate 
qualitative and quantitative information on cannabis (age at first use, 
frequency, duration of use in years, current or past use) and other 
substances of abuse consumption.  
Positive and Negative Syndrome Scale (PANSS) was used to evaluate 
symptom severity (Kay, Fiszbein 1987). 
Childhood traumatic experiences, loss or separation from parents, 
physical and sexual abuse before age of 17 were investigated by the 
Childhood Experience of Care and Abuse (CECA) Questionnaire 
modified version (Bifulco et al., 2005); adult adversities (bullying, 
violence at home, being victim of serious injury, illness or assault), were 
assesed by the Brief Life Events schedule adapted from Bebbington et 
al. (2004).  
CECA and Brief Life Events schedule were included in the assessment 
of the Modified version of the Medical Research Council (MRC) socio-
demographic scale (see Appendix IV). 
A more detailed description of the instruments for the assessment will 
follow in the next paragraph. 
3.5.2.1 The assessment of cases: measurements and variables 
analysed in the study  
Cases were assessed by the following tools:   
1) Socio-demographic data (age; gender; ethnicity; level of education 
and employment status) on cases and controls were collected using a 
modified version of the MRC Sociodemographic Schedule (Mallett, 
Leff et al. 2002). Some variables such as ethnicity and level of education  
have been modified according to the Italian context.  
The relevant information for this thesis were: age at first contact with 
psychiatric services, gender, age, ethnicity, place of birth (used to define 
migration status), employment status, relationship status and living 
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status at the time of the assessment, level of education. The same MRC 
tool was also administered to controls.  
• Age indicated the age at first contact with psychiatric services; in 
controls it indicated the age at the time of the assessment.  
• Ethnicity has been collapsed into a dichotomous variable: Caucasian, 
not Caucasian.  
• Place of birth was considered to create a dichotomous variable: Italy 
or not Italy born. People who were not Italy born were defined as 
“migrant”.   
• Living status included several categories (living alone, living with       
partner/spouse, living with children etc. see appendix for details); to 
simplify the analyses a dichotomous category was created: living 
alone/living with someone.  
• Employment status was descriptively differentiated in employed, 
unemployed, student, retired. It was collapsed in a dichotomous 
category: employed/unemployed. 
• Relationship status was differentiated in two groups: single, 
separated, divorced/in a stable relationship.  
• Level of education was defined into the following categories (the UK 
categories of the tool were modified according to the differences in 
the Italian education system): no qualification, primary school, junior 
high, diploma (secondary school degree), University. To simplify the 
analyses, mean age of leaving education was considered to compare 
cases and controls.  
 
2) The Schedule for Clinical Assessment in Neuropsychiatry 
(SCAN) (WHO, 1992) was used to assess psychopathology.  
This is a set of instruments aimed at assessing and classifying the 
psychopathology of the major psychiatric syndromes. It includes the 
Present State Examination (PSE 10) to evaluate symptoms present for 
the month before assessment.  
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Information on those subjects who could not be interviewed was derived 
by case-notes, employing the section, Item Group Checklist (IGC) of the 
SCAN.  
The diagnosis according to the ICD-10 criteria (F20-29, F30-F33) was 
established by consensus among two adult psychiatrists and two 
trainees (psychiatrists or psychologists) who performed the interview of 
the patient.  
3) The Family Interview for Genetic Studies (FIGS; NIMH Genetics 
Initiative, 1992) was used to gather information about the history of 
psychiatric disorders in first-degree relatives (parents, children) of cases 
and healthy controls. 
This tool requires one to draw a pedigree diagram. General screening 
questions are asked about the relatives in the pedigree to detect mental 
health problems in subjects’ relatives. Then the Face Sheet is used to or 
any affected relatives about whom the informant can provide information 
https://www.nimhgenetics.org/interviews/figs.  
In the analysis I chose to consider psychosis, mood disorders, mania.  
The variables were grouped into: 
• A dichotomous variable indicating the presence or the absence of any 
psychiatric disorder (psychosis, mood disorder, mania) in one of the 
first-degree relatives. 
• A dichotomous variable indicating the presence or the absence of any 
psychotic disorder in one of the first-degree relatives. 
 
4) Cannabis Experience Questionnaire modified version CEQmv, 
(Di Forti, Morgan et al. 2009). This is a questionnaire aimed at gathering 
information on pattern of cannabis consumption. The following variable 
were explored: 
• Age at first cannabis use 
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• Use before and after 15 years: a dichotomous variable has been 
created to split subjects into two groups: (1: those who started 
smoking before 15 years, 0: those who did not). 
• Lifetime cannabis consumption: a dichotomous variable (yes/no) 
exploring whether the subject has ever used cannabis at least once 
during life.  
• Current cannabis consumption: a dichotomous variable (yes/no) 
exploring whether the subject is a current cannabis user. Current 
cannabis use is defined as cannabis consumption within the four 
weeks before the assessment.  
• Frequency of use includes several categories (never used, only once 
or twice, a few times each year, a few times each month, once a 
week, more than once a week, everyday). For power reasons 
frequency has been collapsed into a dichotomous variable: daily 
cannabis consumption/cannabis consumption less than everyday. 
Frequency has been also collapsed into another dichotomous 
variable taking into account the total number the subject has smoked 
cannabis (<50 times, >50 and over 200 times) 
• Mean duration of cannabis use: a dichotomous variable has been 
created; 5 or less than five years/more than five years of cannabis 
use.  
• Other drug consumption: collapsed into a dichotomous variable 
exploring lifetime consumption  (yes/no) of other drugs (including all 
illicit drugs), stimulants, tobacco, alcohol.  
 
5) Childhood Experience of Care and Abuse Questionnaire (CECA 
Q) (Bifulco et al. 2005). A short version of the questionnaire was 
included in the assessment. This questionnaire is aimed at assessing 
early adverse experiences prior of age 17. In this thesis I considered four 
early adversities: parental loss because of death, parental separation, 
physical abuse, sexual abuse.  
• Parental loss was categorised into a dichotomous variable: presence 
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or absence of an experience of losing any parent because of death 
before age 17.  
• The presence or an experience of separation from mother or father 
(not living with one of the parents) for a period of at least six months is 
reported in a dichotomous variable (yes/no). 
• The presence of physical abuse defined as the repeated exposure to 
physical violence from mother or father before age 17. It was analysed 
as a dichotomous variable (yes/no). Physical abuse was scored as 
present (yes) only when the physical punishment was severe (being 
hit repeatedly with an implement, being punched, kicked, or burnt, 
being injured or bruised).  
• The presence of sexual abuse was reported if the abuse was severe 
according to the CECA cut-off points (Bifulco, 2005). It was analysed 
as a dichotomous variable (yes/no).  
6) Brief Life Events Schedule modified version (adapted from 
Bebbington et al. 2004) was included. A list of ten victimization 
experiences (serious injury or assault, bullying, violence at work, violence 
at home, sexual abuse, being expelled from school, running away from 
home, being homeless, taken into local authority care, time in children’s 
institution) was shown to the participant and he/she was asked if he/she 
had experienced any of these victimization experiences at any time 
during his/her life. A dichotomous variable (yes/no) was created for each 
of these experiences.   
7) Positive and Negative Syndromes Scale (Kay, 1987). This is a 30-
item rating scale providing quantitative information on positive and 
negative symptoms and global psychopathology. Each item is rated on a 
7-point (1–7) scale; items are grouped into 3 subscales: positive 
symptoms, negative symptoms and general psychopathology. 
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8) Nottingham Onset Schedule (NOS) (Singh et al., 2005). This is a 
short interview to measure onset in psychosis. Onset is defined as the 
time between the first reported/observed change in mental 
state/behaviour to the development of psychotic symptoms. It provides a 
measure of the duration of untreated psychosis (DUP). In this study DUP 
was defined as the period in weeks from the date of the first appearance 
of clinically relevant psychotic symptoms to the date of first contact with 
mental health services for psychosis (Morgan et al., 2006; Singh et al., 
2005). Since some cases reported long DUP, weeks were converted into 
months to ease the analyses.  
PANNS and NOS have been reported just for descriptive purposes since 
their data has not been entered in the analysis.  
3.5.2.2 The assessment of controls: measurements and variables 
analysed in the study   
Controls inclusion criteria were: 
• Age 18 to 65 
• Resident in the catchment area  
• Absence of learning disabilities  
• Absence of previous psychotic symptoms.  
They were assessed by the Psychosis Screening Questionnaire 
(PSQ) (Bebbington and Nayani 1995) (see appendix V) to exclude the 
presence of a psychotic disorder. The questionnaire includes questions 
to screen symptoms of hypomania, thought interference, persecution, 
perceptual abnormalities, strange experiences and hallucinosis together 
with a question on a previous treatment for a psychiatric problem. 
People were excluded if they had previous treatment for psychosis or if 
they answered positively to at least two of the questions of each 
symptom.  
Four people were excluded because of screening positive on the PSQ.  
They were administered the same questionnaires and schedules as 
cases except for SCAN, NOS, and PANSS.  
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Controls exclusion criteria were: 
• Age under 18 or over 64 




3.5.3 Justification of sample size: power calculation for case- 
control study  
I used the Epi-Info program to calculate the sample size needed to 
achieve a study power of 80% at a 5% significance level (equivalent to a 
95% CI) with an equal number of cases and controls.  
Epi-Info requires 3 information to do the power calculation: 
a. desired level of power (80%) and level of significance (5%) 
b. the expected prevalence of exposure to the risk factor of interest in 
the controls  
c. the expected magnitude of the effect (OR) of the risk factor selected.  
The Epi-Info calculation indicated that to obtain a power of 80%, with a 
level of significance of 5%, assuming a prevalence of exposure to 
cannabis use of 22.4% in the control group (taking into account national 
data on the population prevalence of cannabis consumption), I need a 
sample of 122 people (61 cases and 61 controls), to detect a moderate 
main effect (Odds Ratio=3).  
This thesis also takes into account the exposure to other environmental 
risk factors such as childhood adverse experiences and adult 
adversities. It is not easy to estimate the prevalence of all these adverse 
events in the general population. However I choose sexual abuse that is 
a quite rare event in order to calculate the power I needed to detect a 
moderate effect of abuse on the risk of developing psychosis.  To 
calculate power for sexual abuse, I used the one-sided binomial test 
(Chow, Shao et al. 2003). It indicated that to obtain a power of 80%, with 
a level of significance of 5%, assuming a prevalence of exposure to 
74 
 
sexual abuse of 10% in the general population (taking into account 
European data on the population prevalence of sexual abuse, World 
Report on violence and health, WHO 2002) I need a sample of 110 
subjects (55 cases and 55 controls), to detect a modest effect (Odds 
Ratio=2).  
 
3.5.4 Statistical analysis for the case control study 
The statistical methods commonly used for case control studies are odds 
ratio (OR) and chi square test.  Logistic regression is used to adjust for 
confounding variables. For rare diseases the odds ratio (OR) is equal to 
risk ratio and rate ratio.  
• I compared the prevalence of risk factors between cases and controls 
in the Palermo sample using as appropriate chi square test and 
Fisher exact test.  
• I calculated unadjusted odds ratio for the main exposures (cannabis 
and other illicit drug consumption, childhood traumatic experiences, 
adult adverse events, family history of psychiatric disorders in first 
degree relatives). 
• I calculated adjusted OR applying, whenever it was possible, 
stepwise logistic regression to adjust for the main confounders (age, 
sex, level of education, psychiatric disorders in first degree relatives, 
employment). 
• I applied t test, Wilcoxon, Welch test and ANOVA to analyze 
quantitative variables in cases and controls. 
 
3.6 Software  
Microsoft Excel was used to obtain and manipulate the denominator data 
for the Palermo and the AESOP population (the population standard).  
SPSS (version 20) was used to build both individual datasets including 
all the variables of interest for the case control analyses and collapsed 
datasets with age and sex bands, migration, diagnosis and their 
corresponding denominator to perform incidence analyses.  
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I converted the final datasets into Stata by STAT TRANSFER version 8. 
Stata version 12 has been used for descriptive and analytical analysis.  
3.7 Ethics  
The study was approved by the Ethical Committee of the Palermo 
University Medical School in 2008 and the data collection in the mental 
health services has been authorized by the Department of Mental Health 
of Palermo which is the coordinator of all the psychiatric services in the 
catchment area involved in the study.  
As reported in the previous paragraph when a patient was not available 
to be asked the consent, his/her main clinical and socio-demographic 
data were recorded anonymously according to the Italian law about the 
general authorization to process personal data for scientific research 
purposes  (Gazzetta Ufficiale n° 72, 26 March 2012) which allows the 
collection of anonymous epidemiological data even without a specific 
consent given by the subject. This ensured the possibility to collect all 
data needed to estimate the incidence of psychosis in Palermo. 
 
3.8 Statement of contribution to the investigations 
My work has been inspired and guided by my supervisors.  
Prof. Sir Robin Murray, Prof. Paul Fearon and James Kirkbride have 
helped me in discussing several methodological issues. Prof. Daniele La 
Barbera helped me in organizing the research study.  
I coordinated the Sicilian Genetic and Psychosis study (S-GAP) research 
team of psychologists and psychiatrists in training who performed the 
screening in the mental health services together with me. I was 
responsible for the ethical approval application and I contributed to 
defining the battery of assessments used in the project. I coordinated the 
screening procedure of people referred to the mental health services of 




I attended a training course to administer the SCAN interview and I 
carried out the clinical assessment on a large proportion of the FEP 
recruited. 
I have been actively involved in the recruitment of both cases and 
controls and in the participants’ assessment and in the retrospective 
study on clinical notes in order to identify any missing case of psychosis. 
I organised the project’s initial database (SPSS 20) and I built the 
variables relevant to my thesis. 
I could not have collected all the incidence and case controls data 






Incidence of Psychotic Disorders in Palermo 
4.1 Introduction 
In this chapter I will provide data on the incidence of psychotic disorders 
in Palermo. I will describe in detail the population denominator and the 
catchment area. I will report incidence rates for overall psychotic 
disorders by diagnostic categories and by gender. I will report both crude 
and standardized rates. I will explore whether there is a difference in 
incidence rates by migrant status as it has been reported that migration is 
one of the risk factors for psychosis. I will then compare Palermo 
incidence data with AESOP incidence rates in UK and discuss the main 
possible explanations for any rate differences found.   
 
4.2 Denominator data   
Table 2 reports the population of Palermo residents aged 18-65 years in 
2011 according to the 2011 census (Istat, 2012) and split into native-
born Italians and migrants. The total population was 412,771 people. 
Males were 199,952, females were 212,819. In this thesis I define 
migrants as all the people who originally were born outside Italy. In 2011 
migrants represented 4.2% of the total population (SISTAN, 2012). 
I considered the population in 2011 when there was a new population 
census, in order to use the most accurate data for the denominator.  I 
then multiplied by 3 to obtain the number of persons at risk in the period 
of three years giving a total population at risk of 1,283,739 persons. The 
Palermo population aged 18-65 years and split by age-bands, gender 







Table 2: people resident in Palermo in 2011 aged 18 to 65 years according to 
the census (Istat, 2012). This population has been split into two categories 
(native-born Italians and migrants) providing the denominator for the incidence 
rate calculation.  
 Total (M +F) Males  Females  
Native-born Italians  412,771 199,952 212,819 
Migrants  15,142 7600 7542 
Total residents (Native-born 
Italians + migrants) 
427,913 207,552 220,361 
  
4.3 Numerator data  
Two hundred and four patients with their first episode of psychosis (FEP) 
met the inclusion criteria over the study period. 68 (33.3%) FEP were 
assessed by face to face interviews. 136 (66.7%) cases were not 
assessed in a face to face interview: 72 (35.3%) of the 204 cases, 
refused to be interviewed and 64 (31.3%) were identified by the leakage 
study. The main reason for refusing to be enrolled was lack of interest 
and motivation in the research and the fear of being stigmatized. 
The total sample for analysis therefore comprised 126 males and 78 
females. As described in previous first episode psychosis studies 
(Kirkbride, Fearon et al., 2006), there were more males (61.8%), than 
females (38.2%). 183 (89.7%) cases were native Italians and 21 were 
migrants2 (10.3%).  
 
Table 3: distribution of cases by gender and migration status. 
Palermo Total, (n %) Males n, (%) Females n, (% ) 
Cases  











                                                
2 In this thesis the term migrants refer to people who born outside Italy as 




Fig 3 shows the distribution of the diagnoses in cases. 123 (60.3%) 
subjects met ICD-10 criteria for the diagnosis of F20 schizophrenia, 19 
(9.3%) for F30-33 affective psychoses, 62 (30.4%) for other non- affective 
psychoses F21-29. 
 
Figure 3: the ICD-10 diagnosis distribution among the 204 cases of psychoses.  
   
The affective psychosis category was composed of 12 (63.1%) people 
affected by mania or bipolar disorder and 7 (36.9%) people by depression 
with psychotic symptoms.  
123 subjects were diagnosed with schizophrenia F20; 81 (65.9%) were 
males and 42 (34.2%) females. 19 patients received the diagnosis of 
affective psychosis F30-33, 11 (57.9%) were males and 8 (42.1%) 
females. 62 had other non-affective psychosis F21-29, 34 (54.8%) were 
males and 28 (45.2%) were females. Diagnoses are displayed split by 








Diagnosis in FEP 
schizophrenia affective psychoses other psychoses  
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Table 4: distribution of ICD-10 Diagnostic Categories of the cases by gender 
Sex F20 (n, %) F30-33 (n, 
%) 
F21-29 (n, %) All psychosis (n, 
%) 
M 81 (65.8) 11 (57.9) 34 (54.8) 126 (61.8) 
F 42 (34.2) 8 (42.1) 28 (45.2) 78 (38.2) 
Total  123 (100) 19 (100) 62 (100) 204 (100) 
 
Figure 4: diagnostic categories by gender 
 
If we consider 2 categories: affective and non-affective psychoses, 19 
(9.3%) of subjects had a diagnosis of affective psychosis (mania or 
depressive psychosis), 185 (90.7%) a diagnosis of non-affective 
psychosis (schizophrenia, schizoaffective, other psychosis). 
 
4.3.2 Age of fist contact with mental health services  
The median age of first contact with psychiatric services for all psychoses 
was 28 years (IQR 16); mean and median age at first presentation for 
each diagnostic category is shown in Table 5. Mean and median age is 
different because of the asymmetric distribution of age. I used Kruskal 
Wallis to compare distribution of age of different diagnostic categories 













There was a difference in the distribution of age at first presentation 
across diagnostic categories (chi=12.5, df=2, p-value=0.002, Kruskal 
Wallis) as shown in Fig. 5.  
There was not any difference in median age at first presentation between 
schizophrenia and affective psychoses (chi=0.10, df=1, p-value=0.714, 
Kruskal Wallis) while the difference between median age at first 
presentation of schizophrenia and other non-affective psychoses was 
significant (chi=12.1, df=1, p<0.001, Kruskal Wallis). People diagnosed 
with other non-affective psychotic disorders (F21-29) tended to develop 
the disorder later than those affected by schizophrenia. This finding might 
be explained in part at least by the diagnostic category of F21-29 that 
includes disorders such delusional and schizoaffective disorders which 
tend to have their onset later in life.  
 
Table 5: mean and median age at first presentation by diagnostic category. 
Diagnosis  Mean age of first 
contact (s.d.)* 
Median age of first 
contact (IQR)** 
All psychoses F20-33 31.2 (11.2) 28 (16) 
Schizophrenia F20 29.6 (10.9) 26 (9) 
Affective Psychosis F30-33 29.8 (10.3) 29 (13) 
Other psychosis F21-29 34.9 (11.2) 33 (16) 
*s.d: standard deviation.  












Figure 5: age distribution by diagnostic category. 
 
 
I then compared median age at first presentation by gender for overall 
psychotic disorders and by each diagnostic category. 
Median age at first presentation for overall psychoses was significantly 
higher in females 32.5 (IQR:16) than males 26.5 (IQR:13) (z=2.3, p-
value=0.020, Wilcoxon test) as shown in Fig 6. 
This result overlaps with the AESOP study in which the median age at 
first presentation was 27 years in men (IQR: 22-34) and 30 years in 
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Figure 6: age distribution by gender: females are older than males at their 
psychotic onset when considering overall psychotic disorders.
 
 
Age distribution by diagnostic category and gender is displayed in Fig 7.  
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Age distributionby diagnostic category and gender
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When I split cases into the two categories: affective psychoses (mania 
and depression with psychotic features) and non-affective psychoses 
(schizophrenia and other psychoses), I did not find any significant 
difference in the median age at first presentation (z=0.5, p-value=0.641, 
Wilcoxon test) as shown in Fig 8.  
 
Figure 8: age distribution in affective and non-affective psychoses.  
 
 
Table 6 summarizes mean and median age at first presentation by 
gender and by diagnostic category. 
Median age was lower than mean age because of the positively skewed 
age distribution of psychoses. I applied Wilcoxon test to compare median 
age in males and females by diagnostic category because of the non-
normal distribution of age at first presentation. 
I found a significant difference between median age at first presentation 
by gender for all psychoses (z=2.3, p-value=0.020, Wilcoxon test), but 
when I repeated the analyses by each diagnostic category, the 
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Table 6: mean and median age of first contact of service (years) in cases for 
different diagnostic categories. p values refer to median age at first contact.  










































































*p values from Wilcoxon test  
 
4.3.3 Socio demographic characteristics of the sample  
Socio-demographic data on level of education, relationship and 
employment status, living status (with someone or alone), migration are 
summarized in Table 7. 
Most of the patients had a diploma (42.7%) or a junior high certificate 
(36.7).  
Patients were mostly single or separated (72.7%), and unemployed 
(54.1%). 94.5% of the patients lived with someone in the household and 
only the 5.5% lived by themselves.   
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This may represent a feature of Italian family structure which might differ 
from other countries, and may have implications for the course and the 
outcome of patients affected by a psychotic disorder. 
Table 7: socio-demographic features of 204 cases.  
Cases    n (%) 
Level of education 
No qualification 
Primary school 
Junior high  
Diploma 
University 




























Living with someone 
Yes  
No  












4.4. Incidence rates of psychotic disorders in Palermo  
4.4.1 Specific incidence rates by age bands  
 
Fig 9 displays specific rates and their 95% CI of all psychotic disorders by 
age bands. The highest incidence rates for all psychotic disorder fall in 




Figure 9: specific incidence rates and their 95% CI for overall psychotic 
disorders by age-bands.   
 
Age and gender specific incidence rates for all psychoses are shown in 
Fig 10.  
Males show higher specific rates than females for all psychoses till 30-34 
years; then at 35-39 the rates tend to overlap.  
The same distribution of age has been found in the AESOP study as is 
shown in the Fig 11 (Kirkbride, Fearon et al. 2006) where the curves 
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Figure 10: specific incidence rates and their 95% CI for overall psychotic 
disorders by age-bands and gender. 
 
  
Figure 11: this picture from Kirkbride, Fearon et al. 2006, shows in graph A the 
age and sex specific incidence rates of overall psychotic disorders in the 
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DIAGNOSES
Figure 2 shows the distribution of cases by diagnosis.
Sixty-seven percent of cases received a diagnosis of non-
affective psychosis; 37%,DSM-IV schizophrenia; and 30%,
DSM-IV other nonaffective psychoses. Twenty-eight per-
cent of the sample received a diagnosis of affective psy-
chosis. More than half of these were cases of depression
with psychotic features (53%); the remainder received a
diagnosis of bipolar disorder. The remaining 5% of cases
in the total sample were diagnosed with an SIP. Sixty-
nine percent of both cases with schizophrenia and SIPs
were men, but for other psychoses, sex differences were
moremodest (men, 54%). Just more than half of all cases
of affective psychosis were women (52%).
Table 2 presents the crude and age-sex–
standardized incidence of different psychoses for the com-
bined study areas and by each study center. The IRR com-
paring study centers, adjusted for age and sex of the total
study population, is also presented in Table 2.
All Psychoses
The overall incidence rate (!) of all psychotic disorders
in the ÆSOP study was 34.8 per 100 000 person-years
(95% CI, 32.1-37.8). This figure varied between study
centers such that the crude incidence of first-onset psy-
choses in Southeast London (!=54.5 [95% CI, 48.7-
60.9]) was more than twice that observed in Notting-
ham (!=25.1 [95% CI, 21.9-28.8]) or Bristol (!=22.1
[95%CI, 17.1-28.7]). Standardization for age and sex did
not significantly alter this pattern. The rate of psychoses
in Southeast Londonwas significantly higher than inNot-
tingham (1/IRR, 2.0 [95% CI, 1.7-2.5]) or Bristol (1/
IRR, 2.5 [95% CI, 1.7-3.3]).
Nonaffective Psychosis and Schizophrenia
The adjusted incidence rates described earlier are present-
edgraphically inFigure3, alongwithrates for specificpsy-
chotic disorders using the data presented in Table 2. After
adjustmentforageandsex, theincidenceofnonaffectivedis-
orders remained significantly higher in Southeast London
(!=37.4 [95% CI, 32.3-42.5]) than Nottingham (!=13.1
[95%CI,10.6-15.5])orBristol(!=13.2[95%CI,8.9-17.4]).
This effectwas independentlypresent forbothschizophre-
nia and other nonaffective psychoses (Figure 3).
Affective Psychoses
The crude incidence of affective psychoses in the
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Figure 1. Cumulative proportion of all psychoses by age and sex and age-specific incidence rates of selected psychoses by sex. A, All psychoses. B, Nonaffective










Figure 2. Distribution of cases by diagnosis in the Ætiology and Ethnicity in
Schizophrenia and Other Psychoses (ÆSOP) study.
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Specific incidence rates for schizophrenia by age bands and gender have 
been calculated and displayed in Fig 12.  
 
Figure 12: schizophrenia specific incidence rates by age bands and gender 
with their 95% CI. 
 
When considering the distribution of age by gender for schizophrenia the 
rates tend to overlap both in Palermo Fig 12 and in AESOP Fig. 11 
(graph C) at the age of 40-44. 
 
4.4.2 Incidence rates by diagnostic category and gender 
 
Table 8 shows incidence rates for all psychoses and by diagnostic 
categories.  
Crude rates are displayed per 100,000 person years, (total and by 
gender).  
According to the literature, the incidence of schizophrenia is higher in 
young people and in males. I adjusted incidence rates by age and 
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(IRR) and their 95% CI for each diagnostic category for males and 
females to detect whether there was a difference in risk of developing any 
psychotic disorders between males and females.  
Before adjusting incidence rates by age and migration I tested the 
absence of an interaction between age and migration by the likelihood 
ratio test (LRT), assuming that the rates are homogeneous among native-
born Italians and migrants by each age band.  
 
Table 8: crude incidence rates (total and by gender) for overall psychoses and 
for each diagnostic category (rates are displayed per 100,000 persons per 
year). Crude and adjusted incidence rate ratio (IRR) with their 95% CI for males 
and females.  
 
Incidence rates  Crude rates 
(95% CI) 
Crude IRR 



































































* IRR are adjusted by age and migration by Poisson Regression. 
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The crude incidence rate of all psychotic disorders was 15.9 per 100,000 
person years (95% CI 13.7-18.1), 20.4 (95% CI 16.8-24) in males and 
11.7 (95% CI 9.1-14.3) in females;  
Crude incidence rate of schizophrenia was 9.6 per 100,000 per year 
(95% CI 7.9-11.3), 13.1 (95% CI 10.3-16) in males and 6.3 (95% CI 4.4-
8.2) in females;  
Crude incidence rate of affective psychoses was 1.5 per 100,000 per year 
(95% CI 0.4-1.5), 1.8 (95% CI 0.7-2.8) in males and 1.2 (95% CI 0.4-2) in 
females 
Crude incidence rate of other non-affective psychoses was 4.8 (95% CI 
3.6-6) per 100,000 per year, 5.5 (95% CI 3.7-7.4) in males and 4.2 (95% 
CI 2.6-5-8) in females.  
 
4.4.3 Is the risk of psychosis increased in males? 
As shown in Table 8, incidence rates for overall psychoses and 
schizophrenia are higher in males. I applied Poisson regression model to 
evaluate if males had an increased risk than females to develop 
psychoses calculating the incidence rate ratio (IRR). I applied the 
likelihood ratio test (LRT) to test the interaction between age and 
migration and as shown by p values, I did not find any interaction 
between age and migration. I assume that IRR between males and 
females are homogeneous between native-born Italians and migrants for 
each age band.   
Figure 13 shows crude and adjusted incidence rate ratios (IRR) for males 
and females by diagnostic category.  
Males have a higher risk of developing any psychotic disorders (adjusted 
IRR: 1.7, 95% CI 1.3-2.2) than females; they also show a nearly double 
risk of developing schizophrenia when compared to females (adjusted 
IRR: 2, 95% CI 1.4-2.9). I did not find any difference by gender for 




Figure 13: crude and adjusted IRR (by age and migration) in males versus 
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4.5 Incidence rates of psychosis in migrants   
4.5.1 Introduction  
Previous studies implicate migration as a risk factor for psychosis (Cantor 
Graae and Selten, 2005). In the AESOP studies certain minority ethnic 
groups were at higher risk for developing a psychotic disorder (Fearon, 
Morgan et al. 2006). There is now evidence that the incidence of all 
psychosis is higher in some migrant and minority ethnic populations in 
different countries (Europe, USA, Australia) (Morgan, Charalambides et 
al., 2010). In Italy Tarricone and colleagues found a higher risk for 
psychosis in migrants (IRR: 2.5, 95% CI 2.1-2.9) compared to native-born 
Italians (Tarricone, Mimmi et al. 2012).  
I will describe differences in incidence rates in migrants and native-born 
Italians for overall psychosis and by diagnostic category; I will calculate 
the incidence rate ratios between native-born Italians and migrants to 
verify if migration is associated with an increased risk of developing 
psychotic disorders.  
I will finally compare my results with the previous findings of the AESOP 
study.  
 
4.5.2 Population denominator for migrants 
Migrants who were resident in Palermo on 1°January 2011 represented 
about 4% of the total resident population. The most numerous ethnic 
groups in Palermo come from Sri Lanka (17,3% of all migrants), followed 
by Bangladesh (17,0%) and Romania (11,0%) (ISTAT, 
www.tuttitalia.it/sicilia/81-palermo/statistiche/cittadini-stranieri-2011). 
People aged 18-65 years belonging to ethnic minority group and resident 
in Palermo in 2011 were 15,142 (M: 7600, F: 7542). 
 
4.5.3 Numerator for migrants 
Over 204 cases, 183 (89.7%) were native-born Italians (white Italians) 
and 21 were migrants (10.3%): 7 females (33.3%), 14 males (66.7%). 
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Although migrants were only 21, their proportion exceeded that in the 
general population (10.3% versus 4%). 
There were no differences in the proportion of males and females 
between native-born Italians and migrants. Male native-born Italians were 
61.2% versus 66.7% of male migrants (chi=0.2, df=1, p-value 0.626, χ2 
test).  
All migrants were people who were born in their country of origin (first 
generation migrants). The distribution of ethnicity among 21 migrants is 
showed in Table 9. 
 
Table 9: ethnic groups among cases  
 Total (%) Males (%) Females (%) 
White Italians  183 (89.7%) 112 (88.9%) 71 (91%) 
White Caucasian (Europe) 7  (3.4%) 2 (1.6%) 5 (6.4%) 
Asians  7  (3.4%) 6 (4.8%) 1 (1.3%) 
Africans  7  (3.4%) 6 (4.8%) 1 (1.3%) 
 
1. 7 were white Caucasians from Eastern Europe (5 from Romania, 1 from 
Poland, 1 from Jugoslavia); 
2. 7 came from Asia (4 Indian, 2 Bangladesh, 1 Philippines, 1 Afghanistan); 
3. 7 came from Africa (2 Morocco, 2 Ghana, 1 Ivory Coast, 1 Tunisia (mixed 
Italian), 1 Mauritius). 
White Italians constituted the 89.7% of the sample. Migrants were equally 
distributed in the three wide categories (white Europeans, Asians and 
Africans). Africans and Asians were mostly males while Europeans 
migrants were mostly women.  
17 migrants (80.95%) were diagnosed with schizophrenia, 4 (19.05%) 
were diagnosed with other psychosis. None received the diagnosis of 





4.5.4 Age of first contact with mental health services in migrants 
Median age at first presentation for all psychotic disorder was significantly 
different between native-born Italians (29, IQR 16) and migrants (25, IQR 
10) (z=2.0, p-value=0.049, Wilcoxon test) as shown in Fig 14 and Table 
10.  
 
Figure 14: age of first contact with mental health services in native-born Italians 
and migrants.  
 
 
When we take into account all psychotic disorders, there is an earlier age 
at first presentation to psychiatric services for migrants (z=2.0, p-
value=0.049, Wilcoxon test). However, when we look at the differences in 
the age at first presentation by each diagnostic category, the differences 
disappear. This is likely to be due to the small sample size of migrant 
group in this thesis.  
In table 10 I report both mean and median age at first contact with 
psychiatric services but I compared median age between native-born 
Italians and migrants applying Wilcoxon test because of an asymmetric 
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Table 10: mean and median age at first presentation by each diagnostic 
category by migrant status. p value refer to median age at first contact. 
Diagnosis  Mean age of first contact 
(sd) 




All psychoses F20-33 





















Affective Psychosis F30-33 










Other psychosis F21-29 










*p value from Wilcoxon test 
Fig 15 shows specific incidence rates by age bands for migrant and 
native-born Italians.  
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When we look at specific rates there is a statistically significant difference 
in the incidence of psychosis in native-born Italians and migrants for the 
age band 18-24 while from 30-34 years the curves tend to overlap Fig 15.  
As shown in Table 11, most of the migrants (47.6%) belong to the age 
band 18-24. It is possible that young people are more likely to have 
migrated recently and therefore the stress of migration might cause them 
to develop psychosis.   
 
Table 11: distribution of migrants and native-born Italians by age bands  
 Migrants, n (%) Native-born Italians, n (%) 
18-24 10 (47.6) 61 (33) 
25-29 5 (23.9) 34 (18.6) 
30-34 1 (4.7) 22 (12) 
35-39 3 (14.3) 25 (13.7) 
40-44 1 (4.7) 14 (7.6) 
45-49 0 9 (4.9) 
50-54 1 (4.7) 8 (4.3) 
55-59 0 6 (3.3) 
60-65 0 4 (2.2) 
Total 21 183 
 
4.5.5 Is the risk of psychosis increased in migrants? 
Table 12 shows crude incidence rates and their 95% CI for native-born 
Italians and for migrants for all psychoses and by diagnostic category.   
Crude and adjusted incidence rate ratios (IRR) and their 95% CI are 
presented for each diagnostic category. 
I applied Poisson regression to calculate the incidence rate ratio between 
migrant and native-born Italians after adjusting for age and sex. 
Likelihood ratio test (LTR) excluded interaction between age and gender 
as shown in Table 12.  
The incidence rates for all psychoses were 14.8 (95% CI 12.6-16.9) in 
native-born Italians and 46.2 (95% CI 26.5-66) in migrants.  
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For schizophrenia, incidence rates were 8.6 (95% CI 6.9-10.2) in native-
born Italians and 37.4 (95% CI 19.6-55.2) in migrants and for other non-
affective psychoses incidence rates were 4.7 (95% CI 3.5-5.9) in native-
born Italians born Italians and 8.8 (95% CI 0.2-17.4) in migrants. 
Affective psychosis was only present among native-born Italians with an 
incidence rate of 1.5 (95% CI 0.8-2.1). 
Table 12: Crude incidence rates in native-born Italians and migrants for all 
psychosis and by diagnostic category (rates are displayed per 100,000 persons 
per year). Crude and adjusted (by age and gender) incidence rate ratio (IRR) 
with their 95% for migrants and native-born Italians.   
 





Incidence rates  Crude rates 
(95% CI) 
 


























































Figure 16: crude and adjusted (by age and gender) incidence rate ratio in 
migrants versus native-born Italians.  
 
 
Migrants have a nearly 3 fold increased risk to develop any psychotic 
disorder (adjusted IRR: 2.8, 95% CI 1.8-4.4) and they have 4 fold 
increased risk of developing schizophrenia (adjusted IRR: 4, 95% CI 2.4-
6.7) compared to native-born Italians. No difference in risk has been 
found for other psychotic disorders (Fig. 16).  
These results are in line with the existing literature. In the AESOP study 
the differences in incidence rates are described in details for groups of 
ethnic minorities rather than for native British and migrant people; Afro-
Caribbeans for example showed an IRR of 6.7 (95% CI 5.4–8.3) to 
develop psychotic disorders compared to white British (Fearon, Kirkbride 
et al. 2006).  
 
4.6 Comparing incidence rates of psychosis in Palermo to AESOP 
After calculating crude and adjusted incidence rates and incidence rate 
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in comparing my data to that of AESOP to see whether there was a 
variation in the incidence of overall psychoses and in different diagnostic 
categories.  
 
4.6.1 Differences between Palermo and AESOP cases  
The Palermo sample included 204 cases, the AESOP sample 360 (after 
manipulating the dataset to exclude second generation migrants, cases 
aged less than 18 years and Bristol cases).  
In Palermo sample 60% of cases were affected by schizophrenia, 9.3% 
by affective psychoses, 30.4% non-affective psychoses. In the AESOP 
sample 45% were schizophrenic, 26% were diagnosed with affective 
psychosis, 29% with other non-affective psychoses.  
For overall psychoses, there were no significant differences between the 
distribution of AESOP and Palermo cases by age-bands (Pearson χ2=8, 
df=8, p=0.433) and by gender (Pearson χ2=0.17, df=1, p=0.680).  
In the original AESOP sample, median age at first presentation was 27 
years (IQR:12) in males and females 30 years in females (IQR 15) 
(Kirkbride, Fearon et al. 2006).  In Palermo median age at first contact 
was similar to that found in the AESOP study: median age at first 
presentation in Palermo was 26.5 (IQR:13) in males and 32.5 (IQR:16) in 
females.  
There was a different proportion of migrants in the Palermo and AESOP 
samples (Pearson χ2 =52.2, df=1, p<0.001). In AESOP 61.1% of the 
sample were UK-born people versus 38.9% Non-UK born. In Palermo 
non-Italy born people were just the 10.3% of the sample.  
There was a different distribution of schizophrenia by age-bands between 
Palermo and AESOP (Fisher test, p=0.03). The proportion of 
schizophrenic patients was higher in Palermo (40.6%) than AESOP 
(28.4%) in the age band 18-24, while it was higher in AESOP (18.5%) 
compared to Palermo (8.9%) in the age band 30-34. The proportion of 
migrants among schizophrenic patients was significantly higher in the 
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AESOP sample (47%) compared to Palermo (13.8%) (Pearson χ2=34.3, 
df=1, p<0.001). 
No differences have been found in the distribution of affective psychoses 
by age-band (Fisher test, p=0.945) and gender (Pearson χ2=0.45, df=1, 
p=0.505) between Palermo and AESOP samples. There were not any 
migrants affected by affective psychosis in Palermo sample. In the 
AESOP sample the distribution of affective psychoses was 39.2% in 
migrants and 60.8% in UK born people.  
No differences have been found in the distribution of other non-affective 
psychoses by age-bands (Fisher test, p=0.863) and gender (Pearson 
χ2=0.06, df=1, p=0.796) between Palermo and AESOP samples. There 
was a higher proportion of migrants affected by other psychoses in the 
AESOP sample (34.8%) compared to Palermo (6.4%).  
 
4.6.2 Incidence rates differences between Palermo and UK 
To take into account the difference distribution of age and gender in the 
population structure of Palermo and UK, I standardized incidence rates 
by age and gender.  
I used indirect standardization, applying age and sex specific rates of 
AESOP sample to Palermo population (see the chapter of methods for 
further details).  
Fig 17 shows Palermo age and sex standardized incidence rates for all 
psychoses and for each diagnostic category, compared to AESOP rates. 
AESOP rates differ from those reported by Kirkbride and colleagues in 
their paper (Kirkbride, Fearon et al., 2006) because AESOP incidence 
rates have been recalculated just for London and Nottingham and 
excluding Bristol because of the lack of data on place of birth which I 
used to adjust for migration status (see methods for further details).  
As explained in detail in the previous chapter, AESOP specific incidence 
rates have been recalculated excluding second-generation migrants 
(people who were born in UK but from migrant parents). In this work I 
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compared native-born Italians in Palermo with white British in AESOP, 
and migrants in Palermo to non-UK born people in AESOP. 
Figure 17: standardized incidence rates in Palermo by age and gender. 	  
 
 
Table 13 shows the standardized rates by age and sex for Palermo 
compared to the standardized rates in AESOP. 
In the table I also reported the standardized morbidity ratio (SMR) and its 
reciprocal (1/SMR) with its 95% CI to compare incidence rates in Palermo 
and AESOP. 
The SMR measures how much more or less likely a person is to develop 
a disorder in the study population compared to someone of the same age 
and sex in the standard population (AESOP). If the value is close to 1, 
there are no differences in the likelihood of developing the disorder, a 
value smaller than 1 means that subjects are less likely to become ill 
compared to the standard population (Kirkwood and Sterne, 2006).  
Fig 18 graphically shows all the 1/SMR for all psychoses and by each 
diagnostic category displaying the increased risk in UK compared to 
Palermo.  
After standardizing for age and sex, people in Palermo are less likely to 
develop any psychotic disorder than in London and Nottingham.  
In AESOP the risk of developing any psychotic disorder is 1.5 higher than 
in Palermo with a SMR: 0.6 (95% CI 0.6-0.7).  
18	  
11	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27	  
11	   7	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All	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I did not find any difference in the risk of developing schizophrenia in UK 
and in Palermo respectively SMR: 0.9 (95% CI 0.7-1.1). 
No statistical differences were found between the incidence of non-
affective psychoses in the two sites. 
The most relevant difference is the increased risk of developing an 
affective psychotic disorder in London and Nottingham when compared to 
Palermo. In UK the risk of affective psychoses is 4.5 higher than in 
Palermo with a SMR of 0.2 (95% CI 0.1-0.3). 
So the excess of psychosis in UK appears to be due to the higher 
incidence of affective psychoses in UK when compared to Palermo.  
 
Table 13: comparison of standardized (by age and sex) incidence rates by 
diagnostic categories in Palermo and in AESOP.  
Incidence 
rates  
Standardized rate  
Palermo  by age and sex 
(95% CI) 
Rates AESOP (London 
and Nottingham) (95% CI) 
SMR (95% CI) 




17.5 (15.2-20.1) 27.1 (24.4-30) 
 






















I then stratified the SMR by migration status (Table 14). As reported by 
the SMR values, British natives show a higher risk of developing 
psychoses than Palermo natives-Italian. There were no differences in the 
risk of overall psychosis or its subcategories among non-natives in the 
two countries. There appears to be an increased risk of affective 




Table 14: Comparison of standardized (by age and sex) incidence rates in 
Palermo and in AESOP stratified by migration status; SMR refer to the different 
risk in native born Italians and British natives and in Palermo migrants vs non-
British AESOP cases. 
Incidence rates  Palermo incidence rates 
by age and sex (95% CI) 
AESOP incidence rates  
(London and Nottingham) 
(95% CI) 



































































Figure 18: reciprocal of SMR (1/SMR) and 95% CI for all psychoses and by 




4.7 Comparing incidence rates of psychosis in Palermo to 
AESOP after standardizing for migration  
Since in AESOP the proportion of people belonging to ethnic minorities in 
the sample was higher (38.9%) compared to Palermo (10.3%), I further 
standardized for migration (together with age and gender) in order to take 
into account the differences of the structure of the two samples  (age, 
gender, migration). However, in AESOP there is a detailed description of 
ethnic minorities but there is not a specific category of “migrant”. To 
compare Palermo and AESOP data I defined non-UK born people as 
migrants, as described in chapter 3.  
Fig 19 shows Palermo standardized incidence rates (by age, sex and 
migration) for all psychoses and for each diagnostic category, compared 















All psychoses F20 F30-33 F21-29
SMR London and Nottingham vs Palermo
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Table 15 and Fig. 20 show Palermo standardized incidence rates for 
overall psychoses and for each diagnostic category; the SMR and its 
reciprocal 1/SMR displays the reciprocal of the SMR for each category. 
 




Table 15: comparison of standardized incidence rates (by age, sex and 
migration) by diagnostic categories in Palermo and in AESOP. 
Incidence 
rates  
Standardized rate  
Palermo by age, sex 
and migration  
Rates AESOP (London and 
Nottingham 
SMR (95% CI) 
1/SMR (95% CI) 
All psychoses 21.9 (19-25.1) 27.1 (24.4-30) 0.8 (0.7-0.9) 
1.2 (1.1-1.4) 
F20 15 (12.5-17.9) 11.4 (9.6-13.3) 1.3 (1.1-1.6) 
0.7 (0.6-0.9) 
F30-33 1.9 (1.2-3) 7.3 (5.9-8.9) 0.3 (0.2-0.4) 
3.8 (2.9-4.7) 
























Standardized rates in Palermo vs 






Figure 20: reciprocal of SMR (1/SMR) and 95% CI for all psychoses and by 
each diagnostic category (after standardizing by age, gender and migration).  
 
 
After standardizing for age, gender and migration rates in Palermo the 
magnitude of the difference in risk of psychoses between AESOP and 
Palermo was slightly reduced and the risk of all psychoses was 1.2 higher 
in AESOP when compared to Palermo; 1/SMR: 1.2 (95% CI 1.1-1.4)  
There was still an increased risk for developing affective psychoses in 
UK: SMR: 0.26 (95% CI 0.2-0.4) but schizophrenia rates were higher in 
Palermo than in UK: SMR=1.3 (95% CI 1.08-1.6).  
There was not any difference in the risk of other non-affective psychoses 
between the two sites: SMR: 0.9 (95% CI 0.7-1.2).  
So, assuming that Palermo and AESOP had the same structure in terms 
of age, gender and migration the risk was still modestly increased for 
overall psychoses in UK and substantially increased for affective 















All psychoses F20 F30-33 F21-29
SMR London and Nottingham vs Palermo
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These results off the possibility of some speculations about the 
underlying reasons for these differences which will be discussed in 
chapter 6. 
 
4.8 Summarizing the results  
1. I identified 204 cases of first episode of psychosis over 3 years in 
Palermo 61.8% were males.  
2. The median age at first presentation for all psychoses was 28 years 
(IQR 16); Males had an earlier onset 26.5 (IQR:13) than females 
32.5 (IQR:16), (z=2.3, p-value=0.020, Wilcoxon test),. Migrants had 
an earlier median age at first presentation (25 years, IQR 10) than 
native-born Italians (29, IQR 16) (z=2.0, p-value=0.049, Wilcoxon 
test). 
3. The incidence rate for all psychotic disorders was higher in males: 
IRR: 1.7 (95% CI 1.3-2.2). 
4. Migrants were more likely to develop any psychosis: IRR: 2.8 (95% 
CI 1.7-4.4). 
5. Incidence rates of overall psychoses were lower in Palermo than 
AESOP after standardizing for age and sex; no differences were 
found in the risk of developing schizophrenia and other non-
affective psychoses. So the difference in the overall rate might be 
explained by the lower rates of affective psychoses.  
6. After introducing as explanatory variable migration to age and sex, 
the overall rates of psychoses remained slightly increased in UK 
than in Palermo. Schizophrenia risk tend to be higher in Palermo 









Chapter 5  
Risk factors associated with Psychosis 
 
5.1 Introduction  
Several social and biological risk factors have been associated with an 
increased risk of psychotic disorder (e.g family history for psychiatric 
disorders and for psychosis in first-degree relatives, cannabis and other 
drug consumption, childhood and adult adversities and experiences of 
victimization) (Stilo, Murray, et al., 2010).  
 
5.2 Case control aims 
I carried out a case control analysis in a subsample of the FEP patients 
identified for the incidence study, aimed at: 
1. Comparing the prevalence of certain supposed environmental risk 
factors for psychosis in patients affected by a first episode of 
psychosis, and in healthy controls.  
2. Comparing the prevalence of environmental risk factors between 
Palermo sample of cases and controls and similar samples of first 
episode psychotic patients recruited in London (Genetic and 
Psychosis Study and AESOP study).  
5.3 Hypothesis 
According to the literature, I expect a different prevalence of the main risk 
factors between cases and controls (history of psychiatric disorder in the 
family, cannabis and other illicit drug exposure, adverse childhood 
experiences and victimization experiences lifetime). 
I expect similarities in the prevalence of some of the risk factors as 
reported in the GAP and AESOP studies e.g. family history for psychiatric 
disorders, adverse childhood experiences and lifetime victimization 
experiences but I expect differences in the prevalence of cannabis 
exposure in cases and controls between Italy and UK because of the 
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differences in the prevalence of lifetime cannabis consumption in the 
general population in the two sites (22.4% in Italy, 40% in UK).   
 
5.4 Methods and assessment 
During the study period, we recruited 68 subjects affected by psychosis at 
their onset out of 204 patients identified for the incidence study. They 
accepted to be enrolled in the Sicilian Genetics and Psychosis study. All 
the patients fulfilled the criteria for an ICD 10 diagnosis of psychosis. The 
diagnoses were confirmed by the Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN) (WHO, 1992). Socio-demographic data were 
collected by The Modified version of the Medical Research Council 
(MRC) socio-demographic scale (Mallett, Leff et al. 2002). 
Over the same period, we recruited a sample of 74 healthy controls from 
the local population. They were similar to cases in terms of gender, 
migration status, while there were differences for age, level of education 
and employment status. All the comparisons were then adjusted for these 
differences.  
Table 16 shows the instruments used for the assessment of the risk 
factors in cases and controls. 
Table 16: instruments for the assessment of genetic and environmental risk factors 
Risk factor Questionnaire/Scale 
Family History of Psychiatric 
disorder 
Family Interview for Genetic study (FIGS) (NIMH 
Genetic Initiative) 
Cannabis and Other drug 
consumption  
Cannabis Experience Questionnaire modified version 
(Di Forti, et al 2009) 
Childhood traumatic experiences  Childhood Experience of Care and Abuse (CECA) 
Questionnaire modified version (Bifulco et al., 2005), 
Adult adverse life events Brief Life Events schedule modified version (adapted 
from Bebbington et al. 2004) 






Patients were further assessed by: 
• Positive and Negative Syndrome Scale (PANSS) (Kay, Fiszbein 
1987): was used to evaluate symptom severity.  
• Nottingham onset schedule (NOS DUP) (Singh 2005): is a short 
interview and rating schedule to measure onset in psychosis. 
• Wechsler Adult Intelligence scale (WAIS-R)	   (Wechsler, 1981): was 
used to measure IQ in cases and controls.  
5.5 Statistics 
Logistic regression was used to analyze the association between the 
main risk factors studied and the presence of a psychotic disorder, after 
adjusting for potential confounders.  
 
5.6 Results 
5.6.1 Description of the sample  
68 first episode patients (FEP) (33.3%) out of 204 patients were recruited 
into the study and completed the whole assessment. 
136 (66.6%) patients were not involved in the study either because they 
refused to be interviewed (72, 53%) or because they had been screened 
and identified retrospectively (64, 47%) or by the leakage study (see 
methods for further details). 
We also recruited 74 healthy controls aged 18 to 65 years from the local 
population (see chapter 3 for details about control recruitment). Case and 
controls characteristics are displayed in Table 17.  
There was no difference of gender distribution between the two groups 
(χ2=2.1, df=1, p-value 0.147, χ2 test). 
Age at first contact with psychiatric services was used as an estimate of 
the age of onset of psychosis. This represents just a rough measure of 
the true onset of the disorder, since psychotic disorder often develop in a 
subtle way and sub-threshold symptoms are often present several years 
before the full expression of the disorder. Previous studies considered the 
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date of first contact with services as a proxy for date of onset of psychotic 
disorders (Sartorius, Jablensky et al. 1989; Eranti, Maccabe et al. 2013). 
There was a significant difference in terms of median age of cases (24 
years; IQR 13) than controls (33.5 years; IQR 28) (z=3.5, p-value<0.001, 
Wilcoxon test) (Fig. 21) so all the analyses have been adjusted by age.  
 
Figure 21: age distribution in cases and controls. 
 
Cases had a significantly lower mean IQ (mean 78.7, sd:16.8)  than 
controls IQ (mean 101.6, sd:23)  (t=5.8, df=86, p<0.001, Welch test), 
however only half of the cases completed the assessment so the result 
must be interpreted cautiously. Most of the cases and controls were 
native-born Italians.  
Cases were more likely to be less educated than controls (χ2=21.6, df=1, 
p-value <0.001, χ2 test) and were also more likely to have reached 



















Figure 22: mean age of leaving education in cases and controls. 
 
Mean age of leaving education was 3 years earlier for cases than controls 
(Fig. 22)  (t=5.5, df=115, p<0.001, Welch test). 
Cases were also more likely to be unemployed compared to controls (χ2= 
29.7, df=3, p<0.001, χ2 test). Cases were 6.7 times more likely to be 
single, separated or divorced than controls (χ2= 26.6, df=1, p<0.001, χ2 
test), OR:6.7 (95%CI: 3.15-14.3). Controls were more likely than patients 
to have been ever involved in a long-term relationship (χ2= 10.5, df=1, 

































Age, years mean (s.d.) 
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Ethnicity, n (%) 
Caucasian  











Level of education, n (%) 
No education 


















































Relationship status, n (%)  

















Table 18 summarizes the main characteristics of cases.  72% of cases 
had a diagnosis of schizophrenia.  
Median age at first presentation of psychosis did not differ significantly in 
males and females (z=0.9, p-value=0.382, Wilcoxon test). 
Mean score for PANSS cases was 102.27 (sd:25.1). I did not find any 
difference in mean PANSS score by gender (t=-0.3, df=57, p-
value=0.784, Student t-test).  
Mean duration of untreated psychosis (DUP) was 5.8 months, sd 9.4. 
Applying Wilcoxon test did not show any difference in DUP by gender 
(z=-1.6, p-value 0.094, Wilcoxon test). 
 
Table 18: clinical characteristics of cases 
Cases  68 p value* 

































Mean duration of untreated Psychosis 















* p value from t test, Wilcoxon test 
As shown in Fig. 23 most of the cases (43, 63.2%) have a duration of 
untreated psychosis between 0 and 10 months.  
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Figure 23:  duration of untreated psychosis (DUP) in cases.
 
 
5.6.2 Psychiatric family history  
According to the literature, schizophrenia has a strong familial component 
(Kendler, McGuire, et al. 1993). Patients affected by schizophrenia are 
more likely to have one or more first-degree relatives affected by any 
psychiatric disorder than healthy individuals (Byrne, Agerbo et al. 2002).  
Patients with a higher familial load of psychosis have an earlier age of 
onset of the disorder (Suvisaari, Haukka et al. 1998). 
 
5.6.2.1 Aims 
• Comparing the prevalence of any psychiatric disorders and 
psychotic disorders in the first-degree relatives of cases and 
controls. 
• Comparing the mean age at first presentation among cases in 





















1. I expect cases to have a higher prevalence of a history of any psychiatric 
disorder and of psychotic disorders in first generation degree relatives.  
2. I expect cases with a first-degree relative affected by a psychotic disorder 
to have an earlier age at first presentation than those without. 
5.6.2.3 Methods 
I have used χ2 to test for association between any psychiatric disorder in 
the family and the risk of being a patient.  
Due to the small number of controls (2) with a first-degree relative 
affected by psychosis, I used Fisher exact test to test for the association 
of having a first-degree relative affected by a psychotic disorder and the 
probability of being a case.  
I applied logistic regression to calculate adjusted OR for potential 
confounders (age, gender, education, employment). I selected the 
confounders according to the main socio-demographic differences in the 
two groups (χ2, Welch test). 
I used Welch test to evaluate the association between mean age at first 
presentation in cases and any psychiatric disorder in the family.  
 
5.6.2.4 Results 
Table 19 shows the proportion of any psychiatric disorder and of 
psychotic disorders among first-degree relatives in patients and controls.  
Cases were more likely than controls to have a first-degree relative 
affected by any psychiatric disorder (χ2=14.2, df=1, p-value<0.001, χ2 
test), and they were more likely to have a first-degree relative affected by 
a psychotic disorder (χ2=15.1, df=1, p-value<0.001, χ2 test). 
Among cases, those with a family history of psychiatric disorder had an 
earlier mean age at first presentation (24.9 yrs, sd 7.8) than those without 













Any psychiatric disorder in first-degree 



















































* p value from χ2 tests, Fisher’s tests. 
Applying logistic regression to adjust for age, gender, education and 
employment, the risk of having a first-degree relative affected by any 
psychiatric disorder was 5 times higher for cases than controls, adjusted 
OR: 5 (95% CI 1.6-15.2) (Table 20). 
Table 20: OR of psychotic disorders for the presence of a history of any 
psychiatric or psychotic disorder in a fist degree relatives.  
 Adj OR* 95% CI p value  
Any psychiatric disorder in first-degree 







0.005      
 
Psychosis in first-degree relatives, n (%) 
 
10.3  1.7-62.2 0.01 
*Adjusted for age, gender, education, employment by logistic regression. 
I found a higher risk for cases to have a first-degree relative affected by a 
psychotic disorder with an adjusted OR of 10.3 (95% CI 1.7-62.2) (Table 
20), however this result must be interpreted with caution because of the 
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wide CI due to the low proportion of controls (2.7%) having a first-degree 
relative affected by psychosis Fig. 24. 
 

























History of psychosis in first degree 
relatives 
yes no  
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5.6.3 Cannabis and the risk of psychotic disorder 
Cannabis consumption is associated with an increased risk of developing 
a psychotic disorder (Henquet, Krabbendam et al. 2005; Moore, Zammit 
et al. 2007). The risk is reported to be higher when cannabis consumption 
starts in early adolescence (Arsenault, Cannon et al. 2002). However not 
all the people who smoke cannabis develop a psychotic disorder and the 
risk may be influenced by specific patterns of cannabis exposure such as 
frequency, duration and cannabis potency  (Di Forti, Morgan et al., 2009). 
A meta-analysis reported an earlier age of psychosis onset in cannabis 
users (Large, Sharma, et al. 2011). 
 
 5.6.3.1.Cannabis consumption in Italy  
Cannabis consumption is common in Italy. The General Population 
Survey (GPS-ITA 2010) was conducted in a representative sample of the 
general population aged 15-64 years.  22.4% of the general population 
had used cannabis at least once lifetime, 5.2% had used cannabis in the 
previous year and 3% had used cannabis in the previous month. 
Cannabis use in the previous month was more common among subjects 
aged 15-24 years (males 16.5%, females 10.6%) and among those aged 
25-34 years (males 12.5%, females 7.1%). (GPS-ITA; Dipartimento 
politiche antidroga, 2010). Median age of starting cannabis consumption 
was 18 years. 
Cannabis consumption in the general population progressively increased 
between 2001 and 2008 and then there was a substantial decrease in 
2010.  
The Student population Survey (SPS-ITA) was conducted in 35.018 
students aged 15-19 years in 2011.  22.1% had used cannabis at least 
once lifetime, 18.2% had used cannabis in the previous year and 12.9% 
had used cannabis in the previous month. Among students, males were 
more likely to have used cannabis than females in the previous year 
(33.9% vs 20% of females) and they were also more likely to have 
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smoked more than 20 times than females (30.2% vs 18.4%) (SPS –ITA 
2011). 
According to a survey run in 2007-2010 by the Department of Addiction in 
Milan, 31.7%, of a population sample aged 15-64 years reported lifetime 
cannabis use and 7.4% reported cannabis use in the previous month. As 
far as I know there are not available detailed data on Palermo population.   
 
5.6.3.2. Aims 
1. To compare pattern of cannabis consumption between cases and 
controls (exposure to cannabis lifetime, age at first use, duration of 
cannabis consumption, total number of times used, frequency of use). 
2. To investigate any association of pattern of cannabis use (exposure to 
cannabis lifetime, age at first use, duration of cannabis consumption 
and total number of times used) and age at first presentation of 
psychosis in the group of cases.  
3. To compare my results to those of the Genetic and Psychosis study 
(GAP) (Di Forti, Morgan et al. 2009), to detect any differences in 
patterns of cannabis exposure between South East London and 
Palermo. 
5.6.3.3 Hypothesis 
1. I expect no differences in terms of lifetime ever cannabis consumption in 
cases and controls but I expect a different pattern of consumption 
between the two groups: i.e. I expect cases to have an earlier age of first 
cannabis consumption, higher frequency and increased duration of use 
than controls. 
2. I expect gender differences among cases and controls in patterns of 
using cannabis (lifetime use, frequency of use, duration of use), and I 
expect a higher prevalence of cannabis consumption among males as is 
reported in the general population.  
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3. In the group of cases I expect an earlier age at first presentation in those 
who smoke cannabis than those who do not. 
I expect some similarities but also some differences in patterns of 
cannabis consumption in patients compared to GAP data (Di Forti, 
Morgan et al. 2009). For instance I expect no differences in cannabis 
lifetime use between cases and controls but I expect cases to have a 
higher frequency of cannabis use compared to controls, as in the GAP 
sample. I expect a lower proportion of Palermo cases and controls to 
have been exposed to “high potency cannabis” than in the UK reflecting 
the differences in the national trend of UK and Italy and the differences of 
the illicit drug market in London and in Palermo. 
 
5.6.3.4 Methods 
I compared patterns of cannabis use in cases and controls using where 
appropriate χ2 test or Fisher exact test (cannabis use lifetime, current 
cannabis use, frequency of cannabis use, use before and after 15 years); 
Welch test and Wilcoxon (or Wilcoxon) tests were used to calculate mean 
age at first use and mean duration of cannabis use for cases and controls 
because of unequal variances. I used ANOVA to evaluate differences in 
the mean age of first cannabis consumption by case-control status and by 
gender. 
Logistic regression was used to analyze the association between the 
pattern of cannabis use and the risk of psychosis, controlling for possible 
confounders. Confounders were selected as the main socio-demographic 
differences between cases and controls that might influence the risk of 
psychosis (age, gender, level of education, employment, psychiatric 
family history, other drug use).  
5.6.3.5 Results  





Table 21: patterns of cannabis use in cases and controls. The first row refers to 
all the sample of cases and controls while the following rows of the tables in 
light green refer only to the subgroup of cannabis smokers in cases and 
controls. 
* p value from χ2 tests, Fisher’s tests, t test, Wilcoxon test  
 
In Palermo sample, patients are not more likely to have smoked cannabis 
than controls at least once lifetime OR: 0.4 (95%CI: 0.1-1.1) as I 
expected; this is in line with results of Di Forti and colleagues (2009) who 
did not find a difference in prevalence of lifetime cannabis consumption 
between cases and controls OR: 0.8 (95%CI: 0.6-1.5) table 22, Fig. 25. 
                                                
3 No current use was defined as no cannabis consumption in the previous 4 
weeks as reported in the GAP study  






















Current cannabis use* (at the time of the 
















Frequency of cannabis use, n (%) 
Everyday  











Total number of time used, n (%) 
<50 times 
























This finding can be explained by the fact that cannabis consumption is 
common both in UK and in Italy.  
I did not find any difference in lifetime cannabis consumption by gender 
both in cases (χ2=1.4, df=1, p-value=0.238, χ2 test) and controls (χ2=1.8, 
df=1, p-value=0.178, χ2 test), while in the GAP study males were more 
likely to have a history of cannabis use than females (Di Forti, Sallis et al., 
2013).  
I did not find any difference by gender either in cases and controls when I 
repeated the analysis considering current cannabis use at the time of the 
assessment. 
Table 22: OR of psychotic disorders for measures of exposures to cannabis  
*Adjusted for age, gender, education, family history of psychiatric disorders, other drug 
consumption, by logistic regression  
 
Fig 25 shows lifetime cannabis consumption in cases and controls in the 
GAP sample.  
 
 Adj OR* 95% CI p value 



































































Figure 25: lifetime cannabis consumption in cases and controls in the Genetic 
and Psychosis study (Di Forti, Morgan 2009).  
 
  
Considering all the people who ever smoked cannabis, cases were more 
likely than controls to currently smoke cannabis at the time of assessment 
meaning that they were more likely to having smoked in the previous four 
weeks (χ2=6.8, df=1, p-value=0.017, χ2 test) as shown in Fig. 26. 
Figure 26: cannabis use at the time of assessment in those cases and controls 
who had ever smoked cannabis.  
 
Even after adjusting for possible confounders (age, gender, education, 
employment, psychiatric family history, other drugs abuse) the probability 
of being a current cannabis smoker was higher in cases than controls at 
the time of assessment; cases were over 5 times (adjusted OR: 5.4; 95% 
Assessment
We collected sociodemographic data (age, gender, self-rated
ethnicity, level of education achieved and employment status)
on both cases and controls. All participants were asked about their
use of illicit drugs and those who reported ever using cannabis
were interviewed using the Cannabis Experience Questionnaire.14
This allows a detailed assessment of lifetime patterns of cannabis
and stimulant use, including age at first use, frequency and
duration of use, and the specific type of cannabis used.
Statistical analysis
Logistic regression was used to analyse the relationships between
various aspects of cannabis use (lifetime use, age at first use,
duration and frequency of use, and cannabis potency) and case–
control status, and to test for interaction effects while controlling
for potential confounders. Associations are expressed as odds
ratios.
Results
We found 340 patients with first-episode psychosis who met our
inclusion criteria. Of these patients 60 (17.6%) refused to
participate, leaving 280 cases to be included in our analyses. Most
common reasons for refusal included lack of interest in research
and the length of our study assessment. If patients initially refused
because they were too ill, we approached them again later in case
their refusal was simply due to the severity of their symptoms.
During the same period we recruited 174 individuals to the
control group. There was no significant difference between the
cases and control groups in age, gender, ethnicity, educational
qualifications or employment status at time of assessment
(Table 1).
Lifetime cannabis use
More than half of the cases group (57%, n=159) had used
cannabis at least once in their life (Table 2), compared with 109
controls (63%) (OR=0.8, 95% CI 0.6–1.5). Among those who
had ever used cannabis, 65% (n= 183) of the cases group had first
tried cannabis before the age of 17 years, compared with 52%
(n= 91) of the control group (adjusted OR= 1.1, 95% CI 0.8–3.4).
Patterns of cannabis use
Among those who used cannabis, 59% (n= 94) of the cases group
had used it for more than 5 years compared with 38% (n=41) of
controls (unadjusted OR= 2.4, 95% CI 1.2–4.7). When potential
confounders (age, gender, ethnicity, level of education achieved
and employment status) were adjusted for, this difference was
attenuated slightly (adjusted OR= 2.1, 95% CI 0.9–8.4) and no
longer reached statistical significance. However, those in the cases
group were around six times more likely than the control group to
use cannabis every day, even after adjusting for the above potential
confounders (cases 77% v. controls 33%; unadjusted OR=6.7,
95% CI 2.0–11.5, adjusted OR=6.4, 95% CI 3.2–28.6).
Type of cannabis used
Again considering only those who used cannabis, 78% (n= 125) of
the cases group preferentially used sinsemilla (skunk) compared
with only 31% (n= 41) of the control group (unadjusted
OR= 8.1, 95% CI 4.6–13.5). This association was only slightly
attenuated after controlling for potential confounders (adjusted
OR= 6.8, 95% CI 2.6–25.4).
Combined effects of frequency and type of cannabis
use
There was some evidence of an interaction between frequency and
type of cannabis use: among those who used cannabis, those who
used sinsemilla (skunk) less frequently (not every day) were
around 5 times more likely to be in the cases group (OR= 5.7,
95% CI 2.5–12.6), whereas those who used it daily were around
12 times more likely to be in the cases group (OR=12.1, 95%
CI 3.7–37.3; Mantel–Haenszel test for homogeneity of odds
ratios: w2 = 1.2, P=0.5). The variation in odds ratios was
non-significant, and we consequently did not fit an interaction
term to our final logistic regression model. However, this lack of
significance may be due to limited statistical power, and given that
the difference is in the expected direction (i.e. highest odds in
those who used sinsemilla/skunk daily), the finding remains
noteworthy and certainly merits further investigation.
Discussion
Patients experiencing a first episode of psychosis were not more
likely to have ever taken cannabis or to have started doing so
earlier than the control group. This is not surprising because
cannabis consumption is very common among adolescents in
the UK: 40% of British children aged 15–16 years have used
cannabis.1 However, psychosis was associated with more frequent
and longer use of cannabis. This confirms previous suggestions
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Age, years: mean (s.d.) 25 (6.9) 27 (5.6)
Gender, n (%)
Male 202 (72.0) 113 (65.0)
Female 78 (28.0) 61 (35.0)
Ethnicity, n (%)
White 118 (42.0) 77 (44.5)
Black Caribbean 60 (21.5) 34 (19.2)
Black African 62 (22.3) 29 (16.8)
Other 40 (14.2) 34 (19.5)
Employment, n (%)
Unemployed 164 (58.4) 75 (43.2)
Employed 116 (41.6) 99 (56.8)
Education, n (%)
No qualification 41 (14.6) 19 (10.9)
Any qualification 239 (85.4) 155 (88.1)





Odds ratio (95% CI)
n (%) n (%) Unadjusted Adjusteda
Ever used
No 121 (43.1) 65 (37.5) 1.0
Yes 159 (56.9) 109 (62.5) 0.8 (0.6–1.5)
Age at first useb
Under 17 years 103 (65.3) 57 (52.2) 1.7 (1.0–4.7)* 1.1 (0.8–3.4)
17 years and over 56 (34.7) 52 (47.8) 1.0
a. Adjusted for age, gender, ethnicity, other stimulant use, level of education
achieved and employment status.







yes  no 
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CI: 1.2-24.1) more likely to be a smoker at the time of assessment than 
controls, table 22. 
Age at first cannabis use: Mean age at first use of cannabis differed 
between cases and controls. Patients started cannabis consumption 
about 3 years earlier than controls (t=3.1, df=60, p-value=0.002, Welch 
test). The difference for mean age at first use was calculated using Welch 
test because of unequal variances between cases and controls.  
Applying Anova, mean age at first use of cannabis was different by cases 
and controls (p-value=0.020) and by gender (p-value=0.006). Males 
tended to smoke earlier than females both in case and control groups. 
However there was no interaction between gender and case control 
status (p-value=0.254). 
The probability of using cannabis before 17 years among cases was 4 
times higher than in controls; adjusted OR: 4.2 (95% CI: 1.4-12.8) after 
adjusting for possible confounders by logistic regression. In the GAP 
sample, as shown in Fig. 25 there was no significant difference between 
cases and controls in starting cannabis consumption before 17 years 
(Adjusted OR: 1.1; 95% CI 0.8-3.4).  
Accordingly to the existing literature indicating that age 15 years old might 
be a critical age of first exposure (Casadio, Fernandes et al., 2011; Di 
Forti, Sallis et al. 2013) to cannabis use, I repeated the analysis using as 
a cut off “before and after 15 years”.  Cases were eight times more likely 
to having started using cannabis before 15 years (Adj OR: 8; 95% CI 2.4-
27) than controls, table 22. 
Frequency of cannabis use: Di Forti and colleagues reported that 
patients were around six times more likely than the control group to use 







Figure 27: pattern of cannabis use in the GAP sample by duration, frequency 
and type of cannabis. (adapted with the permission from Di Forti et al., 2009). 
 
In Palermo sample I grouped frequency of cannabis consumption in 
cannabis users in: “frequent” (meaning everyday use and more than 3 
times a week), “sporadic” (meaning that the subject tried cannabis only 
once or twice lifetime, a few times each month and a few times each 
year) to see whether a difference in frequency of cannabis consumption 
might influence the risk of developing a psychotic disorder. Despite the 
lack of differences in lifetime cannabis consumption between cases and 
controls, cannabis users among cases were more likely to smoke more 
frequently than controls, adjusted OR: 4.4 (95% CI:1.08-18).  
I then divided frequency of use into everyday and less than everyday as 
reported in Fig. 28 to compare my data with GAP sample (Di Forti, 
Morgan et al 2009).  
 
Figure 28: proportion of daily cannabis users in Palermo cases and controls 
among people who have ever used cannabis. 
  
 
Di Forti et al
that the risks of both transient psychotic symptoms and
schizophrenia in those who use cannabis are dose-related.6
Our most striking finding is that patients with a first episode
of psychosis preferentially used high-potency cannabis prepara-
tions of the sinsemilla (skunk) variety. In south-east London this
form of cannabis is estimated to contain between 12% and 18%
D9-THC and less than 1.5% cannabidiol. In contrast, those in
the control group who used cannabis were more likely to consume
resin (hash), with an average D9-THC concentration of 3.4% and
a similar proportion of cannabidiol.9
It is not surprising that the higher concentration of D9-THC
in sinsemilla (skunk) is more likely to have detrimental effects
on mental health. An experimental study in normal humans of
the acute effects of intravenous administration of D9-THC found
that the resulting psychotic symptoms were dose-dependent.7
Furthermore, a positron mission tomographic study has shown
that inhalation of D9-THC acutely increases striatal dopamine,15
which is thought to underlie psychotic symptoms.16
The relative lack of cannabidiol in sinsemilla (skunk) may also
be relevant, as there is some evidence that cannabidiol has anti-
psychotic properties.17 Furthermore, Curran et al measured
cannabinoid traces in the hair of three groups of normal
volunteers, and found that those with D9-THC only had higher
levels of schizophrenia-like symptoms than the ‘D9-THC plus
cannabidiol’ and ‘no cannabinoid’ groups.18
The availability of skunk on the UK market has steadily
increased over the past 6 years.8 Our estimate of preferred type
of cannabis used refers not to current use but lifetime use. In fact,
we did ask our participants to indicate among a list of types of
cannabis the one they preferentially smoked at any time during
their period of use. Most of those in the cases group (65%) and
control group (52%) had started using cannabis before age 17,
on average 6 years ago, and had continued to use it for 5 years.
Given that participants in the control group who used cannabis
had been exposed to the same changes in the cannabis market
as those from the cases group, the increased availability of skunk
cannot alone explain why our control group members are less
likely to prefer higher-potency types than the cases group across
time.
Finally, our results suggest that the potency and frequency of
cannabis use may interact in further incr asing the risk of psychosis.
Limitations and strengths
Our findings need to be considered in the light of potential
limitations. In theory, it is possible that our use of non-random
strategies of control recruitment could have biased our findings.
However, the cases and control groups were similar on a number
of sociodemographic factors that are associated with cannabis use
(e.g. education) and there was no evidence that our approach
undersampled those who used cannabis. Indeed, the proportion
of controls who had ever used cannabis (62%) was higher than
the national average (47%) for similar age groups,19 reflecting
the fact that cannabis use is more common in south-east London
than in the UK as a whole. Alternatively, if our sampling strategy
resulted in oversampling those who used cannabis, this would
have had the effect of reducing the strength of the associations
we observed – that is, our findings would underestimate the effects
of different patterns of cannabis use on the risk of schizophrenia.
Is it possible that our control recruitment strategy biased our
sample towards one of mild cannabis users, excluding heavy users
perhaps more likely to use skunk? Our advertising strategy
included internet and local newspapers advertisements as well as
distribution of leaflets at local shops, job centres and community
centres. There is no evidence that such methods of advertising are
more likely to bias towards better-functioning and socially
adjusted individuals; indeed, the opposite might be the case. It
therefore seems unlikely that the striking difference in type of
cannabis used between the cases and control groups is driven by
a recruitment bias. Moreover, there was no reported evidence of
skunk dependence in the clinical record of cases recruited.
We cannot totally exclude the possibility that patients in a
prodromal phase might need higher concentrations of D9-THC.
However, a recent population study has shown that cannabis
use in adolescence is associated with a twofold increase in
prodromal symptoms even when controlling for several con-
founders, including behavioural symptoms.20 We also know from
experimental studies that D9-THC is the active ingredient in
inducing psychotic symptoms and that cannabidiol produces
beneficial effects, including possible amelioration of psychotic
symptoms and reduced anxiety.7,17 Therefore, it remains unclear
why those already experiencing prodomal and/or psychotic
symptoms should choose to use a cannabis type (sinsemilla)with high
levels ofD9-THCwhich is likely to exacerbate their symptoms, rather
than one that contains as much cannabidiol as D9-THC (resin).
Finally, we did not have a biological measure of the type of
cannabis used, such as urine, blood or hair samples. These
methods allow one to test only for recent use, and would not have
helped to confirm the type of cannabis used over past years.
Moreover, participants in our first-episode psychosis group were
in-patients at time of recruitment, and such biological tests could
have produced false results for those tested more than 4 weeks
after admission to hospital. A biological measure would therefore
not have helped to enhance our findings.
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Table 3 Patterns of cannabis use
Cases, n=159 Controls, n=109
Odds ratio (95% CI)
n (%) n (%) Unadjusted Adjusteda
Duration of use
0–5 years 65 (40.8) 68 (62.5) 1.0 1.0
Over 5 years 94 (59.2) 41 (37.5) 2.4 (1.2–4.7) 2.1 (0.9–8.4)*
Frequency of use
Less than
every day 37 (23.1) 73 (66.7) 1.0 1.0
Every day 122 (76.9) 36 (33.3) 6.7 (2.0–11.5) 6.4 (3.2–28.6)*
Type used
Resin (hash) and traditional imported herbal cannabis (D9-THC and CBD both 1%) 34 (21.6) 68 (62.6) 1.0 1.0
Sinsemilla (skunk) (D9-THC 12–18%; CBD 0%) 125 (78.4) 41 (37.4) 8.1 (4.6–13.5) 6.8 (2.6–25.4)*
CBD, cannabidiol; D9-THC, D9-tetrahydrocannabinol.












Similarly to what Di Forti and colleagues reported in their paper, in our 
sample cases were 7.5 times more likely to smoke cannabis everyday 
compared to controls (χ2=9.4, df=1, p-value=0.004, χ2 test), adjusted OR: 
7.5 (95% CI: 1.9-29.7) table 22. In the GAP sample, the adjusted OR was 
6.4 (95% CI: 3.2-28.6). (Di Forti, Morgan et al. 2009). 
Number of times used: when I considered the total number of times 
subjects had smoked cannabis lifetime, I found a significant difference 
between cases and controls. I grouped the total number of times people 
have smoked cannabis in two groups “once or twice-50 times” and 
“between 50 and 200”. Patients were more likely than controls to have 
used cannabis between 50 and over 200 times than controls who were 
more likely to have tried cannabis once or twice or between 10 and 50 
times adjusted OR: 5 (95% CI: 1.5-16.4).  
Duration of use: I did not find a difference in duration of use of cannabis 
between cases and controls. I applied Welch test for unequal variances 
between duration of use among cases and controls mean duration of 
cannabis consumption was 7.4 years for cases and 6.8 years for controls  
(t=-0.3, df=45, p-value=0.785, Welch test).  
This result is similar to that of the GAP study in which the authors did not 
find a higher duration of cannabis consumption among cases (Di Forti, 
Morgan et al. 2009) as reported in Fig. 27. 
Among cases, I did not find any significant difference in duration of 
cannabis use between males and females (p-value=0.182, Fisher test). 
Potency of cannabis used: other authors have considered high potency 
cannabis among those patterns influencing the risk of developing 
psychosis (Di Forti, 2009, 2013). However in our sample only 3 cases 
(13%) of cases and 4 (10.8%) of controls had used high potency 
cannabis (sinsemilla “skunk” with high concentration of THC; Potter, Clark 
et al. 2008) so I had not enough power to detect any difference for the 
risk of developing psychosis.  
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The low prevalence of high potency cannabis consumption probably 
reflects the differences in the types of cannabis which are available in 
London compared to Palermo drug market. In UK in the last years, the 
market share of sinsemilla (skunk) has increased. According to the UK 
Home Office cannabis potency study 2008 herbal cannabis represented 
80.8% of street cannabis confiscated by the police and 97% of that was 
sinsemilla; the mean concentration of THC in sinsemilla was 16.2% 
(Hardwick and King 2008, Home Office Cannabis Potency Study 2008). 
The THC concentration of marijuana grown in Italy is around 4% (Florian, 
L’Espresso, 2010) much lower than the 16% reported for UK by 
(Hardwick and King, 2008). 
 
5.6.3.6 Age at first presentation in cases and cannabis consumption 
Among cases, median age at first presentation was lower for those who 
had smoked cannabis in their lifetime (22 years vs 27; z=2.4, p-value 
0.014, Wilcoxon test). I applied Wilcoxon test because of unequal 
variances and non-normal distribution. When I repeated the analysis for 
current use of cannabis at the time of the assessment, I did not find any 
difference in the median age at first presentation for those who were 
current users and those who were not (22 years vs 22.5; z=-0.4, p-value 
0.715, Wilcoxon test).  
I repeated the analysis to see whether there was an association between 
a higher frequency of use and the median age at first presentation of 
psychosis. Cases who never used cannabis were older (31.6 years) at 
their onset than those who smoked cannabis everyday (27 years) and 
less than everyday (22.5 years) (chi=7.7, df=2, p-value=0.021, Kruskal-
Wallis test). Applying Dunn test to compute multiple pairwise comparisons 
after a Kruskal-Wallis test, there was a statistical significant difference 
between people who smoked less than everyday and people who never 
smoked cannabis (p-value=0.002) while there was not any difference 
between people who never smoked cannabis and people who smoked 




5.6.4 Drug consumption other than cannabis 
5.6.4.1 Introduction  
Another factor influencing the risk of psychosis is other illicit drug 
consumption.  
Stimulants (amphetamines and methamphetamines) and cocaine may 
induce psychotic symptoms that may persist in those with an underlying 
susceptibility (familial loading for psychotic disorders) after ceasing drug 
consumption (Chen, Lin et al., 2005).  Hallucinogens may also induce 
psychotic symptoms.  
In Italy, the lifetime prevalence of drug consumption according to the 
GPS-ITA in the general population aged 15-64 years is 1.9% for 
hallucinogens, 2.8% for stimulants, 1.3% for heroin.  
In 2011 there was a general decrease in heroin, cocaine, stimulants, 
hallucinogens and cannabis consumption among students. 
 
 
5.6.4.2 Aims  
1. To compare lifetime exposure to licit and illicit consumption between 
cases and controls: alcohol, tobacco, other drugs (stimulants, cocaine, 
hallucinogens, opiates). 
2. To investigate the role of cannabis consumption as a confounder in the 
relation between illicit drug consumption and the risk of psychosis. 
 
5.6.4.3 Hypothesis  
I expect cases to have a higher prevalence of other drug consumption 
than controls.  
 
5.6.4.4 Methods 
I applied χ2 to test for the association between being a patient and licit 
and illicit drug consumption. 
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I applied logistic regression to calculate adjusted OR for potential 
confounders (age, gender, education, employment, cannabis 
consumption). 
5.6.4.5 Results  
Table 23 shows the prevalence distribution of other illicit drug 
consumption in cases and controls. In general cases were more likely to 
have ever used other illicit drugs than controls.  
I did not find any difference in alcohol consumption among cases and 
controls (χ2=0.9, df=1, p-value=0.349, χ2 test). 
Cases were over 3 times more likely to have ever tried other drugs 
(stimulants, hallucinogens, opiates, cocaine) than controls (χ2=5.4, df=1, 
p-value=0.019, χ2 test), OR: 3.3 (95%CI: 1.16-9.32), however after 
adjusting lifetime exposure to other drugs for the main confounders (age, 
gender, education, psychiatric family history, cannabis consumption) the 
risk of exposure became non significant: adjusted OR: 2.3 (95% CI: 0.4-
11.2).  
Patients were almost 3 times more likely to smoke tobacco than controls, 
(χ2=8.5, df=1, p-value=0.003, χ2 test), OR: 2.9 (95% CI:1.4-6).  
After controlling tobacco use for age, gender and cannabis consumption 
the OR became non significant: 2.9 (95%CI: 1-8.6). It is not possible to 
disentangle the effect of tobacco alone on the risk of psychosis because 












Table 23: ever used other licit and illicit drugs consumption in cases and 
controls. 
 Cases n, (%) (68)  Controls n, (%) (74) p value* 














































*p value from χ2 tests 
 
Cases were 4 times more likely than controls to have ever used 
stimulants, OR: 4.1 (95%CI: 1.3-12.4) but controlling for the main 
confounders, stimulant use alone could not explain the risk of being a 
patient: adjusted OR: 1.5 (95%CI: 0.3-6.7). A larger sample is needed to 
detect an effect of the stimulants on psychosis.   
Excluding those who never used cannabis, the risk of developing a 
psychotic disorder was nearly 6 times higher in those who used both 
cannabis and other drugs than those who just used cannabis (χ2=9.8, 
df=1, p-value=0.002, χ2 test), OR: 5.8 (95%CI: 1.8-18.5) but this result is 
not confirmed after controlling for confounders by logistic regression OR: 
2.3 (95%CI: 0.5-11.2).  
 
5.6.5 Adult adversities  
5.6.5.1 Introduction  
Bebbington et al. (2004) found an excess of lifetime victimization 
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experiences among people affected by a psychotic disorder (Bebbington, 
Bhugra et al., 2004). A recent meta-analysis confirmed the association 
between adult life events and the increased risk of developing a psychotic 
disorder (Beards, Gayer-Anderson et al., 2013). 
 
5.6.5.2 Aims 
Comparing lifetime exposure to different type of adversities in cases and 
controls. 
5.6.5.3 Hypothesis  




I used χ2 test or Fisher exact test where appropriate to test the 
association between adverse life events and case control-status.  
 
5.6.5.5 Results 
Overall, I did not find an excess of adverse life events among cases as I 
expected, as reported in Table 24. However, I found a higher proportion 
of injury assault (χ2=7.2, df=1, p-value=0.007, χ2 test), having been 
expelled from school (p-value 0.002, Fisher test), running away from 
home (p-value<0.001, Fisher test) and been forced into authority care (p-
value=0.013, Fisher test) among cases. However, due to the small 













Table 24: victimization experiences in cases and controls   
Victimization events lifetime, n (%) 
 




















































































































































5.6.6.Childhood adversities  
5.6.6.1 Introduction 
Recent meta-analyses report an association between exposure to 
childhood adversities and the risk of later developing a psychotic disorder 
(Matheson, Shepherd et al. 2012; Varese, Smeets et al. 2012).  
There is some evidence that parental loss or permanent separation from 
parents (Morgan, Kirkbride et al 2006), bullying (Trotta, Di Forti et al 
2013), physical (Fisher, Jones et al., 2010) and sexual abuse 
(Bebbington, Jonas et al. 2011) before age 16 are associated with an 
increased risk of developing psychosis in adulthood. However, the 
specificity of childhood abuse in psychotic disorders has not yet been 
demonstrated (Sideli, Mulè et al. 2012).  
 
5.6.6.2 Aims 
• To compare the prevalence of childhood traumatic experiences such 
as parental loss or separation, physical abuse, sexual abuse before 
age 16 between cases and controls 
• To evaluate the role played by traumatic experiences in increasing the 
risk of developing a psychotic disorder after controlling for the main 
confounders.  
5.6.6.3 Hypothesis  
I expect cases to be more likely to have experienced some of the 
childhood traumatic experiences than controls. 
 
5.6.6.4 Methods  
I used χ2 test or Fisher exact test where appropriate to test the 
association between life events and case control-status. Logistic 







Table 25 reports traumatic experiences in childhood and early 
adolescence (before age 16) in cases and controls. Four adverse events 
were reported: loss of on parents because of death, separation from one 
parent for more than six month for any reason, physical abuse and sexual 
abuse.  
Table 25: traumatic experiences before 16 years in cases and controls 
 Cases n (%)(68)  Controls n (%)(74) p value 
Loss of one parent (death) 
Yes  
No  


















































*p value from χ2 tests, Fisher’s test 
 
I did not find any differences between cases and controls for traumatic 
childhood experiences of parental loss because of death (χ2=0.1, df=1, p-
value=0.840, χ2 test) or being separated from one parent before 17 years 
(χ2=0.9, df=1, p-value=0.341, χ2 test), table 25. 
Using Fisher’s exact test, I found an association between being a patient 
and having experienced either physical abuse before 16 years (p-
value=0.055, Fisher test) or sexual abuse (p-value=0.008, Fisher test) 





Table 26: OR of psychotic disorders for adverse childhood experiences  
 Adj OR* 95% CI p value 
 
























*Adjusted for age and gender by logistic regression  
 
After adjusting for the main confounders (age, gender, family history of 
psychiatric disorders), the risk of having been a victim of sexual abuse 
among cases was 5.5 higher than controls (adjusted OR: 5.5 95% CI: 1.3-
22.7) table 26.  
The risk of being exposed to physical abuse among cases was 4.2 times 
higher than in controls (adjusted OR: 4 95% CI: 1.01-17.3) after adjusting 
for the main confounders (age, gender, family history of psychiatric 
disorders); however, this result must be interpreted with caution because 
the CI is close to 1, table 26. 
Similarly, in the AESOP study the authors found an increased risk of 
being a victim of sexual abuse during childhood among cases. However, 
after controlling for confounders the association lost statistical 
significance (Fisher, Morgan et al., 2009).  
These results must be interpreted with caution because of the small 
sample size and the proportion of missing data. Some patients (7,3%) 
refused to cooperate maybe because of the intimate nature of these 
questions. 
 
5.7 Conclusions  
Summarizing the results of the main risk factor examined in this case-
control study, I found: 
138 
 
1) Family history for psychiatric disorder was significantly more common 
among patients than controls. Psychotic disorders were more common in 
first-degree relatives of patients compared to controls though this result 
should be interpreted with caution.  
2) Cannabis consumption was higher among cases at the time of 
assessment. Patients were more likely than healthy controls to have 
started to smoke cannabis before 15 years, and to have a higher 
frequency of use.  
3) I did not find any significant differences between cases and controls in 
other drug consumption after considering confounders. 
4) I found a higher prevalence of sexual abuse and physical abuse 
























6.1 Introduction  
In this chapter I will summarize the key finding of this thesis. I’ll 
address methodological issues, strengths and limitations of the study, 
and I’ll suggest how my findings might contribute to the future direction 
of epidemiology research into psychotic disorders.  
First I’ll discuss the epidemiological findings in the Palermo sample 
and I’ll compare my results with the literature on this topic. Then I’ll 
comment on the case-control results to examine the possible impact of 
certain environmental risk factors in my area.   
 
6.2 Variation in the incidence rates of psychotic disorders  
6.2.1 My Original Hypothesis  
1. I expect similar incidence rates of psychoses when compared to 
that reported in other Italian sites (Tarricone, Mimmi et al., 2012 
Lasalvia, Bonetto et al. 2014). 
2. I expect to find an increased risk of psychosis in some subgroups 
(males and migrants).  
3. I expect lower rates than those reported in UK in the AESOP study.  
 
6.2.2 Findings  
6.2.2.1 Are the incidence rates of psychosis in different centres in 
Italy similar? 
The crude incidence rate of all psychotic disorders in Palermo is 15.9 per 
100,000 per year (95% CI 13.7-18.1). The incidence of schizophrenia in 
Palermo is 9.6 (95% CI 7.9-11.3), and falls into the lower part of the wide 




Previous studies carried out in Italy reported similar rates but these rates 
are not comparable because of different methodology.  
The Bologna FEP study (BoFEP) was carried out in three mental health 
services of West Bologna; the methodology was similar to that in the 
AESOP study (inclusion and exclusion criteria, FEP diagnosis).  
In Bologna the overall median IR for all psychotic disorders was 16.4 per 
100,000 inhabitants per year (IQR 14.3–17.8) and it is similar to that 
found in Palermo. The differences in rates for other diagnostic categories 
are displayed in table 27 but unfortunately Bologna and Palermo rates 
are not strictly comparable because I did not apply standardization in 
order to adjust for potential differences in the population structure 
between the two sites. I did not.   
 
Table 27: crude incidence rates in Palermo and Bologna by diagnostic 
categories  
 Crude IR* in 
Palermo (95% CI) 























* Results are displayed per 100,000 persons/year 
 
Taking into account the methodological limitations of this comparison, we 
can say that there are not striking differences in the rates of overall 
psychoses, schizophrenia and affective psychosis between Palermo and 
Bologna; indeed, the results are quite similar. The incidence rate of other 
non-affective psychoses seems to be higher in Bologna than in Palermo. 
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Further studies are needed to compare incidence rates in different Italian 
sites with a design allowing a comparison in order to detect potential 
differences and a different distribution of social and environmental risk 
factors.  
The Psychosis Incident Cohort Outcome Study (PICOS) was carried out 
in Veneto region with a methodology close to that in the AESOP study. It 
is a multisite study aiming at exploring the epidemiological characteristics 
of psychosis in the Veneto region. It reported very recently incidence 
rates for psychotic disorders in Veneto (Lasalvia, Bonetto et al. 2014).  
A direct comparison between the two studies was not allowed by the 
differences in methodology (e.g. age of first episode recruitment, 
inclusion of substance induced psychosis) and the rates are not 
comparable due to the lack of standardization to control for the 
differences in the two population structures. Table 28 shows crude 
incidence rates in Palermo and in Veneto. 
 
Table 28: crude incidence rates in Palermo and Veneto by diagnostic 
categories  
 Crude IR* in 
Palermo (95% CI) 



























It is possible to have just a general idea of the similarities in incidence 
rates between the two sites taking into account the fact that the Veneto 
rates come from different sites both urban and rural.  
Overall rates of psychosis in Veneto is 18.1 per 100,000 per year; rates of 
affective psychosis is 3.8 per 100,000 per year which is higher than in 
Palermo but lower than in the AESOP study. Previous studies in Verona 
reported a similar rate of affective psychoses: 4 per 100,000 per year 
(Tansella, Balestrieri et al. 1991). 
In the Veneto sample, there is not any significant difference in gender 
composition of cases while in Palermo males are overrepresented. The 
different gender distribution or the age of population may account for the 
rate differences in affective psychosis.  
 
6.2.2.2 Is the incidence of psychosis in Palermo the same in all 
subgroups? Is there variation by gender and migrant status? 
Male gender has been associated with an increased risk of 
schizophrenia. 
In the Palermo sample there is an increased risk for all psychoses IRR: 
1.7 (95% 1.3-2.2) and for schizophrenia IRR: 2 (95% CI 1.4-2.9), in 
males. This result is in line with previous FEP studies reporting an 
increased risk of developing psychoses and schizophrenia in males. 
In the AESOP study males had an increased risk of developing any 
psychotic disorder: IRR: 1.5  (95% CI 1.3-1.8). The risk was significantly 
higher in males than females for other non affective psychosis IRR: 1.8 
(95% CI 1.4-2.2) and for schizophrenia IRR:2.4 (95% CI 1.8-3.2) but not 
for affective psychoses. (Kirkbride, Fearon et al. 2006). In Bologna males 
had a higher risk of overall psychoses IRR:1.4 (95% CI 1.08-1.7) and 
schizophrenia IRR:2.1 (95% CI 1.7-2.6); the different risk by gender was 
evident in young people but after 35-45 the difference disappeared 
(Tarricone, Mimmi et al 2012). In the PICOS study no differences by 
gender for overall psychoses were observed except for schizophrenia, 
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males had an increased risk of compared to females IRR: 1.7 (95% CI 
1.2–2.3) (Lasalvia, Bonetto et al 2014).  
I did not find any gender differences for the risk for affective psychoses 
and other non affective psychoses; the lack of difference in the incidence 
of affective psychoses in men and women has been also reported in UK 
in the AESOP study (Kirkbride, Fearon et al. 2006) and in a systematic 
review on the incidence and prevalence of schizophrenia and other 
psychoses in England (Kirkbride, Errazuriz 2012). 
Migration in Palermo is a relatively recent phenomenon, and it is less 
widespread than in other cities especially when compared to London UK 
and the Northern Italian cities. This can be explained by the fact that 
Palermo, the main city of Sicily, is among the regions in Italy with the 
highest rate of unemployment (19.2% in 2012, Istat); so it does not 
represent a very attractive destination for people who are looking for a 
job.  
The overall earlier age at first presentation of migrants might depend on 
the small proportion, among migrants, of people with a diagnosis of other 
non-affective psychoses (4 cases over 21) which usually includes 
disorders developing later in life. It also might be that people of an older 
age go back to their country of origin especially when they become ill. 
Migration status has been associated to an increased risk of developing a 
psychotic disorder (Cantor-Graae and Selten, 2005). In Palermo sample, 
migrants have a near 3 fold increased risk of developing all psychoses 
when compared to native-born Italians. The risk of schizophrenia was 4 
times higher in migrants. These results were controlled by age and 
gender because migrants tend to be younger than native-born Italians. 
No increased risk has been found by migration for other non-affective 
psychoses and it was not possible to evaluate the role of migration on 
affective psychoses because of the absence of affective psychoses 
among migrants. The sample of migrants was very small and a larger 




My findings are similar to those in the BoFEP study. Tarricone and 
colleagues (2012) found a higher risk of developing psychoses in 
migrants compared to natives: IRR: 2.5 (95% CI 2.1-2.9) and an 
increased risk of schizophrenia: IRR: 3.4 (95% CI 3-3.8). Despite some 
differences in the methodology, the categories “migrant” and “natives” 
applied for cases and population in the denominator overlap in both 
Palermo and BoFEP study.  
An increased risk of overall psychosis in migrants: IRR: 2.3 (95% CI 1.8-
2.7) was also reported by the PICOS study in Veneto (Lasalvia, Bonetto 
et al. 2014).  
The reason why migration is associated to higher incidence of psychosis 
is not completely clarified yet. The increased risk may be related to social 
exclusion, discrimination and isolation (Boydell, van Os, et al. 2001; 
Veling, Selten et al. 2006). Unfortunately, the present study did not 
explore such variables.  
The AESOP study reported higher risk of psychoses in ethnic minorities, 
especially schizophrenia and mania in Black Caribbean and Black African 
ethnic minorities compared to the White British (Fearon, Kikbride et al. 
2006).  
In the Palermo sample, I did not have enough power to detect differences 
among ethnic minorities; migrants have been divided in broad categories 
which certainly do not reflect the complexity of cultural and genetic 
differences.   
Only 10% of cases were born outside Italy. They were equally distributed 
by continent of origin (7 from Asia, 7 from Africa and 7 from other 
European countries). However they came from very different places of 
each continent and they belonged to different ethnicities. For example 
among those coming from Africa there were people from Tunisia and 
Morocco which are geographically very close to Sicily and people from 
Ghana which is different from the ethnic and cultural point of view with 
respect to people coming from Northern Africa.  
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The small numbers of cases among non-Italian born people did not allow 
me to differentiate them according to ethnicity and I preferred to group 
people by migration status assuming that being a migrant in a foreign 
country represents a risk factor for the development of a psychotic 
disorder.  
The term migrant used in this thesis is different from the concept of ethnic 
minorities used in the AESOP study. Migrant, according to the Italian 
census, refers to people who were born outside Italy while in the AESOP 
study belonging to an ethnic minority, does not necessarily mean that one 
was born outside UK.  
 
6.2.2.3 Incidence rates of psychosis in Palermo and in the AESOP 
study: is the risk of developing psychosis the same in Sicily and 
UK?  
When compared to the AESOP study, the distribution of psychotic 
disorders in Palermo is quite different.  
In AESOP the sample comprised of 45% cases of schizophrenia and 
26% other non affective psychoses) while in Palermo schizophrenia 
represented  60% of all psychoses.  
In AESOP the proportion of affective psychoses is higher than in Palermo 
(29% versus 9.3%).  
In both the Palermo and AESOP studies the median age at first 
presentation of all psychoses was significantly lower in men than women 
(26.5 and 27 respectively). This is in line with previous studies (Castle, 
Sham et al. 1998; Hafner 2003; Eranti, MacCabe et al., 2013). 
As shown in fig. 10 and 11 in chapter 4, males have higher rates of all 
psychotic disorders till 30-34 years both in Palermo and in AESOP with a 
similar trend. This may be explained by the higher risk of schizophrenia in 
earlier stage of life in men compared to other non-affective and affective 
psychoses. The differences by gender tend to disappear with aging.  
When looking at the standardized incidence rates in Palermo, obtained by 
applying AESOP specific incidence rates to Palermo population, there is 
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a difference for overall psychotic disorders. After standardizing for age 
and gender, the incidence in Palermo is 17.5 per 100,000 per year (95% 
CI 15.2-20.1) compared to 27.1 per 100,000 per year (95% CI 24.4-30) in 
AESOP with a reciprocal of the SMR of 1.5. So people in London and 
Nottingham have a higher risk of developing a psychotic disorder 
compared to Palermo.  
However, I did not find any difference in the risk of developing 
schizophrenia or other non-affective psychoses in Palermo and AESOP 
so the excess of psychoses in UK may be due to the higher risk of 
developing affective psychoses in UK. The risk of developing depression 
with psychotic features and mania is 4.5 fold higher in London and 
Nottingham than in Palermo and this result raises the question whether 
this is a true difference or whether there is a methodological bias.  
Then I stratified the risk of psychosis for migration status to see whether 
the differences in rates found between Palermo and AESOP were due to 
differences between native groups or to the migrant groups.  
I did not find any difference in the risk of overall psychosis between 
migrants in Palermo and UK. The difference of overall psychosis 
remained higher in British natives compared to Palermo natives-Italian 
because of an excess of affective psychoses in native British compared 
to Italians.  
The systematic review by Kirkbride and colleagues (Kirkbride, Errazuriz 
2012) reported a pooled annual incidence of 12 per 100,000 persons year 
for affective psychoses in UK. In London and Nottingham, the rate for 
affective psychosis was 7.3 per 100,000 per year (95% CI 5.9-8.9). In 
Palermo it was 1.6 (95% CI 1-2.5). However, previous studies in Italy 
reported a lower rate of affective psychoses compared to other sites in 
Europe (Tansella, Balestrieri et al. 1991); the authors put forward the 
hypothesis that affective psychoses were more likely to be treated by 
general practitioners or by neurologists in Italy (Bebbington and Tansella, 
1989) so it might be that a proportion of those with affective psychosis 
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might have been treated privately or by family doctors and not reported to 
the study.  
Furthermore, despite the effort to the same diagnostic procedures as in 
AESOP it could have been that there are transnational differences in the 
way in which a diagnosis of affective psychosis is made in UK and in 
Palermo.  
One of the reasons for the difference of psychoses rates between the two 
sites could have been the different proportion of migrants in the samples.  
Standardization was applied also for migration to take into account the 
differences in the population structure between Palermo and AESOP. 
The risk remained slightly higher in UK for overall psychoses: SMR: 0.8 
(95% CI 0.7-0.9) and affective psychoses SMR:0.3 (95% CI 0.2-0.4) but 
the risk of schizophrenia became higher in Palermo than London and 
Nottingham (SMR: 1.3 (95% CI 1.1-1.6).  
There was not any significant difference in the rate of other non-affective 
psychosis in Palermo and in AESOP. The absence of affective psychoses 
among migrants might be due to cultural and linguistic barriers precluding 
to get some psychopathological feature in migrants, with an 
overestimation of schizophrenia versus affective or other non-affective 
psychoses. 
I excluded second generation migrants from the AESOP sample as 
explained in details the methods chapter because such a classification is 
not available in the Italian census. This was a pity since, as reported by 
literature, they may be particularly vulnerable to psychosis risk (Cantor-
Grae and Selten, 2005).  
Migration alone cannot explain the difference in risk observed between 
sites. Probably other factors may play a role in increasing the risk of 
psychosis in UK, however further studies are needed to clarify these 
findings.  
The lower rates of affective psychoses in Palermo compared to AESOP  
raises some questions. Is this a true difference or it is due to a bias in the 
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screening of affective psychoses or in the diagnosis of these disorders? If 
we detect a true difference how can we explain this variation?  
First, Palermo study has been designed with a very similar methodology 
to AESOP on purpose, to try to detect differences among sites. So the 
screening procedure and the assessment of diagnoses, was similar. A 
leakage study was carried out to detect any missing cases, so it is 
unlikely that I have missed so many affective psychotic cases to 
determine such a difference in rates.  
However, it might be that people with affective psychosis do not look for 
psychiatric care in public mental health services. They may search for 
help from private psychiatrists; unfortunately there are no published data 
on the pathway to care in Sicily for different psychiatric disorders.  
Second, crude rates of affective psychoses in Palermo and in Bologna 
were similar (1.5 in Palermo and 1.7 in Bologna per 100,000 per year) 
even though the lack of standardization does not allow one to make a 
proper comparison.  
Another hypothesis is that there might be a protective factor in South 
Europe against affective psychoses, but if so, what can it be? 
I can speculate that some factors known as exerting a protective function 
in mood disorder play also role in affective psychoses. 
Is there a North-South gradient in the risk of psychotic disorder? Other 
diseases such as multiple sclerosis, certain cancers (prostate, breast and 
colorectal), insulin-dependent diabetes mellitus and schizophrenia have 
been linked to hypovitaminosis D (McGrath, 2011); prevalence of multiple 
sclerosis shows a latitude gradient (Simpson, Blizzard et al. 2011). 
McGrath (McGrath, 1999) made the hypothesis that low maternal vitamin 
D was associated with an increased risk of developing schizophrenia and 
recently a mini meta-analysis reported a decrease in vitamin D levels in 
patients with psychosis (McGrath, Eyles et al. 2010; Belvederi Murri, 
Respino et al. 2013; Crews, Lally et al. 2013). Casual sunlight exposure 
is the major source of vitamin D (Holick, 1990). Is it possible that affective 
psychoses are influenced by sunlight exposure? Lack of sunlight and 
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reduced serotonin levels are associated with seasonal affective disorder. 
Patients affected by seasonal affective disorder (SAD) develop 
depression during the autumn or winter; symptoms remit in the spring or 
summer and the exposure to light provide benefits (Partonen and 
Lönnqvist, 1998). It is more common in countries that are far away from 
the equator during the winter months.  
To answer these questions further studies are needed to: 
1. compare affective psychosis incidence rates among different Italian 
sites  
2. compare Italian rates with northern European countries ones.  
 
6.2.2.4 Do social factors play a role in explaining the difference in 
rates of affective psychoses between Palermo and UK? 
Another possible explanation for the lower incidence of affective 
psychoses in Palermo might be the differences in social factors and 
family structure in Italy and in UK. 
People affected by psychotic disorders often experience marked social 
disadvantage in adult life (Morgan, Kirkbride et al. 2008), they are more 
likely to live alone, be unemployed, and have few close relationships. In 
the AESOP study, cases were more likely to be socially disadvantaged 
and isolated than healthy controls (Morgan, Kirkbride et al. 2008). 
In the Genetic and Psychosis study (GAP) subjects suffering from 
affective psychoses were significantly more likely to report adult social 
disadvantage than controls although social disadvantage was more 
pronounced for patients affected by non-affective psychoses (Stilo, Di 
Forti et al., 2012). 
Some authors have suggested that living alone is associated with an 
increased risk of mental health problems, higher rates of consumption of 
psychotropic drugs, and a higher risk of suicide compared to living with 
other persons in the same household (e.g. Pulkki-Råback, Kivimäki et al. 
2012). The same authors reported increased antidepressant consumption 
associated with living alone (Pulkki-Råback, Kivimäki et al. 2012). 
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Higher suicide rates have been reported in people living alone in London 
(Sainsbury, 1955); living alone may represent a risk factor for self-harm 
behaviours (Haw and Hawton, 2011). 
In the Palermo sample socio demographic variables were collected using 
the same instruments in Palermo and AESOP (the Medical Research 
Council Sociodemographic Schedule, MRC).  
94.6 % of the patients in Palermo sample lived with someone else at the 
time of onset; 61% lived with their parents and 18.7% with their own 
family (with partner or partner and children); only 3.1 % of cases lived 
alone. 
In the AESOP study the proportion of people living alone was much 
higher 43.3% (Morgan, Kirkbride et al. 2008). This represents a 
potentially important difference between Palermo and UK although I did 
not make a direct comparison of the two samples.  
There were not such big differences in other indicators of social 
disadvantage; the proportion of unemployment people in Palermo (54%) 
and AESOP (53%) were similar and also the relationship status: 72.7% of 
cases in Palermo and 71.3% in AESOP were single.  
It might be that living with parents or with the family exerts a protective 
role against the development of affective psychoses but there are at least 
two issues about that. First, living alone and other markers of social 
disadvantage have been reported to be important for psychosis and for 
schizophrenia, but schizophrenia rates are not lower in Palermo 
compared to UK.  Second, it would be strange if a single social factor 
explained the rates differences. It is more probable that multiple 
environmental factors such as social isolation, urbanicity, migration and 
substance consumption interact with biological and genetic factors in 
modulating the risk of psychoses. Multi-centric epidemiological and case 
controls studies are needed to describe incidence patterns in Europe and 





6.3 Strengths of the incidence study  
Most of the knowledge about epidemiology and risk factors associated 
with first episode psychoses comes from research in Northern Europe. 
This epidemiological study is the first ever carried out in Sicily and one 
of the few from Southern Europe. It is an incidence and case control 
first-episode study including all potential cases who presented to 
services within the catchment area with a broad definition of 
psychosis. Thus, it may contribute to increasing the awareness of 
similarities and differences in terms of incidence across Europe and in 
Italy.  
The methodology is similar to that in the AESOP study both in the 
design of the study and in the assessments; this allowed me to make 
comparisons of the incidence rates in Palermo and UK applying 
indirect standardization to obtain true differences between sites. 
Similar methods have been applied for the Bologna and Veneto 
epidemiological studies so one future direction may be to compare 
rates among the three sites applying standardization to obtain reliable 
and comparable results. Identifying differences in incidence rates of 
psychotic disorders in Italy and in Europe may lead to further clues on 
the different impact of risk factors.    
The catchment area was well defined and included all the mental 
health services of the city. I used 2011 census data to obtain the 
population denominator to allow comparability with other future 
epidemiological studies.   
The accuracy of denominator has been confirmed by the Italian Post 
Enumeration Survey. The aim of the survey, which took place from 
April to July 2012, was to estimate the number of individuals really and 
usually resident at the reference time of the 15th General Census of 
Population and Housing (October 9th, 2011) and the coverage rate, 
defined as the ratio between the number of individuals found at 
Census and the number of individuals really resident. At the national 
level, the under coverage is 1.07% that is the legal population of the 
152 
 
Census under enumerated for approximately 642,000 individuals 
(ISTAT, 2015). 
The screening procedure of cases involved both inpatient and 
outpatient units. If a case was missed when admitted in the hospital, it 
is unlikely that we would have missed him/her also afterwards because 
s/he would have been referred to the outpatient units, which were 
screened regularly. Further, a leakage study was conducted to avoid 
missing cases and the basic socio-demographic information needed to 
calculate incidence was collected.  
The diagnosis was based on operational criteria and it was reached by 
consensus.  
The comparison of incidence rates between Palermo and AESOP 
study was done recalculating specific AESOP incidence rates after 
excluding people belonging to UK born ethnic minorities in order to 
make the two samples comparable. In the Palermo sample, I had a 
dichotomous variable distinguishing people who were native Italians 
and people who were migrants (non-Italy born). The AESOP sample 
originally included White British, ethnic minorities who born abroad, 
and ethnic minorities who born in UK; it would have been incorrect to 
consider the latter as the native category and, at the same time, it 
would have been incorrect to include them in migrants; so the 
analyses were performed without those people to allow an accurate 
comparison.  
The knowledge of the epidemiology of psychosis and the prevalence 
of environmental risk factors in Palermo area will help mental health 
services to plan adequate prevention and clinical strategies to 
implement the treatment of psychotic disorders.  
 
6.4 Limitations of the incidence study 
One of the main concerns in an epidemiological study is to be sure about 
the accuracy of numerator and the denominator.  
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For the numerator the issue is being sure of having identified all cases 
affected by a psychotic episode in the period considered. In the Palermo 
sample, accuracy of the data collected relied on the weekly screening at 
the mental health services and clinical notes consultation. After the end 
of the data collection, I did a leakage study to identify any missing cases; 
in this way the main socio-demographic and clinical features have been 
collected.  
One reason for missing cases could have been that a certain number of 
people in the population might have asked private psychiatrists for 
psychiatric care because of the fear of being stigmatized; however, since 
patients who were prescribed new antipsychotics had to pay a lot till 
2012, to buy medication without a special receipt released only by the 
public mental health services.  
As mentioned in Chapter 3, I did not have the chance to reach patients 
who looked for care in private individual settings. While all the private 
psychiatric hospitals in the catchment area have been covered; it is not 
possible to exclude the possibility that I missed some of those patients 
treated exclusively by private psychiatrists, however, it would be unlikely 
that I have missed a great proportion of patients; it is more likely that 
most of the people affected by psychosis would seek care both in private 
and in public hospitals because a number of reasons.  
First, as already explained, during the study period, antipsychotic 
medications were too expensive unless prescribed by a public mental 
health service. Second, people affected by a first episode of psychosis 
have a high probability to be admitted to hospital at least once in a three-
year period; although specific regional data are not available, the 
international literature data report high hospitalization rates (80%) for 
people affected by a first episode of psychosis (Sipos, Harrison et al. 
2002). 
Thus, although I can’t exclude that a proportion of patients have been 




Another source of missing cases could have been admission outside the 
catchment area. It may have happened that some patients at their first 
episode could have been admitted outside the catchment area. This is 
because people admitted at the emergency room of one of the hospitals 
within the catchment area for an acute episode of psychosis, might then 
be admitted to another hospital outside Palermo or even outside the 
province, because of the lack of beds. However, after the admission, 
such patients would have been referred back to the outpatient unit they 
belonged to, according to their residence area. So it would be unlikely to 
have missed patients at their first episode unless they had just a single 
episode and they immediately totally recovered.  
Because of geographical reasons (Sicily is an island), it is very unlikely 
that people affected by a first episode of psychosis are treated outside 
the region. Of course we might have missed people who are temporary 
outside the region for studying or for work reasons. However, if they are 
resident in Palermo it is unlikely that we have missed them in a three-year 
period.  
This study relies on treated cases of psychosis so it is possible that 
incidence rates are influenced by the pattern of access to healthcare 
services; however, I tried to reduce any possible underestimation of 
incidence cases by involving all the inpatient and outpatient mental health 
services and private hospitals of Palermo.  
Migrants have high rates and rate ratios with wide confidence intervals. 
This might be due to an underestimation of the population of migrants in 
the census. About 500,000 over 642,000 individuals who were missing in 
the enumeration census at the national level, were individuals with 
foreign citizenship; this represents a signal of the difficulty in detecting 
people coming from another country (ISTAT, 2015); however, as 
previously reported, the national undercover is about 1% so it is unlikely 
that this would have affect the incidence rates in migrants.  
Another hypothesis would be that Italian born cases have been 
underestimated, however this seems unlikely since migrants may have 
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more difficulties in accessing mental health services and more complex 
pathways to care than the general native population (Tarricone, 
Stivanello et al., 2012).  
With respect to the numerator, it is possible that I have missed a 
proportion of migrant people affected by psychosis but who did not have 
the chance/wish to look for psychiatric care. However, having 
underestimated the number of migrant people affected by psychosis 
would have raised the rates rather than lower them.  
Since this study was not supported by any special grant, the lack of 
funds did not allow me to follow-up first episode cases. In psychiatry, 
clinical expression may vary across time. It would have been valuable to  
had the chance of confirming the diagnosis 12 months after the onset. 
However, other studies in the literature reported incidence data, based 
on baseline analyses (Kirkbride, Fearon et al 2006; Tarricone, Mimmi et 
al 2012). 
The denominator has been calculated using the most reliable source of 
national statistical information. There could, however, be an 
underestimation of migrants both in the denominator (because the 
official census does not take into account illegal migrants) and of the 
numerator because it is likely that the access to mental is less easy for 
migrants who are less aware about the way to access health services.   
Palermo and AESOP epidemiological data were collected in different time 
periods: Palermo incidence data were collected between 2008-2011 while 
AESOP data between 1997-1999. However, UK incidence rates of 
psychoses have tended to be stable over time as reported by a recent 
meta-analyses; it has been reported an increased rate of schizophrenia 
between 1965 and 1997 in London (possibly due to increases in the 
proportion of ethnic minority populations); by contrast, data from studies 
in Nottingham found no evidence of an increase in schizophrenia over 
roughly the same time period or reported a decrease; however, the 
authors found no evidence to support an overall change in the incidence 
of psychotic disorder over time in UK (Kirkbride, Errazuriz et al., 2012).  
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Palermo and Bologna rates could not be compared applying 
standardization because of the lack of specific incidence rates for the 
same age bands in Bologna. So I just compared crude rates which do 
not take into account any differences in the population structure between 
the two sites. Bologna has a higher proportion of migrants 12.7% 
(compared to the 4% in Palermo) and they are both external (from other 
countries) and internal migrants (people coming from other regions in 
Italy). I did not compare Palermo and Veneto rates standardizing for the 
same population because of methodological differences.  
Another possible limitation of the study is that age at first contact with 
psychiatric services has been used as a proxy for the age of onset. I am 
aware that it is not a precise measure of the actual onset, but because of 
the course of psychotic disorders that are often subtle in their onset, it is 
not easy to indicate the precise date the disorder appeared. However 
previous studies have considered the date of first contact with services as 
a proxy for date of onset of psychotic disorders (Sartorius, Jablensky et al 
1989; Eranti, Maccabe et al 2013).  
 
6.5 Risk factors for psychosis in Palermo  
6.5.1 Original Hypothesis  
1. I expected a higher prevalence of psychiatric and psychotic disorders 
in first-degree relatives of cases when compared to relatives of healthy 
controls. I expected cases with a first-degree relative affected by a 
psychotic disorder to have an earlier age at first presentation than 
those without. 
2. I expected cases to report a higher exposure to cannabis than healthy 
controls. I expected a different pattern of consumption (frequency, 
duration, age at first use) between the two groups. I expected gender 
differences among cases and controls in patterns of using cannabis 
(lifetime use, frequency of use, duration of use), I expected a higher 
prevalence of cannabis consumption among males as is reported in 
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the general population. In the group of cases I expected an earlier age 
at first presentation in those who smoke cannabis than those who do 
not. 
3. I expected a prevalence of other illicit drug consumption in cases than 
healthy controls. I expected an excess of childhood traumatic 
experiences in cases compared to controls and I expected some of the 
adult life events to be more common in the group of cases than 
controls. 
 
6.5.2 Findings  
6.5.2.1 Family history of psychiatric disorders and risk of 
schizophrenia	  
Byrne and colleagues reported an increased risk of schizophrenia in 
people with a family history of all psychiatric disorders (and with a 
family history of suicide (Byrne, Agerbo et al. 2002). In the Palermo 
sample, 44% of patients had a first-degree relative affected by a major 
psychiatric disorder (mood disorder or psychosis) compared to 15% of 
healthy controls. Cases were 5 times more likely to have a first-degree 
relative affected by any psychiatric disorder. Due to the small sample 
size I could not explore the differences in the risk by diagnostic 
category.  
If cases had an excess of first-degree relatives (e.g. having more 
siblings than controls), this might have influenced the differences 
between cases and controls; since the total number of first-degree 
relatives in cases and controls was not available, I could not control for 
that. However, it is unlikely that the difference in the risk between 
cases and controls is explained by this.   
It would be interesting to see whether the increased risk due to familial 
load is specific for schizophrenia or if it plays a role also in affective 
and other non-affective psychoses in a larger sample. I also found a 
higher risk for cases to have a first-degree relative affected by a 
psychotic disorder compared to healthy controls but this result must be 
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interpreted with caution due to the small proportion of controls with a 
first-degree relative affected by psychosis and the wide confidence 
interval.  As reported by other studies (Suvisaari, Haukka et al. 1998; 
Byrne, Agerbo et al. 2002) my results support the association between 
having a first-degree relative affected by a psychiatric disorder and an 
earlier onset of psychosis compared to those without a family history 
of psychiatric disorders.   
6.5.2.2 Cannabis use and the risk of psychosis  
 
Cannabis exposure is reported to increase the risk of developing 
schizophrenia and psychosis (Henquet and Murray 2005; Moore, Zammit 
et al., 2007). In the Palermo sample lifetime cannabis exposure was 
similar in patients and in healthy controls, as in the GAP study where the 
authors did not find any difference in lifetime prevalence of cannabis use 
between patients and controls.  
This might be explained by the high prevalence of lifetime cannabis use 
among young people in South London and in Italy. However, lifetime 
cannabis use does not say much about the extent of exposure to 
cannabis. It is likely that some people only tried cannabis a few times in 
their life.  
A more significant index of cannabis exposure is cannabis consumption 
before the onset; in this work I considered “cannabis consumption at the 
time of assessment”. People were considered as non-cannabis users at 
the time of the assessment if they had not used any cannabis in the 
previous four weeks. Excluding cases and controls who never smoked 
cannabis, I found that cases were 5 times more likely than controls to be 
current users at the time of assessment, adjusted OR: 5.4 (95% CI: 1.2-
24.1), but again this does not say much about the amount of cannabis 
exposure and only suggests that patients may have smoked more 
recently than healthy controls.  
I did not find any difference in cannabis use (lifetime and current use), 
thus disconfirming my expectation of gender differences both in cases 
159 
 
and controls, while in the GAP study there was a higher prevalence in 
cannabis consumption in males among cases (p<0.01) (Di Forti, Sallis et 
al., 2013).  
Moore and colleagues (2007) reported a dose-response relationship 
between cannabis consumption and risk of psychotic disorder. Frequency 
is one of the parameters of cannabis consumption that can modulate the 
risk of psychosis (Di Forti, Sullis et al., 2009).  
In the Palermo sample, frequency of cannabis use was significantly 
higher in cases after controlling for the main confounders (age, gender, 
education, employment, psychiatric family history, other illicit drugs 
abuse).  
Frequency of cannabis consumption was classified as “frequent” 
(grouping everyday use and more than 3 times a week), or as “sporadic” 
(only once or twice lifetime, a few times each month and a few times each 
year cannabis consumption). After controlling for the main confounders, 
cannabis users among cases were four time more likely to be frequent 
users than controls who tended to use cannabis in a sporadic way.  
I also examined daily use and I found that cases were 7.5 times more 
likely to smoke cannabis everyday compared to controls; this result is in 
line with the GAP study findings.  In the GAP study the strongest predictor 
of case-control status was daily use of high potency cannabis (Di Forti, 
Morgan et al. 2009). I did not have the chance to measure the effect of 
low and high potency kinds of cannabis due to the low exposure in 
Palermo sample to high potency cannabis (only 3 cases and 4 controls 
had ever tried high potency cannabis).  
The results in this sample confirm the role of frequency of use in 
increasing the risk of developing psychotic disorder. 
No differences were found in the duration in years of cannabis use 
between cases and controls; this result diverges from the GAP study in 
which the authors found a higher duration of cannabis consumption 
among cases (Di Forti, Morgan et al. 2009) as reported in Fig. 28, 
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however, after adjusting for the confounders the difference did not reach 
the statistical significance because the confidence interval includes 1. 
Arsenault and colleagues (2002) reported an association between earlier 
age at first cannabis use and a higher risk of schizophrenia. In Palermo 
sample, cases started to smoke cannabis significantly earlier than 
controls; cases were more likely than healthy controls to have started 
cannabis consumption before the age of 15 years and to smoke more 
frequently. This is interesting because some authors suggested that 
cannabis consumption may impact on brain development, and that early 
adolescence may, therefore, be a critical period for effects that do not 
occur when exposure begins later (Wilson, Mathew et al. 2014).  
These results confirm the different pattern of cannabis consumption in 
people affected by psychosis and this may lead to consider cannabis as a 
contributing factor in the aetiology of psychotic disorders. I controlled for 
the role of possible confounders as socio-demographic (age, gender, 
level of education and employment) and other environmental risk factors 
(other drug use and stimulant use). Demonstrating that frequency of use 
and early cannabis consumption is associated to an increased risk of 
psychosis may have relevance in public health prevention strategies and 
in organizing specific educational programs with adolescents.  
Psychotic patients with a history of cannabis use have an earlier age at 
first presentation of psychosis than those without such a history by almost 
3 years (Large, Sharma et al. 2011; Donoghue, Doody et al., 2014).  
In Palermo sample, mean age at first presentation in cases was earlier for 
those who had smoked cannabis lifetime (24.2 years vs 31.6) but the 
difference in mean age at first presentation was not significant any longer 
when I repeated the analysis for current users at the time of the 
assessment. 
My results partially confirm the observation of the GAP study: cases who 
never used cannabis were significantly older at their onset than those 
who smoked cannabis.  
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In Palermo sample, frequency of cannabis consumption does not seem to  
have an effect on the earlier onset of psychosis.This result differs from 
the GAP study that reported an earlier onset of psychosis for those who 
smoke cannabis daily and especially high potency cannabis (Di Forti, 
Morgan et al. 2009). In Palermo sample however I could not explore the 
role of cannabis potency in the earlier onset of psychosis because of lack 
of detailed data, as explained in chapter five.  
 
6.5.2.3 Other risk factors for psychosis  
 
I also investigated the role of other environmental risk factors associated 
to psychosis as illicit and licit drug consumption, adverse experiences and 
childhood traumatic events.  
Cases were more likely than controls to report other illicit drug 
consumption such as stimulant and tobacco use. However, exposure to 
tobacco and stimulants did not increase the risk of psychosis after 
adjusting for potential confounders (age, gender, education, employment, 
psychiatric family history, cannabis consumption) possibly because of the 
small sample size. I also found a higher risk of developing psychosis in 
those who ever used both cannabis and other drugs compared to those 
who only used cannabis but this result was not significant after controlling 
for the confounders. These results should be replicated in a larger case-
control sample.  
Some lifetime victimization experiences as having been injured or 
assaulted, having been expelled from school, running away from home 
and having been forced into authority care were more represented among 
cases than controls. However, I could not adjust the results by the main 
confounders (age, gender, education and employment) because of the 
small proportion of people exposed to each event. 
The role and the specificity of childhood victimization experiences is still 
controversial. In the Palermo sample among childhood traumatic 
experiences there was not any difference between cases and controls in 
loss or separation from parents.  
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Physical and sexual abuses were significantly more common in cases. 
The risk of reporting sexual abuse during childhood and early 
adolescence among cases was 5.5 higher than among controls. The risk 
of being exposed to physical abuse among cases was 4.2 times higher 
than in controls (even though the result must be interpreted with caution 
because the CI is close to 1). 
However, only a small proportion of cases and controls report physical or 
sexual abuse so this result must be interpreted with caution and 
replicated in a larger case control study.  Similarly, in the AESOP study 
the authors found an increased risk of being a victim of sexual abuse 
during childhood among cases. However, after controlling for 
confounders the association lost statistical significance (Fisher, Morgan et 
al., 2009).  
 
6.6 Strengths and limitation of the case-control study 
The case control study is suitable for rare diseases as psychosis because 
the exposures are collected retrospectively. It allows to compare the 
prevalence of certain risk factors in a group of people affected by the 
disorder and a group of healthy controls. Unfortunately, only 33.3% of 
204 patients completed the whole assessment. 136 cases identified for 
the incidence analysis were not enrolled in the study either because they 
refused to be interviewed (53%) or because they had been screened and 
identified retrospectively (47%) by the leakage study. 
When cases have been identified retrospectively and it was not possible 
to contact them (either because they refused to be assessed or because 
they were not in contact any longer with the mental health services), data 
were collected from clinical notes. So it was not possible to obtain 
quantitative and sometimes qualitative details on their substance abuse, 
family history of psychotic disorders, PANSS scores. However it was still 
possible to collect the basic socio-demographic information and the 
symptoms of psychosis and this allowed me to make a proper diagnosis 
and to use the core information for epidemiological purposes.  
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Case-control designs are prone to selection bias of both cases and 
controls.  
Bias selection of cases may have occurred because only one third of the 
patients identified for the incidence study were then recruited and 
assessed for the case-control analysis; it may be argued that they are not 
representative of the population of cases. However, as discussed in 
Chapter 3, when the group of recruited cases were compared to those 
who have not been recruited, no significant differences were found in 
several variables that might have affected the measure of the association 
with the risk factors under investigation. There were no differences in 
terms of gender, ethnicity migration, level of education; recruited cases 
tend to be older than non-recruited ones and there was a higher 
proportion of schizophrenia diagnosis among the recruited people. The 
implication of this difference is that the risk factors identified in cases 
might be more specific for schizophrenic patients than for other 
psychoses.    
It might be argued that symptom severity might have biased the selection 
of cases excluding for example those with a more severe illness.   
Unfortunately a direct measure of symptoms severity was not available 
for non-recruited cases since PANSS has only been administered to 
cases who were assessed by interviews; however I can infer that there 
were not substantial differences in symptoms severity between the 
recruited and the not recruited group by indirect clues.  
First, not recruited and recruited cases had the same probability to have 
been identified in private and public hospitals (Pearson χ2=0.0025, df=1, 
p=0.960). People admitted to private hospitals are often less acute than 
patients admitted to public services because in private hospitals they are 
not allowed to impose compulsory treatment. If cases belonging to the 
“non-recruited” group were the more severe patients, I would expect 
them to be admitted more frequently in public hospitals. 
Cases who have been recruited were more likely to be selected in public 
hospital settings rather than in outpatient services compared to those 
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who were not recruited (Pearson χ2=19.7,df=2, p<0.001) but this is not 
an effect of a different symptom severity. Generally, patients were more 
open to be assessed while they were admitted at the hospital because 
the research team used to reach them and to spend some time with 
them and so they were more likely to cooperate.  
When cases were identified by screening the outpatient services and 
they were asked by the research team to join the study they were more 
reluctant to reach the service to go through the interview. For this reason 
I do not think that a selection bias might have occurred because of 
genuine differences in symptom severity or because of different 
characteristics between recruited and not recruited cases  
 In this study the recruitment of controls has been challenging. 
A sample of individuals aged 18–64 years was recruited from the 
population of the same geographical areas as the cases. The recruitment  
was carried out by advertising and leaflets. An effort has been made to 
get a representative sample of the general population of healthy controls 
who were selected by quota sampling method.  
The control sample was similar, according to the last Italian census data 
(2011) on a number of socio-demographic factors (age, gender, migrant 
status, level of education) to the population the cases come from.  
There are some differences in terms of mean age and socio-demographic 
features between cases and controls. Mean age of cases and controls 
was significantly different (p<0.01) so all the analyses were adjusted 
taking into account age as a confounder in the logistic regression. Other 
socio-demographic factors (level of education, employment, relationship 
status) were different in cases and controls so I applied logistic regression 
to control for those differences. I analysed a small sample of controls and 
this can limit the validity of results for those variables which exposure is 
rare (e.g. sexual abuse). However power calculation indicated that the 
sample of cases and controls was sufficient to detect a modest effect of 
sexual abuse.  
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Cases had a significantly lower mean IQ (mean 78.7, sd: 16.8) than 
controls IQ (mean 101.6, sd: 23)  (p<0.01). This magnitude of difference 
may reflect a limitation of the study methodology because cases were 
often assessed early when they were still unwell and just a few days after 
the admission to the hospital. We tried to contact them after discharge but 
most of them were not interested in coming back to be interviewed again. 
So the gap between cases and control in the mean IQ probably does not 
reflect a reliable difference.  
There are a few limitations about the possibility to draw definite 
conclusions about the risk of cannabis exposure on psychosis in this 
sample. 
An issue is that lifetime cannabis consumption among controls is reported 
by more than a half of the sample (57%) and cannabis consumption in 
the previous month is 21%. The lifetime prevalence of cannabis 
consumption in Italy as reported by the GPS-ITA study (22.4%) and by 
the Milan survey (31.7%) and the cannabis consumption in the previous 
month, 3% (GPS-ITA ) and 7.4% (Milan survey) are lower than cannabis 
use in our control sample. This may raise the issue of a selection bias of 
controls and their representativeness of the general population. However, 
the leaflet and the advertisement for controls recruitment did not mention 
cannabis use at all, so that it is not likely that the way controls were 
recruited has biased the selection.  
Another explanation of this discrepancy is that the general population 
prevalence of cannabis consumption may be different across different 
sites in Italy.   
Data on cannabis consumption in the general population come from 
surveys run at the national level. No detailed differences are reported by 
regions and by sites. In Milan (2007-2010) for example, the prevalence of 
cannabis consumption was higher than the national one (31.7%).  
Sicily, is the first region in Italy for cannabis production; it produces  90% 
of the total cannabis amount produced in Italy because of a peculiar 
micro climate which is favorable to grow cannabis. In 2011 in Sicily has 
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been registered the 91% of the total national cannabis seizure (Chiusolo, 
D’Onofrio, Dipartimento Politiche Antidroga, 2011). This may lead to a 
higher availability of cannabis in Palermo illicit drug market.  
Another explanation may be that the median age of the sample taken 
from the general population survey on cannabis use is higher than 
median age of controls in my sample, so that the likelihood of being 
exposed to cannabis is increased in Palermo sample because people 
tend to smoke at younger age. Unfortunately, detailed data on median 
age of participants in the GPS-ITA study have not been reported.  
However, an overestimation of cannabis exposure among healthy 
controls would have reduced the odds of cannabis use on psychosis so I 
am confident about the differences in the risk I found. 
Another limitation is that in the present study it was not possible to detect 
an effect of tobacco in psychosis risk. Tobacco exposure was not 
associated with an increased risk of psychosis after controlling for the 
main confounders; further, cannabis exposure cannot be distinguished 
from tobacco because in Palermo sample all the cases and controls 
exposed to cannabis used to smoke it together with tobacco.  
Another source of bias in case-control studies is recall bias because the 
information is collected after the disease onset. 
For cannabis exposure it is unlikely that people under-report cannabis 
consumption because the prevalence of lifetime cannabis consumption 
was higher both in cases (44%) and controls (56.7%) than the prevalence 
reported for the Italian general population (22%).  
Sexual traumatic experiences could have been under reported because 
of the intimate nature of the questions both in cases and controls, so the 
effect of sexual abuse during childhood might be underreported; however, 
Fisher and colleagues supported the reliability of retrospective reports of 
childhood abuse obtained from individuals with psychotic disorders 
(Fisher, Craig et al. 2011).   Another limitation in obtaining a reliable risk 
effect of childhood traumatic experiences was the sample size. The 
association between the risk of psychosis and physical abuse was weak 
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and it will valuable to confirm this association with a larger sample. 
Another limitation is represented by the lack of the analysis of a 
synergistic effect of the different childhood victimization experiences.   
 
6.7 Conclusions and future direction 
This study confirms that the incidence of psychosis is lower in Italy than 
reported in the UK. Age, gender and migration have an effect on the 
incidence of psychotic disorders. It would be valuable to compare 
incidence rates in different sites in Italy and in Europe in order to find 
differences and similarities and to develop hypothesis on the role of risk 
factors influencing the differences in the rates.  
The European network of national schizophrenia networks studying gene-
environment interaction (EUGEI) is a large on-going European first 
episode psychosis study coordinated by Maastricht University (MUMC). It 
is aimed at identifying the genetic, clinical and environmental 
determinants and their interactions involved in the development, severity 
and outcome of schizophrenia (http://www.eu-gei.eu/about-the-project). It 
will also compare differences in incidence rates across several sites in 
Europe and it will provide data about differences and similarities across 
countries.  
Migration is confirmed as a risk factor for psychosis in Palermo sample. 
However, further studies are needed to explore the role of social factors 
as social disadvantage (Morgan, Kirkbride et al., 2008) mediating this 
association. 
The EUGEI study will provide details on psychosocial factors associated 
to the risk of developing psychosis at an individual, neighbourhood and 
social level (e.g. exposure to childhood trauma, substance consumption, 
measures of social deprivation, social fragmentation, migration history) so 
I’ll have the chance to replicate some of the findings of this case-control 
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Appendix I  
Classification of Psychotic disorders according to ICD-
10 
Diagnostic criteria for research  
F20 - F29 SCHIZOPHRENIA, SCHIZOTYPAL AND DELUSIONAL DISORDERS 
F20 SCHIZOPHRENIA 
This overall category includes the common varieties of schizophrenia, together with 
some less common varieties and closely related disorders. 
F20.0 - F20.3 
General criteria for Paranoid, Hebephrenic, Catatonic and Undifferentiated type of 
Schizophrenia: 
G1. Either at least one of the syndromes, symptoms and signs listed below under (1), 
or at least two of the symptoms and signs listed under (2), should be present for most 
of the time during an episode of psychotic illness lasting for at least one month (or at 
some time during most of the days). 
(1) At least one of the following: 
a) Thought echo, thought insertion or withdrawal, or thought broadcasting. 
b)  Delusions of control, influence or passivity, clearly referred to body or limb 
movements or specific thoughts, actions, or sensations; delusional perception.  
c)  Hallucinatory voices giving a running commentary on the patient's behaviour, or 
discussing him between themselves, or other types of hallucinatory voices coming from 
some part of the body.  
d)  Persistent delusions of other kinds that are culturally inappropriate and completely 
impossible (e.g. being able to control the weather, or being in communication with 
aliens from another world).  
(2) or at least two of the following: 
e)  Persistent hallucinations in any modality, when occurring every day for at least one 
month, when accompanied by delusions (which may be fleeting or half-formed) without 
clear affective content, or when accompanied by persistent over-valued ideas.  
f)  Neologisms, breaks or interpolations in the train of thought, resulting in incoherence 
or irrelevant speech.  
g)  Catatonic behaviour, such as excitement, posturing or waxy flexibility, negativism, 
mutism and stupor.  
h)  "Negative" symptoms such as marked apathy, paucity of speech, and blunting or 
incongruity of emotional responses (it must be clear that these are not due to 
depression or to neuroleptic medication).  
G2.  Most commonly used exclusion criteria: If the patient also meets criteria for manic 
181 
 
episode (F30) or depressive episode (F32), the criteria listed under G1.1 and G1.2 
above must have been met before the disturbance of mood developed.  
G3.  The disorder is not attributable to organic brain disease or to alcohol- or drug-
related intoxication, dependence or withdrawal.  
 
F20.0 Paranoid schizophrenia 
A. The general criteria for Schizophrenia (F20.0 - F20.3 above) must be met.  
B. Delusions or hallucinations must be prominent (such as delusions of persecution, 
reference, exalted birth, special mission, bodily change or jealousy; threatening or 
commanding voices, hallucinations of smell or taste, sexual or other bodily sensations).  
C.Flattening or incongruity of affect, catatonic symptoms, or incoherent speech must 
not dominate the clinical picture, although they may be present to a mild degree. 
F20.1 Hebephrenic schizophrenia 
A. The general criteria for Schizophrenia (F20.0 - F20.3) above must be met.  
B. Either (1) or (2):  
(1)  Definite and sustained flattening or shallowness of affect;  
(2)  Definite and sustained incongruity or inappropriateness of affect.  
C.Either (1) or (2):  
(1) Behaviour which is aimless and disjointed rather than goal-directed; 
(2) Definite thought disorder, manifesting as speech which is disjointed, rambling or 
incoherent. 
D. Hallucinations or delusions must not dominate the clinical picture, although they 
may be present to a mild degree. 
F20.2 Catatonic schizophrenia 
A. The general criteria for Schizophrenia (F20.0 - F20.3 above) must eventually be 
met, though this may not be possible initially if the patient is uncommunicative. 
B. For a period of at least two weeks one or more of the following catatonic prominent: 
(1)  Stupor (marked decrease in reactivity to the environment and reduction and 
activity) or mutism;  
(2)  Excitement (apparently purposeless motor activity, not influenced by  
(3)  Posturing (voluntary assumption and maintenance of inappropriate or  
(4)  Negativism (an apparently motiveless resistance to all instructions or movement in 
the opposite direction);  
(5)  Rigidity (maintenance of a rigid posture against efforts to be moved);  
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(6)  Waxy flexibility (maintenance of limbs and body in externally imposed positions) 
(7) Command automatism (automatic compliance with instructions). 
C. Other possible precipitants of catatonic behaviour, including brain disease and 
metabolic disturbances, have been excluded. 
F20.3 Undifferentiated schizophrenia 
A. The general criteria for Schizophrenia (F20.0 - F20.3) above must be met.  
B. Either (1) or (2):  
(1)  There are insufficient symptoms to meet the criteria of any of the sub-types F20.0, 
.1, .4, or .5;  
(2)  There are so many symptoms that the criteria for more than one of the subtypes 
listed in B(1) above are met.  
F20.4 Post-schizophrenic depression 
A. The general criteria for schizophrenia (F20.0 - F20.3 above) must have been met 
within the past twelve months, but are not met at the present time.  
B. One of F20 G1.2 e, f, g or h must still be present.  
C.The depressive symptoms must be sufficiently prolonged, severe and extensive to 
meet criteria for at least a mild depressive episode (F32.0).  
F20.5 Residual schizophrenia 
A. The general criteria for Schizophrenia (F20.0 - F20.3 above) must have been met at 
some time in the past, but are not met at the present time.  
B. At least four of the following 'negative' symptoms have been present throughout the 
previous twelve months:  
(1)  Psychomotor slowing or underactivity;  
(2)  Definite blunting of affect;  
(3)  Passivity and lack of initiative;  
(4)  Poverty of either the quantity or the content of speech;  
(5) Poor non-verbal communication by facial expression, eye contact, voice modulation 
or posture; 
(6) Poor social performance or self-care.  
F20.6 Simple schizophrenia 
A. Slowly progressive development over a period of at least one year, of all three of the 
following: 
(1)  A significant and consistent change in the overall quality of some aspects of 
personal behaviour, manifest as loss of drive and interests, aimlessness, idleness, a 
self-absorbed attitude, and social withdrawal.  
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(2)  Gradual appearance and deepening of "negative" symptoms such as marked 
apathy, paucity of speech, under- activity, blunting of affect, passivity and lack of 
initiative, and poor non-verbal communication (by facial expression, eye contact, voice 
modulation and posture).  
(3)  Marked decline in social, scholastic, or occupational performance.  
B. Absence, at any time, of any symptoms referred to in G1 in F20.0 - F20.3, and of 
hallucinations or well- formed delusions of any kind, i.e. the subject must never have 
met the criteria for any other type of schizophrenia, or any other psychotic disorder.  
C.Absence of evidence of dementia or any other organic mental disorder listed in 
section F0.  
F20.8 Other schizophrenia 
F20.9 Schizophrenia, unspecified 
F21 SCHIZOTYPAL DISORDER 
A. The subject must have manifested, over a period of at least two years, at least four 
of the following, either continuously or repeatedly: 
(1) Inappropriate or constricted affect, subject appears cold and aloof;  
(2) Behaviour or appearance which is odd, eccentric or peculiar;  
(3) Poor rapport with others and a tendency to social withdrawal;  
(4) Odd beliefs or magical thinking influencing behaviour and inconsistent with 
subcultural norms;  
(5) Suspiciousness or paranoid ideas;  
(6) Ruminations without inner resistance, often with dysmorphophobic, sexual or 
aggressive contents;  
(7) Unusual perceptual experiences including somatosensory (bodily) or other illusions, 
depersonalization or derealization;  
(8) Vague, circumstantial, metaphorical, over-elaborate or often stereotyped thinking, 
manifested by odd speech or in other ways, without gross incoherence;  
(9) Occasional transient quasi-psychotic episodes with intense illusions, auditory or 
other hallucinations and delusion-like ideas, usually occurring without external 
provocation.  
B. The subject must never have met the criteria for any disorder in F20 
(Schizophrenia). 
F22 PERSISTENT DELUSIONAL DISORDERS 
F22.0 Delusional disorder 
A. The presence of a delusion or a set of related delusions other than those listed as 
typical schizophrenic under F20 G1.1b or d (i.e. other than completely impossible or 
culturally inappropriate). The commonest examples are persecutory, grandiose, 
hypochondriacal, jealous (zelotypic) or erotic delusions.  
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B. The delusion(s) in A must be present for at least three months.  
C.The general criteria for schizophrenia (F20.0 - F20.3) are not fulfilled.  
D.Persistent hallucinations in any modality must not be present (but transitory or 
occasional auditory hallucinations that are not in the third person or giving a running 
commentary, may be present).  
E. Depressive symptoms (or even a depressive episode (F32.-)) may be present 
intermittently, provided that the delusions persist at times when there is no disturbance 
of mood.  
F. Most commonly used exclusion criteria: There must be no evidence of primary or 
secondary brain disease as listed under F0, or a psychotic disorder due to 
psychoactive substance use (F1x.5).  
Specification for possible subtypes: The following types may be specified, if desired: 
persecutory type; litiginous type; self-referential type; grandiose type; hypochondriacal 
(somatic) type; jealous type; erotomanic type. 
 
F22.8 Other persistent delusional disorders 
 
This is a residual category for persistent delusional disorders that do not meet the 
criteria for delusional disorder (F22.0). Disorders in which delusions are accompanied 
by persistent hallucinatory voices or by schizophrenic symptoms that are insufficient to 
meet criteria for schizophrenia (F20.-) should be coded here. Delusional disorders that 
have lasted for less than three months should, however, be coded, at least temporarily, 
under F23.-. 
F22.9 Persistent delusional disorder, unspecified 
F23 ACUTE AND TRANSIENT PSYCHOTIC DISORDERS 
G1. An acute onset of delusions, hallucinations, incomprehensible or incoherent 
speech, or any combination of these. The time interval between the first appearance of 
any psychotic symptoms and the presentation of the fully developed disorder should 
not exceed two weeks.  
G2.  If transient states of perplexity, misidentification, or impairment of attention and 
concentration are present, they do not fulfill the criteria for organically caused clouding 
of consciousness as specified in F05 A.  
G3.  The disorder does not meet the symptomatic criteria for manic episode (F30), 
depressive episode (F32), or recurrent depressive disorder (F33).  
G4.  No evidence of recent psychoactive substance use sufficient to fulfil the criteria of 
intoxication (F1x.0), harmful use, (F1x.1), dependence (F1x.2) or withdrawal states 
(F1x.3 and F1x.4). The continued moderate and largely unchanged use of alcohol or 
drugs in amounts or frequencies to which the subject is accustomed does not 
necessarily rule out the use of F23; this must be decided by clinical judgement and the 
requirements of the research project in question.  
G5.  Most commonly used exclusion criteria: absence of organic brain disease (F0) or 
serious metabolic disturbances affecting the central nervous system (this does not 
include childbirth).  A fifth character should be used to specify whether the acute onset 
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of the disorder is associated with acute stress (occurring within two weeks prior to 
evidence of first psychotic symptoms). 
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia 
A. The general criteria for acute and transient psychotic disorders (F23) must be met.  
B. The symptomatology is rapidly changing in both type and intensity from day to day or 
within the same day.  
C.The presence of any type of either hallucinations or delusions, for at least several 
hours, at any time since the onset of the disorder.  
D.Symptoms from at least two of the following categories, occurring at the same time:  
(1) Emotional turmoil, characterized by intense feelings of happiness or ecstasy, or 
overwhelming anxiety or marked irritability;  
(2)  Perplexity, or misidentification of people or places;  
(3)  Increased or decreased motility, to a marked degree.  
E. Any of the symptoms listed in Schizophrenia F20, G1.1 and G1.2 that are present, 
are only present for a minority of the time since the onset, i.e. criterion B of F23.1 is not 
fulfilled.  
F. The total duration of the disorder does not exceed three months.  
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia 
A. Criteria A, B, C, and D of acute polymorphic psychotic disorder (F23.0) must be met.  
B. Some of the symptoms specified for schizophrenia (F20.0 - F20.3) must have been 
present for the majority of the time since the onset of the disorder, but not necessarily 
meeting these criteria completely, i.e. at least any one of the symptoms in F20, G1.1a 
to G1.2g.  
C.The symptoms of schizophrenia in B above do not persist for more than one month.  
F23.2 Acute schizophrenia-like psychotic disorder 
A. The general criteria for acute and transient psychotic disorders (F23) must be met.  
B. The criteria for schizophrenia (F20.0 - F20.3) are met, with exception of the duration 
criterium.  
C. The disorder does not meet the criteria B, C and D for acute polymorphic psychotic 
disorder (F23.0).  
D. The total duration of the disorder does not exceed one month.  
F23.3 Other acute predominantly delusional psychotic disorder 
A. The general criteria for acute and transient psychotic disorders (F23) must be met.  
B. Relatively stable delusions and/or hallucinations are present, but they do not fulfil the 
symptomatic criteria for schizophrenia (F20.0 - F20.3).  
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C.The disorder does not meet the criteria for acute polymorphic psychotic disorder 
(F23.0).  
D.The total duration of the disorder does not exceed three months.  
F23.8 Other acute and transient psychotic disorders 
Any other acute psychotic disorders that are unclassifiable under any other category in 
F23 (such as acute psychotic states in which definite delusions or hallucinations occur 
but persist for only small proportions of the time) should be coded here. States of 
undifferentiated excitement should also be coded here if more detailed information 
about the patient's mental state is not available, provided that there is no evidence of 
an organic cause. 
F23.9 Acute and transient psychotic disorder, unspecified 
F24 INDUCED DELUSIONAL DISORDER 
A. The subject must develop a delusion or delusional system originally held by 
someone else with a disorder classified in F20-F23.  
B. The two people must have an unusually close relationship with one another, and be 
relatively isolated from other people.  
C.The subject must not have held the belief in question prior to contact with the other 
person, and must not have suffered from any other disorder classified in F20-F23 in the 
past.  
F25 SCHIZOAFFECTIVE DISORDERS  
Note: This diagnosis depends upon an approximate "balance" between the number, 
severity and duration of the schizophrenic and affective symptoms. 
G1.  The disorder meets the criteria of one of the affective disorders of moderate or 
severe degree, as specified for each sub-type.  
G2.  Symptoms from at least one of the symptom groups listed below, clearly present 
for most of the time during a period of at least two weeks (these groups are almost the 
same as for schizophrenia (F20.0 - F20.3)):  
(1) Thought echo, thought insertion or withdrawal, thought broadcasting (F20 G1.1a)  
(2) Delusions of control, influence or passivity, clearly referred to body or limb 
movements or specific thoughts, actions or sensations (F20 G1.1b)  
(3) Hallucinatory voices giving a running commentary on the patient's behaviour, or 
discussing him between themselves; or other types of hallucinatory voices coming from 
some part of the body (F20 G1.1c)  
(4) Persistent delusions of other kinds that are culturally inappropriate and completely 
impossible, but not merely grandiose or persecutory (F20 G1.1d), e.g. has visited other 
worlds; can control the clouds by breathing in and out; can communicate with plants or 
animals without speaking, etc.  
(5) Grossly irrelevant or incoherent speech, or frequent use of neologisms (a marked 
form of F20 G1.2f)  
(6) The intermittent but frequent appearance of some forms of catatonic behaviour, 
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such as posturing, waxy flexibility and negativism (F20 G1.2g)  
G3.  Criteria G1 and G2 must be met within the same episode of the disorder, and 
concurrently for at least some time of the episode. Symptoms from both criteria G1 and 
G2 must be prominent in the clinical picture.  
G4.  Most commonly used exclusion criteria: the disorder is not attributable to organic 
brain disease (in the sense of F0), or to psychoactive substance-related intoxication, 
dependence or withdrawal (F1).  
F25.0 Schizoaffective disorder, manic type 
A. The general criteria for schizoaffective disorder (F25) must be met.  
B. Criteria of a manic disorder must be met (F30.1 or F31.1).  
F25.1 Schizoaffective disorder, depressive type  
A. The general criteria schizoaffective disorder (F25) must be met. 
B. The criteria for depressive disorder, at least moderate severity must be met (F32.1, 
F32.2, F31.3 or F31.4).  
F25.2 Schizoaffective disorder, mixed type 
A. The general criteria for schizoaffective disorder (F25) must be met.  
B. The criteria for mixed bipolar affective disorder must be met (F31.6).  
F25.8 Other schizoaffective disorders  
F25.9 Schizoaffective disorder, unspecified 
F28 OTHER NONORGANIC PSYCHOTIC DISORDERS 
Psychotic disorders that do not meet the criteria for schizophrenia (F20.-) or for 
psychotic types of mood [affective] disorders (F30-F39), and psychotic disorders that 
do not meet the symptomatic criteria for persistent delusional disorder (F22.-) should 
be coded here (such as persistent hallucinatory disorder). Include here also 
combinations of symptoms not covered by the previous categories of F20, such as 
delusions other than those listed as typical schizophrenic under F20 G1.1.b or d (i.e. 
other than completely impossible or culturally inappropriate) plus catatonia. 
F29 UNSPECIFIED NONORGANIC PSYCHOSIS 
F30 - F39 MOOD [AFFECTIVE] DISORDERS 
 
F30 MANIC EPISODE 
F30.0 Hypomania 
A. The mood is elevated or irritable to a degree that is definitely abnormal for the 
individual concerned and sustained for at least four consecutive days.  
B. At least three of the following must be present, leading to some interference with 
personal functioning in daily living:  
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(1)  increased activity or physical restlessness;  
(2)  increased talkativeness;  
(3)  difficulty in concentration or distractibility;  
(4)  decreased need for sleep;  
(5)  increased sexual energy;  
(6)  mild spending sprees, or other types of reckless or irresponsible behaviour;  
(7)  increased sociability or over-familiarity.  
C. The episode does not meet the criteria for mania (F30.1 and F30.2), bipolar 
affective disorder (F31.-), depressive episode (F32.-), cyclothymia (F34.0) or anorexia 
nervosa (F50.0). 
D. Most commonly used exclusion criteria: the episode is not attributable to 
psychoactive substance use (F1) or any organic mental disorder, in the sense of F0. 
F30.1 Mania without psychotic symptoms 
A. A mood which is predominantly elevated, expansive or irritable and definitely 
abnormal for the individual concerned. This mood change must be prominent and 
sustained for at least a week (unless it is severe enough to require hospital admission).  
At least three of the following must be present (four if the mood is merely irritable), 
leading to severe interference with personal functioning in daily living:  
(1) Increased activity or physical restlessness;  
(2) Increased talkativeness ('pressure of speech');  
(3) Flight of ideas or the subjective experience of thoughts racing;  
(4) Loss of normal social inhibitions resulting in behaviour which is inappropriate to the 
circumstances;  
(5) Decreased need for sleep;  
(6) Inflated self-esteem or grandiosity;  
(7) Distractibility or constant changes in activity or plans;  
(8) Behaviour which is foolhardy or reckless and whose risks the subject does not 
recognize e.g. spending sprees, foolish enterprises, reckless driving;  
(9) Marked sexual energy or sexual indiscretions.  
C. The absence of hallucinations or delusions, although perceptual disorders may 
occur (e.g. subjective hyperacusis, appreciation of colours as specially vivid, etc.). 
D. Mot commonly used exclusion criteria: the episode is not attributable to 
psychoactive substance use (F1) or any organic mental disorder, in the sense of F0. 
F30.2 Mania with psychotic symptoms 
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A. The episode meets the criteria for mania without psychotic symptoms (F30.1) with 
exception of criterion C.  
B. The episode does not simultaneously meet the criteria for schizophrenia (F20) or 
schizo-affective disorder, manic type (F25.0).  
C.Delusions or hallucinations are present, other than those listed as typical 
schizophrenic in F20 G1.1b, c and d (i.e. delusions other than those that are 
completely impossible or culturally inappropriate and hallucinations, that are not in the 
third person or giving a running commentary). The commonest examples are those 
with grandiose, self-referential, erotic or persecutory content.  
D.Mot commonly used exclusion criteria: the episode is not attributable to psychoactive 
substance use (F1) or any organic mental disorder, in the sense of F0.  
A fifth character may be used to specify whether the hallucinations or delusions are 
congruent or incongruent with the mood: 
F30.20  mania with mood congruent psychotic symptoms (such as grandiose delusions 
or voices telling the subject that he has superhuman powers)  
F30.21  mania with mood incongruent psychotic symptoms (such as voices speaking to 
the subject about affectively neutral topics, or delusions of reference or persecution).  
F30.8 Other manic episodes  
F30.9 Manic episode, unspecified 
F31 BIPOLAR AFFECTIVE DISORDER 
Note: Episodes are demarcated by a switch to an episode of opposite or mixed polarity 
or by a remission. 
F31.0 Bipolar affective disorder, current episode hypomanic 
A. The current episode meets the criteria for hypomania (F30.0).  
B. There has been at least one other affective episode in the past, meeting the criteria 
for hypomanic or manic episode (F30.-), depressive episode (F32.-) or mixed affective 
episode (F38.00).  
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms 
A. The current episode meets the criteria for mania without psychotic symptoms 
(F30.1).  
B. There has been at least one other affective episiode in the past, meeting the criteria 
for hypomanic or manic episode (F30.-), depressive episode (F32.) or mixed affective 
episode (F38.00).  
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms 
A. The current episode meets the criteria for mania with psychotic symptoms (F30.2).  
B. There has been at least one other affective episode in the past, meeting the criteria 




A fifth character may be used to specify whether the psychotic symptoms are 
congruent or incongruent with the mood: 
F31.20 with mood congruent psychotic symptoms  
F31.21 with mood incongruent psychotic symptoms 
F31.3 Bipolar affective disorder, current episode moderate or mild depression 
A. The current episode meets the criteria for a depressive episode of either mild (F32.0) 
or moderate severity (F32.1).  
B. There has been at least one other affective episode in the past, meeting the criteria 
for hypomanic or manic episode (F30.-), or mixed affective episode (F38.00).  
 A fifth character may be used to specify the presence of the somatic syndrome as 
defined in F32, in the current episode of depression: 
F31.30 without somatic syndrome  
F31.31 with somatic syndrome 
F31.4 Bipolar affective disorder, current episode severe depression without psychotic 
symptoms 
A. The current episode meets the criteria for a severe depressive episode without 
psychotic symptoms (F32.2).  
B. There has been at least one well authenticated hypomanic or manic episode (F30.-) 
or mixed affective episode (F38.00) in the past.  
F31.5 Bipolar affective disorder, current episode severe depression with psychotic 
symptoms 
A. The current episode meets the criteria for a severe depressive episode with 
psychotic symptoms (F32.3).  
B. There has been at least one well authenticated hypomanic or manic episode (F30.-) 
or mixed affective episode (F38.00) in the past.  
A fifth character may be used to specify whether the psychotic symptoms are 
congruent or incongruent with the mood. 
F31.50 with mood congruent psychotic symptoms 
F31.51 with mood incongruent psychotic symptoms 
 
F31.6 Bipolar affective disorder, current episode mixed 
A. The current episode is characterized by either a mixture or a rapid alternation (i.e. 
within a few hours) of hypomanic, manic and depressive symptoms.  
B. Both manic and depressive symptoms must be prominent most of the time during a 
period of at least two weeks.  
C.There has been at least one well authenticated hypomanic or manic episode (F30.-), 
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depressive (F32.-) or mixed affective episode (F38.00) in the past.  
F31.7 Bipolar affective disorder, currently in remission 
A. The current state does not meet the criteria for depressive or manic episode in any 
severity, or for any other mood disorder in F3 (possibly because of treatment to reduce 
the risk of future episodes).  
B. There has been at least one well authenticated hypomanic or manic episode (F30.-) 
in the past and in addition at least one other affective episode (hypomanic or manic 
(F30.-), depressive (F32.- ), or mixed (F38.00)). 
F31.8 Other bipolar affective disorders 
F31.9 Bipolar affective disorders, unspecified 
F32 DEPRESSIVE EPISODE 
G1.  The depressive episode should last for at least 2 weeks.  
G2.  There have been no hypomanic or manic symptoms sufficient to meet the criteria 
for hypomanic or manic episode (F30.-) at any time in the individual's life.  
G3.  Most commonly used exclusion clause. The episode is not attributable to 
psychoactive substance use (F10- F19) or to any organic mental disorder (in the sense 
of F00-F09).   
Somatic syndrome  
Some depressive symptoms are widely regarded as having special clinical significance 
and are here called "somatic". (Terms such as biological, vital, melancholic, or 
endogenomorphic are used for this syndrome in other classification.) 
A fifth character (as indicated in F31.3; F32.0 and F32.1; F33.0 and F33.1) may be 
used to specify the presence or absence of the somatic syndrome.  
To qualify for the somatic syndrome, four of the following symptoms should be present 
(1)  marked loss of interest or pleasure in activities that are normally pleasurable;  
(2)  lack of emotional reactions to events or activities that normally produce an 
emotional response;  
(3)  waking in the morning 2 hours or more before the usual time;  
(4)  depression worse in the morning;  
(5)  objective evidence of marked psychomotor retardation or agitation (remarked on or 
reported by other  people);  
(6)  marked loss of appetite;  
(7)  weight loss (5% or more of body weight in the past month);  
(8)  marked loss of libido.  
F32.0 Mild depressive episode 
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A. The general criteria for depressive episode (F32) must be met.  
B. At least two of the following three symptoms must be present:  
(1) depressed mood to a degree that is definitely abnormal for the individual, present 
for most of the day and almost every day, largely uninfluenced by circumstances, and 
sustained for at least 2 weeks.  
(2) loss of interest or pleasure in activities that are normally pleasurable;  
(3) decreased energy or increased fatiguability.  
C. An additional symptom or symptoms from the following list should be present, to 
give a total of at least four: 
(1) loss of confidence and self-esteem;  
(2) unreasonable feelings of self-reproach or excessive and inappropriate guilt;  
(3) recurrent thoughts of death or suicide, or any suicidal behaviour;  
(4) complaints or evidence of diminished ability to think or concentrate, such as 
indecisiveness or vacillation;  
(5) change in psychomotor activity, with agitation or retardation (either subjective or 
objective);  
(6) sleep disturbance of any type;  
(7) change in appetite (decrease or increase) with corresponding weight change). 
A fifth character may be used to specify the presence or absence of the "somatic 
syndrome" (defined on page xx): 
F32.00 Without somatic syndrome  
F32.01 With somatic syndrome 
F32.1 Moderate depressive episode 
A. The general criteria for depressive episode (F32) must be met.  
B. At least two of the three symptoms listed for F32.0, criterion B, must be present.  
C.Additional symptoms from F32.0, criterion C, must be present, to give a total of at 
least six .  
A fifth character may be used to specify the presence or absence of the "somatic 
syndrome" as defined on page xx: 
F32.10  Without somatic syndrome  
F32.11  With somatic syndrome  
F32.2 Severe depressive episode without psychotic symptoms 
Note: If important symptoms such as agitation or retardation are marked, the patient 
may be unwilling or unable to describe many symptoms in detail. An overall grading of 
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severe episode may still be justified in such a case. 
A. The general criteria for depressive episode (F32) must be met.  
B. All three of the symptoms in criterion B, F32.0, must be present.  
C.Additional symptoms from F32.0, criterion C, must be present, to give a total of at 
least eight.  
D.There must be no hallucinations, delusions, or depressive stupor.  
F32.3 Severe depressive episode with psychotic symptoms 
A. The general criteria for depressive episode (F32) must be met.  
B. The criteria for severe depressive episode without psychotic symptoms (F32.2) must 
be met with the exception of criterion D.  
C.The criteria for schizophrenia (F20.-) or schizoaffective disorder, depressive type 
(F25.1) are not met.  
D.Either of the following must be present:  
(1) delusions or hallucinations, other than those listed as typically schizophrenic in F20, 
criterion G1(1)b, c, and d (i.e. delusions other than those that completely impossible or 
culturally inappropriate and hallucinations that are not in the third person or giving a 
running commentary); the commonest examples are those with depressive, guilty, 
hypochondriacal, nihilistic, self-referential, or persecutory content; 
(2) depressive stupor. 
A fifth character may be used to specify whether the psychotic symptoms are 
congruent or incongruent with mood: 
F32.30 With mood-congruent psychotic symptoms (i.e. delusions of guilt, 
worthlessness, bodily disease, or impending disaster, derisive or condemnatory 
auditory hallucinations) 
F32.31 With mood-incongruent psychotic symptoms (i.e. persecutory or self-referential 
delusions and hallucinations without an affective content) 
F32.8 Other depressive episodes 
Episodes should be included here which do not fit the descriptions given for depressive 
episodes in F32.0-F32.3, but for which the overall diagnostic impression indicates that 
they are depressive in nature. Examples include fluctuating mixtures of depressive 
symptoms (particularly those of the somatic syndrome) with non- diagnostic symptoms 
such as tension, worry, and distress, and mixtures of somatic depressive symptoms 
with persistent pain or fatigue not due to organic causes (as sometimes seen in 
general hospital services). 
 
F32.9 Depressive episode, unspecified 
 
F33 Recurrent depressive disorder 
G1.  There has been at least one previous episode, mild (F32.0), moderate (F32.1), or 
194 
 
severe (F32.2 or F32.3), lasting a minimum of 2 weeks and separated from the current 
episode by at least 2 months free from any significant mood symptoms.  
G2.  At no time in the past has there been an episode meeting the criteria for 
hypomanic or manic episode (F30.-). 
G3. Most commonly used exclusion criteria: the episode is not attibutable to 
psychoactive substance use (F1) or any organic mental disorder, in the sense of F0. 
It is recommended to specify the predominant type of previous episodes (mild, 
moderate, severe, uncertain). 
F33.0 Recurrent depressive disorder, current episode mild 
A. The general criteria for recurrent depressive disorder (F33) are met.  
B. The current episode meets the criteria for depressive episode, mild severity (F32.0). 
 A fifth character may be used to specify the presence of the somatic syndrome, as 
defined in F32, in the  
current episode: 
F33.00 without somatic syndrome  
F33.01 with somatic syndrome 
 F33.1 Recurrent depressive disorder, current episode moderate 
A. The general criteria for recurrent depressive disorders (F33) are met.  
B. The current episode meets the criteria for depressive episode, moderate severity 
(F32.1).   
A fifth character may be used to specify the presence of the somatic syndrome, as 
defined in F32, in the current episode: 
F33.10 without somatic syndrome 
F33.11 with somatic syndrome 
F33.2 Recurrent depressive disorder, current episode severe without psychotic 
symptoms 
A. The general criteria for recurrent depressive disorders (F33) are met.  
B. The current episode meets the criteria for severe depressive episode without 
psychotic symptoms (F32.2).  
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms 
A. The general criteria for recurrent depressive disorders (F33) are met.  
B. The current episode meets the criteria for severe depressive episode with psychotic 
symptoms (F32.3).   
A fifth character may be used to specify whether the psychotic symptoms are 
congruent or incongruent with the mood: 
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F33.30 with mood congruent psychotic symptoms  
F33.31 with mood incongruent psychotic symptoms 
F33.4 Recurrent depressive disorder, currently in remission 
A. The general criteria for recurrent depressive disorder (F33) have been met in the 
past. 
B. The current state does not meet the criteria for a depressive episode (F32.-) of any 
severity, or for any other disorder in F3 (the patient may receive treatment to reduce 
the risk of further episodes). 
 
F33.8 Other recurrent depressive disorders 
 

































Palermo population aged 18-65 years and split by age-bands, 
gender and migrant status  
 
Ageband  Gender Migration  
Palermo 
Population  
Denominator x 3 
years  
18-24 female migrant 686 2058 
25-29 female migrant 1007 3021 
30-34 female migrant 1277 3831 
35-39 female migrant 1151 3453 
40-44 female migrant 1137 3411 
45-49 female migrant 1001 3003 
50-54 female migrant 693 2079 
55-59 female migrant 383 1149 
60-65 female migrant 207 621 
18-24 male migrant 793 2379 
25-29 male migrant 1011 3033 
30-34 male migrant 1462 4386 
35-39 male migrant 1313 3939 
40-44 male migrant 1119 3357 
45-49 male migrant 878 2634 
50-54 male migrant 602 1806 
55-59 male migrant 287 861 
60-65 male migrant 135 405 
18-24 female native 29717 89151 
25-29 female native 18992 56976 
30-34 female native 20256 60768 
35-39 female native 23062 69186 
40-44 female native 24403 73209 
45-49 female native 25564 76692 
50-54 female native 23920 71760 
55-59 female native 22466 67398 
60-65 female native 26157 78471 
18-24 male native 27999 83997 
25-29 male native 19775 59325 
30-34 male native 18462 58386 
35-39 male native 21690 65070 
40-44 male native 22296 66888 
45-49 male native 22869 68607 
50-54 male native 21011 63033 
55-59 male native 19980 59940 
60-65 male native 23152 69456 
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Psychosis Screening Questionnaire  
  
217 
 
  
 
 
 
 
 
